e10vk
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, DC
20549
Form 10-K
|
|
|
(Mark One)
|
|
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the fiscal
year ended December 31,
2010
|
OR
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
Commission File Number: 001-33155
IPG PHOTONICS
CORPORATION
(Exact name of registrant as
specified in its charter)
|
|
|
Delaware
|
|
04-3444218
|
(State or other jurisdiction
of
incorporation or organization)
|
|
(IRS Employer
Identification No.)
|
50 Old Webster Road, Oxford, Massachusetts
(Address of principal
executive offices)
|
|
01540
(Zip
Code)
|
Registrants telephone number, including area code:
(508) 373-1100
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
Title of Class
|
|
Name of Exchange on Which Registered
|
|
Common Stock, Par Value $0.0001 per share
|
|
The NASDAQ Stock Market LLC
|
Securities registered pursuant to Section 12(g) of the
Act: None
Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities
Act. Yes o No þ
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or Section 15(d) of the
Act. Yes o No þ
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been
subject to such filing requirements for the past
90 days. Yes þ No o
Indicate by check mark whether the registrant has submitted
electronically and posted on its corporate Web site, if any,
every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of
Regulation S-T
(§ 232.405 of this chapter) during the preceding
12 months (or for such shorter period that the registrant
was required to submit and post such
files). Yes o No o
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of
Regulation S-K
is not contained herein, and will not be contained, to the best
of registrants knowledge, in definitive proxy or
information statements incorporated by reference in
Part III of this
Form 10-K
or any amendment to this
Form 10-K. o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated
filer and smaller reporting company in Rule
12b-2 of the
Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer o
|
|
Accelerated filer þ
|
|
Non-accelerated filer o
|
|
Smaller reporting company o
|
|
|
(Do not check if a smaller reporting company)
|
Indicate by check mark whether the registrant is a shell company
(as defined in
Rule 12b-2
of the
Act). Yes o No þ
As of June 30, 2010, the aggregate market value of the
registrants common stock held by non-affiliates of the
registrant was approximately $384 million, calculated based
upon the closing price of our common stock of $15.23 per share
as reported by the Nasdaq Global Market on June 30, 2010.
As of March 8, 2011, 47,215,469 shares of the
registrants common stock were outstanding.
DOCUMENTS
INCORPORATED BY REFERENCE
Portions of the registrants Proxy Statement for its 2010
Annual Meeting of Stockholders to be filed pursuant to
Regulation 14A within 120 days of the end of the
registrants fiscal year ended December 31, 2009 are
incorporated by reference into Part III of this Annual
Report on
Form 10-K.
This Annual Report on
Form 10-K
contains certain forward-looking statements within the meaning
of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, and we
intend that such forward-looking statements be subject to the
safe harbors created thereby. For this purpose, any statements
contained in this Annual Report on
Form 10-K
except for historical information are forward-looking
statements. Without limiting the generality of the foregoing,
words such as may, will,
expect, believe, anticipate,
intend, could, estimate, or
continue or the negative or other variations thereof
or comparable terminology are intended to identify
forward-looking statements. In addition, any statements that
refer to projections of our future financial performance, trends
in our businesses, or other characterizations of future events
or circumstances are forward-looking statements.
The forward-looking statements included herein are based on
current expectations of our management based on available
information and involve a number of risks and uncertainties, all
of which are difficult or impossible to accurately predict and
many of which are beyond our control. As such, our actual
results may differ significantly from those expressed in any
forward-looking statements. Factors that may cause or contribute
to such differences include, but are not limited to, those
discussed in more detail in Item 1 (Business) and
Item 1A (Risk Factors) of Part I and Item 7
(Managements Discussion and Analysis of Financial
Condition and Results of Operations) of Part II of this
Annual Report on
Form 10-K.
Readers should carefully review these risks, as well as the
additional risks described in other documents we file from time
to time with the Securities and Exchange Commission (the
SEC). In light of the significant risks and
uncertainties inherent in the forward-looking information
included herein, the inclusion of such information should not be
regarded as a representation by us or any other person that such
results will be achieved, and readers are cautioned not to rely
on such forward-looking information. We undertake no obligation
to revise the forward-looking statements contained herein to
reflect events or circumstances after the date hereof or to
reflect the occurrence of unanticipated events.
PART I
Our
Company
IPG Photonics Corporation (IPG, the
Company, the Registrant, we,
us or our) was incorporated in Delaware
in 1998. We are the leading developer and manufacturer of a
broad line of high-performance fiber lasers for diverse
applications in numerous markets. Fiber lasers are a new
generation of lasers that combine the advantages of
semiconductor diodes, such as long life and high efficiency,
with the high amplification and precise beam qualities of
specialty optical fibers to deliver superior performance,
reliability and usability.
Our diverse lines of low, mid and high-power lasers and
amplifiers are used in materials processing, advanced,
communications and medical applications. We sell our products
globally to original equipment manufacturers, or original
equipment manufacturers (OEMs), system integrators
and end users. We market our products internationally primarily
through our direct sales force and also through agreements with
independent sales representatives and distributors. We have
sales offices in the United States, Germany, Italy, the United
Kingdom, France, Japan, China, South Korea, Singapore, India and
Russia.
We are vertically integrated. We design and manufacture most key
components used in our finished products, including
semiconductor diodes, optical fiber preforms and cables,
finished fiber lasers and amplifiers. We also manufacture
certain complementary products used with our lasers including
optical heads, beam splitters and chillers. Our vertically
integrated operations allow us to reduce manufacturing costs,
ensure access to critical components, rapidly develop and
integrate advanced products and protect our proprietary
technology.
Industry
Background
Conventional
Laser Technologies
Since the laser was invented over 50 years ago, laser
technology has revolutionized a broad range of applications and
products in various industries, including automotive, medical,
research, consumer products,
2
electronics, semiconductors and communications. Lasers provide
flexible, non-contact and high-speed ways to process and treat
various materials. They are widely used to transmit large
volumes of data in optical communications systems, in various
medical applications and in test and measurement systems. For a
wide variety of applications, lasers provide superior
performance and a more cost-effective solution than non-laser
technologies.
Lasers emit an intense light beam that can be focused on a small
area, causing metals and other materials to melt, vaporize or
change their character. These properties are utilized in
applications requiring very high-power densities, such as
marking, printing, welding, cutting, drilling, cladding and
other materials processing procedures. Lasers are well-suited
for imaging and inspection applications, and the ability to
confine laser light to narrow wavelengths makes them
particularly effective in medical and sensing applications. A
laser works by converting electrical energy to optical energy.
In a laser, an energy source excites or pumps a lasing medium,
which converts the energy from the source into an emission
consisting of particles of light, called photons, at a
particular wavelength. Lasers are used as an energy or light
source for various applications. They are also incorporated into
manufacturing, medical and other systems by OEMs, system
integrators and end users.
Historically,
CO2
gas lasers and crystal lasers have been the two principal laser
types used in materials processing and many other applications.
They are named for the materials used to create the lasing
action. A
CO2
laser produces light by electrically stimulating a gas-filled
tube. A crystal laser uses an arc lamp, pulsed flash lamp, or
diode stack or array to optically pump a special crystal. The
most common crystal lasers use yttrium aluminum garnet (YAG)
crystals infused with neodymium or ytterbium.
Introduction
of Fiber Lasers
Fiber lasers use semiconductor diodes as the light source to
pump specialty optical fibers, which are infused with rare earth
ions. These fibers are called active fibers and are comparable
in diameter to a human hair. The laser emission is created
within optical fibers and delivered through a flexible optical
fiber cable. As a result of their different design and
components, fiber lasers are more reliable, efficient, robust
and portable, and easier to operate than conventional lasers. In
addition, fiber lasers free the end users from fine mechanical
adjustments and the high maintenance costs that are typical for
conventional lasers.
Although low-power fiber lasers have existed for approximately
four decades, their increased recent adoption has been driven
primarily by our improvements in their performance, increases in
output power levels and decreased costs including technological
improvements in optical components such as active fibers that
have increased their power capacities and improved their
performance. Fiber lasers now offer output powers that exceed
those of conventional lasers in many categories. Also,
semiconductor diodes historically have represented the majority
of the cost of fiber lasers. The high cost of diodes meant that
fiber lasers could not compete with conventional lasers on price
and limited their use to high value-added applications. Over the
last several years, however, our semiconductor diodes have
become more affordable and reliable due, in part, to substantial
advancements in semiconductor diode technology and increased
production volumes. As a result, the average cost per watt of
output power has decreased dramatically over the last decade.
Because of these improvements, our fiber lasers can now
effectively compete with conventional lasers over a wide range
of output powers and applications. As a pioneer in the
development and commercialization of fiber lasers, we have
contributed to many advancements in fiber laser technology and
products.
Advantages
of Fiber Lasers over Conventional Lasers
We believe that fiber lasers provide a combination of benefits
that include:
|
|
|
|
|
Superior Performance. Fiber lasers provide
high beam quality over the entire power range. In most
conventional laser solutions, the beam quality is sensitive to
output power, while in fiber lasers, the output beam is
virtually non-divergent over a wide power range, meaning the
beam can be focused to achieve high levels of precision,
increased power densities and greater distances over which
processing can be completed. The superior beam quality and
greater intensity of a fiber lasers beam allow tasks to be
accomplished rapidly and with lower-power units than comparable
conventional lasers.
|
3
|
|
|
|
|
Lower Cost. Fiber lasers offer strong value to
customers because of their generally lower total cost of
ownership due to their lower required maintenance costs, high
reliability and energy efficiency. The initial purchase price
for fiber lasers is generally below that of YAG lasers and
comparable to that of conventional
CO2
lasers. Fiber lasers convert electrical energy to optical energy
approximately 2 to 3 times more efficiently than diode-pumped
YAG lasers, approximately 3 times more efficiently than
conventional
CO2
lasers and approximately 15 to 30 times more efficiently than
lamp-pumped YAG lasers. Because fiber lasers are much more
energy-efficient and place lower levels of thermal stress on
their internal components, they have substantially lower cooling
requirements compared to those of conventional lasers and lower
or no maintenance costs.
|
|
|
|
Ease of Use. Many features of fiber lasers
make them easier to operate, maintain and integrate into
laser-based systems as compared to conventional lasers.
|
|
|
|
Compact Size and Portability. Fiber lasers are
typically smaller and lighter in weight than conventional
lasers, saving valuable floor space. While conventional lasers
are delicate due to the precise alignment of mirrors, fiber
lasers are more durable and able to perform in variable
environments.
|
|
|
|
Choice of Wavelengths and Precise Control of
Beam. The design of fiber lasers generally
provides a broad range of wavelength choices, allowing users to
select the precise wavelength that best matches their
application and materials.
|
Fiber amplifiers are similar in design to fiber lasers, use many
of the same components, such as semiconductor diodes and
specialty optical fibers, and provide many of the same
advantages in the applications that require amplification.
Notwithstanding the benefits offered by fiber lasers, there
remain applications and processes where conventional laser
technologies may provide superior performance with respect to
particular features. For example, crystal lasers can provide
higher peak power pulses and fiber lasers do not generate the
deep ultraviolet light that is used for photolithography in many
semiconductor applications. In addition,
CO2
lasers operate at wavelengths that are optimal for use on many
non-metallic materials, including plastics.
Our
Competitive Strengths
We believe that our key strengths and competitive advantages
include the following:
Differentiated Proprietary Technology
Platform. At the core of our products is our
proprietary pumping technology platform that allows our products
to have higher output powers and superior beam quality than are
achievable through other techniques. Our technology platform is
modular, scalable, robust and electrically efficient.
Leading Market Position. As a pioneer and
technology leader in fiber lasers, we have built leading
positions in our various end markets with a large and diverse
customer base. Based on our leadership positions, we are driving
the proliferation of fiber lasers in existing and new
applications.
Breadth and Depth of Expertise. Since the
founding of our company in 1990, our core business has been
developing, designing, manufacturing and marketing advanced
fiber lasers and amplifiers. We have extensive know-how in
materials sciences, which enables us to make our specialty
optical fibers, semiconductor diodes and other critical
components.
Vertically Integrated Development and
Manufacturing. We develop and manufacture all of
our key high-volume specialty components, including
semiconductor diodes, active fibers, passive fibers and
specialty optical components. Our proprietary components are
capable of handling the stress of the high optical powers from
our products and we believe many of them exceed the performance
of commercially available components. We believe that our
vertical integration and our high-volume production enhances our
ability to meet customer requirements, accelerate development,
manage costs, improve component yields and protect our
intellectual property, while maintaining high performance and
quality standards.
4
Diverse Customer Base, End Markets and
Applications. Our diverse customer base, end
markets and applications provide us with many growth
opportunities. Our products are used in a variety of
applications and end markets worldwide. Our principal end
markets and representative applications within those markets
include:
|
|
|
|
|
|
|
|
|
|
Materials Processing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Marking, engraving and
printing
|
|
|
General manufacturing
|
|
Welding, hybrid welding and
cutting
|
|
|
|
|
Prototyping, cladding and
stripping
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
High-strength steel cutting
and welding
|
|
|
Automotive
|
|
Welding tailored metal
blanks, frames, seats and transmissions
|
|
|
|
|
Cutting frames, sheets and
plastic bumpers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hardening and welding pipes
in nuclear, wind turbine and pipeline industries
|
|
|
Heavy industry
|
|
Welding and cutting thick
plates for ships and rail cars
|
|
|
|
|
Drilling concrete and rock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Welding titanium air frames
|
|
|
Aerospace
|
|
Cladding parts
|
|
|
|
|
Percussion drilling of parts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Electronics and credit card
marking
|
|
|
Consumer
|
|
Diamond marking and cutting
|
|
|
|
|
Welding razor blades and
batteries
|
|
|
|
|
Stent and pacemaker
manufacturing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Computer disk manufacturing
and texturing
|
|
|
Semiconductor and
electronics
|
|
Photovoltaic manufacturing
|
|
|
|
|
Memory repair and trim
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Directed energy
|
Advanced Applications
|
|
Obstacle warning and light
detecting and ranging
|
|
|
|
|
Materials destruction testing
|
|
|
|
|
Research, sensing and
instrumentation
|
|
|
|
|
|
|
|
|
|
|
|
|
Broadband fiber
to premises
|
Communications
|
|
Broadband cable
video signal transport
|
|
|
|
|
Metro and long-haul
wire-line DWDM transport
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Skin rejuvenation and
wrinkle removal
|
Medical
|
|
General surgery and urology
|
|
|
|
|
Dental
|
|
|
|
|
Fat removal
|
|
|
|
|
|
|
|
|
|
|
Broad Product Portfolio and Ability to Meet Customer
Requirements. We offer a broad range of standard
and custom fiber lasers and amplifiers that operate between 0.5
and 2 microns. Our vertically integrated manufacturing and broad
technology expertise enable us to design, prototype and commence
high-volume production of our products rapidly, allowing our
customers to meet their
time-to-market
requirements.
5
Our
Strategy
Our objective is to maintain and extend our leadership position
by pursuing the following key elements of our strategy:
Leverage Our Technology to Gain Market
Share. As fiber lasers become more widely
accepted, we plan to continue to leverage our brand and position
as the leader in developing and commercializing fiber lasers to
increase our position in the broader market. Our lasers continue
to displace conventional lasers in numerous low and mid-power
materials processing applications, such as marking, engraving,
printing and sintering. Our high-power lasers also have been
penetrating several applications that use conventional lasers,
such as welding, cutting and cladding of metal parts.
Target New Applications for Lasers. We intend
to continue to enable and penetrate additional applications
where lasers have not traditionally been used. We believe that
fiber laser technology can overcome many of the limitations that
have hindered the adoption of conventional lasers. We target
applications where higher power, portability, efficiency, size
and flexible fiber cable delivery can lead customers to adopt
fiber lasers instead of non-laser solutions. Examples of such
targeted new applications include solar cell processing and
hybrid and robotic spot welding.
Expand Our Product Portfolio. We continue to
invest in research and development to add additional
wavelengths, power levels and other parameters while also
improving beam quality. In 2010, we: (i) acquired welding
tool technology that integrates seamlessly with our fiber laser,
enabling IPG to provide turnkey robotic laser welding solutions
for automotive and other materials processing applications;
(ii) acquired a producer of active and passive laser
materials and middle-infrared lasers for scientific, biomedical
and technological applications; (iii) introduced new
quasi-pulsed CW lasers and green pulsed lasers; and
(iv) introduced a retro-fit service that allows customers
to replace YAG and
CO2
lasers with fiber laser sources in their existing laser systems.
Optimize Our Manufacturing Capabilities. We
plan to seek further increases in the automation of our
component manufacturing processes and device assembly to improve
component yields and increase the power outputs and capacities
of the various components that we make. We intend to leverage
our technology and operations expertise to manufacture
additional components in order to reduce costs, ensure component
quality and ensure supply. In 2010, we redesigned the
electronics of certain of our low and mid-power products to
simplify manufacturing, improve quality and decrease costs. In
addition, we expanded production of our lower cost internally
developed optical delivery systems. These initiatives, in
addition to optimizing our manufacturing capabilities and
maintaining efficient labor costs, are intended to improve
margins.
Expand Global Reach to Attract Customers
Worldwide. In 2010, almost 80% of our sales came
from international customers. Last year, we opened application
and development centers in Italy and South Korea and we expanded
our sales office and application development center in Chubu,
Japan. We intend to capitalize on and grow our global customer
base by opening new application development centers as well as
sales and service offices in Russia, Asia, Europe and South
America.
Products
We design and manufacture a broad range of high-performance
optical fiber-based lasers and amplifiers. We also make packaged
diodes, direct diode laser systems and communications systems
that utilize our optical fiber-based products. Many of our
products are designed to be used as general purpose energy or
light sources, making them useful in diverse applications and
markets.
Our products are based on a common proprietary technology
platform using many of the same core components, such as
semiconductor diodes and specialty fibers, which we configure to
our customers specifications. Our engineers and scientists
work closely with OEMs and end users to develop and customize
our products for their needs. Because of our flexible and
modular product architecture, we offer products in different
configurations according to the desired application, including
modules, rack-mounted units and tabletop units. Our engineers
and other technical experts work directly with the customer in
our application
6
and development centers to develop and configure the optimal
solution for each customers manufacturing requirements. We
also make complementary products and components that are used
with our ultra-high power products, such as fiber couplers, beam
switches, optical beam delivery cables and chillers. In
addition, we make laser marking and welding systems for certain
applications and geographic markets. .
Lasers
Our laser products include low (1 to 99 watts), medium (100 to
999 watts) and high (1,000 watts and above) output power lasers
from 0.5 to 2 microns in wavelength. These lasers either may be
continuous wave (CW) or may be modulated at different rates. We
offer several different types of lasers, which are defined by
the type of gain medium they use. These are ytterbium, erbium,
thulium and Raman. We also sell fiber pigtailed packaged diodes
and fiber coupled direct diode laser systems that use
semiconductor diodes rather than optical fibers as their gain
medium. In addition, we offer high-energy pulsed lasers,
multi-wavelength lasers, tunable lasers, single-polarization and
single-frequency lasers, as well as other versions of our
products.
We believe that we produce the highest power solid-state lasers
in the industry. Our ytterbium fiber lasers reach power levels
up of to 50,000 watts. We also make single-mode output ytterbium
fiber lasers with power levels of up to 10,000 watts and
single-mode output erbium and thulium fiber lasers with power
levels of up to 400 watts. Our compact, durable design and
integrated fiber optic beam delivery allows us to offer
versatile laser energy sources and simple laser integration for
complex production processes without compromising quality, speed
or power.
We also sell laser diode chips and packaged laser diodes
operating at 9XX nanometers. Recently, we started to sell our
own family of high power optical fiber delivery cables, fiber
couplers, beam switches, chillers and other accessories for our
fiber lasers.
IPG introduced a retrofit service which replaces
CO2
and YAG lasers sources with fiber lasers in the many welding,
cutting, drilling and other systems allowing customers to retain
their existing laser systems. IPG is also developing systems
capabilities for special customer projects and for certain
international markets. IPG makes a welding seam stepper and
picker, which is an automated welding tool, that integrate with
our fiber lasers. The seam stepper and picker can be used in
automotive assembly, sheet metal production and other materials
processing applications. IPG also makes active and passive laser
materials and tunable lasers in the middle-infrared region.
Amplifiers
Our amplifier products range from milliwatts to up to 1,500
watts of output power from 1 to 2 microns in wavelength. We
offer erbium-doped fiber amplifiers, commonly called EDFAs,
Raman amplifiers and integrated communications systems that
incorporate our amplifiers. These products are predominantly
deployed in broadband networks such as fiber to the home (FTTH),
fiber to the curb (FTTC) and passive optical networks (PON), and
dense wavelength division multiplexing, or DWDM, networks. We
also offer ytterbium and thulium specialty fiber amplifiers and
broadband light sources that are used in advanced applications.
In addition, we sell single-frequency, linearly polarized and
polarization-maintaining versions of our amplifier products. As
with our fiber lasers, our fiber amplifiers offer some of the
highest output power levels and highest number of optical
outputs in the industry. We believe our line of fiber amplifiers
offers the best commercially available output power and
performance.
7
The following summarizes some of our product offerings by
product family, primary markets and representative applications
for each product family:
|
|
|
|
|
|
|
Product Family
|
|
|
Primary Markets
|
|
|
Representative
Applications
|
Lasers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short Pulse Ytterbium
Fiber Lasers
|
|
|
Manufacturing
Semiconductor
Solar
Display Panels
Microelectronics
Jewelry
|
|
|
Marking
and engraving
Coating
removal
Cutting
Diamond
marking
Scribing
|
|
|
|
|
|
|
|
Multi-Mode Output
Ytterbium Fiber Lasers
|
|
|
Automobiles
Shipbuilding
Aerospace
Heavy Industry
Construction
Defense
|
|
|
Welding
of automotive tailored blanks and transmissions
Remote
welding of automotive frames, doors and seats
Cutting
of hydro-formed automotive frames
Cladding
of blades and drill bits
|
|
|
|
|
|
|
Materials
destruction testing
|
|
|
|
|
|
|
Plate
welding and cutting
|
|
|
|
|
|
|
|
Single-Mode Output Ytterbium Fiber Lasers
|
|
|
Manufacturing
Printing
Consumer
Medical Devices
Microelectronics
Defense
|
|
|
Engraving
of printing rolls and plates
Stent
cutting
Welding
Ceramic
scribing
Optical
trapping of cells
Cutting
|
|
|
|
|
|
|
|
Long Pulse Ytterbium Fiber Lasers
|
|
|
Manufacturing
Aerospace
Medical
|
|
|
Welding
Drilling
Medical
device welding
|
|
|
|
|
|
|
|
Diode Lasers
|
|
|
Manufacturing
Computers
Aerospace
Medical
Defense
|
|
|
Welding
and bending of disk drive flexure
Plastic
welding
Urology
and dental
Optical
pumping
|
|
|
|
|
|
|
|
Erbium Fiber Lasers
|
|
|
Medical
Manufacturing
Aerospace
Rapid Prototyping
Scientific Research
Communications
|
|
|
Skin
rejuvenation and stretch mark removal
Pumping
of crystal lasers
Photonic
Doppler velocimetry
Interferometry
Remote
sensing
Non-wireline
communications
|
|
|
|
|
|
|
|
Tunable, Ytterbium,
Erbium and
Thulium Fiber Lasers
|
|
|
Scientific Research
Medical
Instrumentation
|
|
|
Spectroscopy
Optical
fiber and component characterization
Component
stress-testing
Diagnostic
equipment
|
|
|
|
|
|
|
|
Pulsed Erbium Fiber
Lasers
|
|
|
Aerospace
Manufacturing
Scientific Research
|
|
|
Obstacle
detection
LIDAR
and 3-D mapping
Atmospheric
and remote sensing
|
|
|
|
|
|
|
|
Thulium Fiber Lasers
|
|
|
Aerospace
Manufacturing
Scientific Research
Medical
|
|
|
Optical
pumping of lasers
Pollution
sensing
Medical
treatments
Micromachining
of plastics
|
|
|
|
|
|
|
|
Raman Fiber Lasers
|
|
|
Communications
Scientific Research
|
|
|
Distributed
Raman amplification
Remote
amplifier pumping
Optical
pumping of lasers
|
|
|
|
|
|
|
|
Picosecond Pulsed Lasers
|
|
|
Scientific Research
Manufacturing
|
|
|
Hole
drilling
Memory
repair
|
|
|
|
|
|
|
|
Green Fiber Lasers
|
|
|
Semiconductor
Consumer
Medical
|
|
|
LCD
display processing
Scribing
Marking
|
|
|
|
|
|
|
|
8
|
|
|
|
|
|
|
Product Family
|
|
|
Primary Markets
|
|
|
Representative
Applications
|
Amplifiers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Erbium Fiber Amplifiers
|
|
|
Broadband Access
Cable TV
DWDM
Instrumentation
Scientific Research
|
|
|
Telephony,
video on demand and high-speed internet
Ultra-long-haul
transmission
Non-wireline
optical communications
Coherent
and spectral beam combining
High-power
component testing
|
|
|
|
|
|
|
|
Raman Fiber Amplifiers
|
|
|
DWDM
Instrumentation
Scientific Research
|
|
|
Distributed
Raman amplification
Remote
amplifier pumping
|
|
|
|
|
|
|
Repeaterless
submarine systems
WDM
Raman amplifiers
|
|
|
|
|
|
|
|
Communications Systems
|
|
|
DWDM
|
|
|
200Km
to 400Km long-span transmissions
2.5
and 10 gbit/second transmissions
|
|
|
|
|
|
|
|
Ytterbium Fiber Amplifiers
|
|
|
Scientific Research
Life Sciences
|
|
|
Coherent
and spectral beam combining
Detection
and sensing systems
Non-linear
frequency conversion
|
|
|
|
|
|
|
|
Materials
Processing
The most significant materials processing applications for fiber
lasers are marking, printing, welding and cutting. Other
applications include micromachining, surface treatment,
drilling, soldering, annealing, rapid prototyping and
laser-assisted machining.
Marking, Engraving and Printing
Applications. With the increasing need for source
traceability, component identification and product tracking as a
means of reducing product liability and preventing
falsification, as well as the demand for modern robotic
production systems, industrial manufacturers are increasingly
demanding marking systems capable of applying serialized
alphanumeric, graphic or bar code identifications directly onto
their manufactured components. Laser engraving is similar to
marking but forms deeper grooves in the material. In contrast to
conventional acid etching and ink-based technologies, lasers can
mark a wide variety of metal and non-metal materials, such as
ceramic, glass and plastic surfaces, at high speeds and without
contact by changing the surface structure of the material or by
engraving. Laser marking systems can be easily integrated into a
customers production process and do not subject the item
being marked to mechanical stress.
In the semiconductor industry, lasers typically are used to mark
wafers and integrated circuits. In the electronics industry,
lasers typically are used to mark electrical components such as
contactors and relays, printed circuit boards and keyboards.
With the increase in marking speed in the past few years, the
cost of laser marking has decreased. In the photovoltaic (solar
panel) industry, pulsed lasers increasingly are used to remove
materials and to scribe (cut) solar cells. The high beam
quality, increased peak output powers, flexible fiber delivery
and competitive price of fiber lasers have accelerated the
adoption of fiber lasers in these low-power applications.
Historically, the printing industry has depended upon
silver-halide films and chemicals to engrave printing plates.
This chemical engraving process requires several time-consuming
steps. In recent years, we have worked closely with OEMs in the
printing industry to employ fiber lasers for alternative
computer-to-plate,
or CTP, processes. As a result, our ytterbium fiber lasers are
now widely used for CTP printing, an environmentally friendly
process that saves production time by writing directly to plates
and greatly reduces chemical waste.
Welding Applications. Laser welding offers
several important advantages over conventional welding
technology as it is non-contact, easy to automate, provides high
process speed and results in narrow-seamed, high quality welds
that generally require little or no post-processing machining.
Parts can be accurately machined before welding because laser
welding does not overly heat or otherwise damage or distort the
material being processed. The high beam quality of our fiber
lasers coupled with high CW power offers deep
9
penetration welding as well as shallow conduction mode welding.
High modulation frequencies offer very high throughput in pulsed
applications. In addition, fiber lasers can be focused to a
small spot with extremely long focal lengths, enabling remote
welding on the fly, a flexible method of
three-dimensional welding in which the laser beam is positioned
by a robot-guided scanner. Such remote welding stations equipped
with fiber lasers are used for welding door panels and the
multiple welding of spot and lap welds over the entire auto body
frame. Typically, mid to high-power ytterbium fiber lasers and
long pulse quasi-continuous wave ytterbium fiber lasers are used
in welding applications.
Cutting Applications. Laser-based cutting
technology has several advantages compared to alternative
technologies. Laser cutting is fast, flexible, and highly
precise and can be used to cut complex contours on flat, tubular
or three-dimensional materials. The laser source can be
programmed to process many different kinds of materials such as
steel, aluminum, brass, copper, glass, ceramic and plastic at
various thicknesses. Laser cutting technology is a non-contact
process that is easy to integrate into an automated production
line and is not subject to wear of the cutting medium. We sell
low, mid and high-power ytterbium fiber lasers for laser
cutting. The operating wavelength, high beam quality, wide
operating power range, power stability and small spot size are
some of the qualities offered by fiber lasers for most cutting
applications.
Advanced
Applications
Our fiber lasers and amplifiers are utilized by commercial firms
and by academic and government institutions worldwide for
manufacturing of commercial systems and for research in advanced
technologies and products. These markets may use specialty
products developed by us or commercial versions of our products.
Directed Energy. Our high-power fiber lasers
and amplifiers have been used in variety of demonstrations.
Obstacle Warning and Mapping. Our products are
used aboard aircraft for obstacle warning and
3-dimensional
mapping of earth surfaces.
Special Projects. Due to the high power,
compactness, performance, portability, ruggedness and electrical
efficiency of our fiber lasers and amplifiers, we sell our
commercial products for government research and projects. These
include materials testing, ordnance destruction, coherent beam
combining, advanced communications and research.
Research and Development. Our products are
used in a variety of applications for research and development
by scientists and industrial researchers, including for example
atom trapping. In addition, our lasers and amplifiers are used
to design, test and characterize components and systems in a
variety of markets and applications.
Optical Pumping and Harmonic
Generation. Several types of our lasers are used
to optically pump other solid-state lasers and for harmonic
generation and parametric converters to support research in
sensing, medical and other scientific research in the infrared
and visible wavelength domains. Our lasers are used as a power
source for these other lasers. Green visible lasers are used to
pump titanium sapphire lasers. Visible lasers can be used in
optical displays, planetariums and light shows.
Optical Communication. We provide high-power
EDFAs and ytterbium fiber amplifiers for deployment in both
point-to-point
and
point-to-multipoint
free space optical networks. These networks permit
communications between two or more points on land or in the sky
without the use of fiber optic lines or radio or microwaves.
Remote Sensing. Our products are used in light
detection and ranging, also called LIDAR, a laser technique for
remote sensing. Optical fiber can be used as a sensor for
measuring changes in temperature, pressure and gas concentration
in oil wells, atmospheric and pollution measurements and seismic
exploration.
10
Communications
We design and manufacture a DWDM transport system with varying
output power and wavelengths and a full range of fiber
amplifiers and Raman pump lasers that enhance data transmission
in broadband access and DWDM optical networks. We are leveraging
our high-power diode and fiber technology through the
qualification and sale of high-value integrated solutions for
network suppliers.
DWDM. DWDM is a technology that expands the
capacity of optical networks, allowing service providers to
extend the life of existing fiber networks and reduce operating
and capital costs by maximizing bandwidth capacity. We provide a
broad range of high-power products for DWDM applications
including EDFAs and Raman lasers. We provide a DWDM transport
system that offers service providers and private network
operators a simple, flexible, optical layer solution scalable
from 8 to 40 channels that operates at 10 gigabits per second
per channel. We also have introduced a DWDM system capable of
wavelengths operating at 40 gigabits per second per channel with
OTN multiplexing capabilities.
Broadband Access. The delivery to subscribers
of television programming and Internet- based information and
communication services is converging, driven by advances in IP
technology and by changes in the regulatory and competitive
environment. Fiber optic lines offer connection speeds of up to
1 gigabit per second, or 100 times faster than digital
subscriber lines (DSL) or cable links. We offer a series of
specialty multi-port EDFAs and cable TV nodes and transmitters
that support different types of passive optical network
architectures, enabling high speed data, voice, video on demand
and high definition TV. We provide an EDFA that supports up to
64 ports, which allows service providers to support a high
number of customers in a small space, reducing overall power
consumption and network cost. End users for our products include
communications network operators for video wavelength division
multiplexing overlay solutions, operators of metro and long-haul
networks for DWDM and amplification solutions, as well as cable
and multiple system operators for optical amplification
solutions.
Medical
We sell our commercial fiber and diode lasers to OEMs that
incorporate our products into their medical laser systems.
Continuous wave and pulsed lasers from 1 to 150 watts and diode
laser systems can be used in medical and biomedical
applications. Aesthetic applications addressed by lasers include
skin rejuvenation, skin resurfacing and stretch mark removal.
Purchasers use our diode lasers in dental, skin tightening and
fat removal procedures. Surgical applications include prostate
surgery. Fiber lasers have the ability to fine-tune optical
penetration depth and absorption characteristics and can be used
for ear, nose and throat, urology, gynecology and other surgical
procedures.
Technology
Our products are based on our proprietary technology platform
that we have developed and refined since our formation. The
following technologies are key elements in our products.
Specialty
Optical Fibers
We have extensive expertise in the disciplines and techniques
that form the basis for the multi-clad active and passive
optical fibers used in our products. Active optical fibers form
the laser cavity or gain medium in which lasing or amplification
of light occurs in our products. Passive optical fibers deliver
the optical energy created in our products. Our active fibers
consist of an inner core that is infused with the appropriate
rare earth ion, such as ytterbium, erbium or thulium, and outer
cores of un-doped glass having different indices of refraction.
We believe that our large portfolio of specialty active and
passive optical fibers has a number of advantages as compared to
other commercially available optical fibers. These advantages
include higher concentrations of rare earth ions, fibers that
will not degrade at the high power levels over the useful life
of the product, high lasing efficiency, ability to achieve
single-mode outputs at high powers, ability to withstand high
optical energies and temperatures and scalable side-pumping
capability.
11
Semiconductor
Diode Laser Processing and Packaging Technologies
Another key element of our technology platform is that we use
multiple multi-mode, or broad area, single-emitter diodes rather
than diode bars or stacks as a pump source. We believe that
multi-mode single-emitter diodes are the most efficient and
reliable pumping source presently available, surpassing diode
bars and stacks in efficiency, brightness and reliability.
Single-emitter diodes have substantially reduced cooling
requirements and typically have estimated lifetimes of more than
100,000 hours at high operating currents, compared to
typical lifetimes of 10,000 to 20,000 hours for diode bars.
We developed advanced molecular beam epitaxy techniques to grow
alumina indium gallium arsenide wafers for our diodes. This
method yields high-quality optoelectronic material for
low-defect density and high uniformity of optoelectronic
parameters. In addition, we have developed numerous proprietary
wafer processes and testing and qualification procedures in
order to create a high energy output in a reliable and
high-power diode. We package our diodes in hermetically sealed
pump modules in which the diodes are combined with an optical
fiber output. Characteristics such as the ability of the package
to dissipate heat produced by the diode and withstand vibration,
shock, high temperature, humidity and other environmental
conditions are critical to the reliability and efficiency of the
products.
Specialty
Components and Combining Techniques
We developed a wide range of advanced optical components that
are capable of handling high optical power levels and contribute
to the superior performance, efficiency, reliability and
uniqueness of our products. In addition to fibers and diodes,
our optical component portfolio includes fiber gratings,
isolators and combiners. We also developed special methods and
expertise in splicing fibers together with low optical energy
loss and on-line loss testing. We believe that our internal
development and manufacturing of key optical components allows
us to lower our manufacturing costs and improve product
performance.
Side
Pumping of Fibers and Fiber Block Technologies
Our technology platform allows us to efficiently combine a large
number of multi-mode single-emitter semiconductor diodes with
our active optical fibers that are used in all of our products.
A key element of this technology is that we pump our fiber
lasers through the cladding surrounding the active core. We
splice our specialty active optical fibers with other optical
components and package them in a sealed box, which we call a
fiber block. The fiber blocks are compact and eliminate the risk
of contamination or misalignment due to mechanical vibrations
and shocks as well as temperature or humidity variations. Our
design is scalable and modular, permitting us to make products
with high output power by coupling a large number of diodes with
fiber blocks, which can be combined in parallel and serially.
High-Stress
Testing
We employ high-stress techniques in testing components and final
products that help increase reliability and accelerate product
development. For example, we test all of our diodes with high
current and temperatures to accelerate aging. We also have built
a large database of diode test results that allows us to predict
the estimated lifetime of our diodes. This testing allows us to
eliminate defective diodes prior to further assembly and thus
increase reliability.
Customers
We sell our products globally to OEMs, system integrators and
end users in a wide range of diverse markets who have the
in-house engineering capability to integrate our products into
their own systems. We have hundreds of customers worldwide. Our
end markets include materials processing (comprised of general
manufacturing, automotive, heavy industry, aerospace, consumer
products and medical device manufacturing, photovoltaic
semiconductor and electronics customers), advanced applications
(comprised of commercial companies, universities, research
entities and government entities), communications (comprised of
system integrators, utilities and municipalities) and medical
(medical laser systems manufacturers and researchers).
12
We believe that our customer and end-market diversification
minimizes dependence on any single industry or group of
customers.
The following table shows the allocation of our net sales (in
thousands) among our principal markets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
Materials Processing
|
|
$
|
252,014
|
|
|
|
84.2
|
%
|
|
$
|
140,864
|
|
|
|
75.8
|
%
|
|
$
|
187,720
|
|
|
|
81.9
|
%
|
Advanced Applications
|
|
|
25,196
|
|
|
|
8.4
|
|
|
|
26,557
|
|
|
|
14.3
|
|
|
|
24,670
|
|
|
|
10.8
|
|
Communications
|
|
|
14,020
|
|
|
|
4.7
|
|
|
|
10,867
|
|
|
|
5.8
|
|
|
|
12,904
|
|
|
|
5.6
|
|
Medical
|
|
|
8,026
|
|
|
|
2.7
|
|
|
|
7,606
|
|
|
|
4.1
|
|
|
|
3,782
|
|
|
|
1.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
299,256
|
|
|
|
100.0
|
%
|
|
$
|
185,894
|
|
|
|
100.0
|
%
|
|
$
|
229,076
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
None of our customers accounted for 10% or more of our net sales
for the years ended December 31, 2010, 2009 or 2008.
Our net sales (in thousands) were derived from customers in the
following geographic regions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
North America(1)
|
|
$
|
61,706
|
|
|
|
20.6
|
%
|
|
$
|
45,668
|
|
|
|
24.6
|
%
|
|
$
|
52,018
|
|
|
|
22.7
|
%
|
Europe
|
|
|
112,456
|
|
|
|
37.6
|
|
|
|
70,413
|
|
|
|
37.9
|
|
|
|
94,077
|
|
|
|
41.1
|
|
Asia and Australia
|
|
|
124,254
|
|
|
|
41.5
|
|
|
|
66,100
|
|
|
|
35.5
|
|
|
|
77,582
|
|
|
|
33.9
|
|
Rest of World
|
|
|
840
|
|
|
|
0.3
|
|
|
|
3,713
|
|
|
|
2.0
|
|
|
|
5,399
|
|
|
|
2.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
299,256
|
|
|
|
100.0
|
%
|
|
$
|
185,894
|
|
|
|
100.0
|
%
|
|
$
|
229,076
|
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The substantial majority of sales in North America are to
customers in the United States. |
Backlog
At December 31, 2010, our backlog of orders (generally
scheduled for shipment within one year) was approximately
$171.6 million compared to $68.1 million at
December 31, 2009. At December 31, 2010, our backlog
included $98.6 million of orders with firm shipment dates
and $73.0 million of frame agreements that we expect to
ship within one year, compared to $47.8 million of orders
with firm shipment dates and $20.3 million of frame
agreements at December 31, 2009. Frame agreements generally
are agreements without committed shipment dates. Orders used to
compute backlog are generally cancelable without substantial
penalties. Historically, the rate of cancellation experienced by
us has not been significant. We manage the risk of cancellation
by establishing the right to charge a cancellation fee that
generally covers a portion of the purchase price, any materials
and development costs incurred prior to the order being
cancelled. Our ability to enforce this right depends on many
factors including, but not limited to, the customers
requested length of delay, the number of other outstanding
orders with the customer and our ability to quickly convert the
cancelled order to another sale.
We anticipate shipping a substantial majority of the present
backlog during fiscal year 2011. However, our backlog at any
given date is not necessarily indicative of actual sales for any
future period.
Sales,
Marketing and Support
We market our products internationally primarily through our
direct sales force and also through agreements with independent
sales representatives and distributors. We have sales offices in
the United States, Germany, Russia, Italy, China, Japan, South
Korea, India, the United Kingdom, Singapore and France. Our
independent sales representatives and distributors are located
in the United States, Russia, Japan, Brazil, Mexico and other
parts of the world. Only one of these arrangements is on an
exclusive basis. Foreign sales to customers are generally priced
in local currencies and are therefore subject to currency
exchange fluctuations.
13
We maintain a customer support and field service staff in our
major markets. We work closely with customers, customer groups
and independent representatives to service equipment, train
customers to use our products and explore additional
applications for our technologies. We have materials processing
application centers in the United States, Germany, Russia,
China, Italy, Japan and South Korea, which we use to demonstrate
our products and develop new applications. We may expand our
support and field service, particularly in locations where
customer concentration or volume requires local service
capabilities. We repair products at our facilities or at
customer sites.
We typically provide one to three-year parts and service
warranties on our lasers and amplifiers. Most of our sales
offices provide support to customers in their respective
geographic areas. Warranty reserves have generally been
sufficient to cover product warranty repair and replacement
costs.
Manufacturing
Vertical integration is one of our core business strategies
through which we control our proprietary processes and
technologies as well as the supply of key components and
assemblies. We believe that our vertically integrated business
model gives us the following advantages:
|
|
|
|
|
maintaining a technological lead over competitors;
|
|
|
|
reducing component and final product costs compared to market
prices available to competitors;
|
|
|
|
ensuring access to critical components, enabling us to better
meet customer demands;
|
|
|
|
controlling performance, quality and consistency; and
|
|
|
|
enabling rapid development and deployment of new products and
technologies.
|
Our vertically integrated manufacturing operations include
optical preform making, specialty fiber drawing, semiconductor
wafer growth, diode processing and packaging, specialty optical
component manufacturing, fiber block and fiber module assembly
for different power units, software and electronics development,
final assembly, as well as testing, tool manufacturing and
automated production systems. Over the last several years, we
added additional production capabilities, including three
multi-wafer growth reactors, diode test stations, fiber pre-form
and fiber drawing equipment, low, mid and high-power production
and testing, in order to increase our capacity as well as reduce
the risks associated with our production process.
We operate our own semiconductor foundry for the production of
the multi-mode single-emitter diodes. Diodes are the pumps that
are used as the light source in each device we make. We also
process, package and extensively test all of our diodes. Because
pump diodes represent a significant component cost of the final
laser or amplifier, we have chosen to develop internal
manufacturing capabilities for diodes. As a result of our high
volume production levels of pump diodes, proprietary processes
and use of limited chip designs, we have been able to increase
yields, lower component costs and assure high quality. We also
design, manufacture and optimize many of our own test
instruments, diode test racks, robotic and automated assembly
tools and machines.
We developed these proprietary components, manufacturing tools,
equipment and techniques over many years in an effort to address
the major issues that had been inhibiting the development of
fiber laser technology and to provide products that
differentiate us from our competitors. We believe that the
proprietary components, manufacturing tools, equipment,
techniques and software utilized in all of our product lines
provide extensive barriers to potential competitors. Generally,
we do not sell our proprietary components to third parties,
except that in 2008, we started selling our diodes to third
parties. Using our technology platform, we configure standard
products based upon each customers specifications. Through
our vertically integrated manufacturing operations, we can
develop, test and produce new products and configurations with
higher performance and reliability and in less time than by
working with external vendors. We have developed proprietary
testing methodologies that allow us to develop higher power
components and products in short
14
periods of time, enable us to introduce products to the market
more quickly, capitalize on new opportunities and provide
superior service to our customers.
Our in-house manufacturing generally includes only those
operations and components that are critical to the protection of
our intellectual property, the reduction of our costs or the
achievement of performance and quality standards. We purchase
from vendors common and specialized mechanical, electrical and
optical parts and raw materials, such as printed circuit boards,
wafer substrates and various optical components.
Research
and Development
We have extensive research and development experience in laser
materials, fiber and optoelectronic components. We have
assembled a team of scientists and engineers with specialized
experience and extensive knowledge in fiber lasers and
amplifiers, critical components, testing and manufacturing
process design.
We focus our research and development efforts on designing and
introducing new and improved standard and customized products
and the mass production of components that go into our products.
In addition to our cladding-pumped specialty fiber platform, we
have core competencies in high-power multi-mode semiconductor
laser diodes, diode packaging, specialty active and passive
optical fibers, high-performance optical components, fiber gain
blocks and fiber modules, as well as splicing and combining
techniques and high-stress test methods. Our research and
development efforts are aided by our vertical integration and
our proprietary high-stress testing techniques that result in
accelerated development cycles. The strategy of developing our
proprietary components has allowed us to leverage our optical
experience and large volume requirements to lower the cost of
our products. We concentrate our research and development
efforts on advancements in performance as well as capacity to
hold and produce higher optical power levels.
Our research and development efforts are also directed at
expanding our product line by increasing power levels, improving
beam quality and electrical efficiency, decreasing the size of
our products and lowering the cost per watt. We also are engaged
in research projects to expand the spectral range of products
that we offer. Our team of experienced scientists and engineers
work closely with many of our customers to develop and introduce
custom products that address specific applications and
performance requirements.
We incurred research and development costs of approximately
$19.2 million in 2010, $18.5 million in 2009 and
$15.8 million in 2008. We plan to continue our commitment
to research and development and to introduce new products,
systems and complementary products that would allow us to
maintain our competitive position. See Item 7,
Managements Discussion and Analysis of Financial
Condition of Results of Operations.
Intellectual
Property
We seek to protect our proprietary technology primarily through
U.S. and foreign laws affording protection for trade
secrets, and to seek U.S. and foreign patent, copyright and
trademark protection of our products and processes where
appropriate. Historically, we relied primarily on trade secrets,
technical know-how and other unpatented proprietary information
relating to our product development and manufacturing
activities. We seek to protect our trade secrets and proprietary
information, in part, by requiring our employees to enter into
agreements providing for the maintenance of confidentiality and
the assignment to us of rights to inventions that they make
while we employ them. We also enter into non-disclosure
agreements with our consultants and suppliers to protect
confidential information delivered to them. We believe that our
vertical integration, including our long experience in making a
wide range of specialty and high-power capacity components, as
well as our technology platform make it difficult for others to
reverse engineer our products.
We have increased our efforts to expand our patent portfolio. We
now have over 100 patents issued and over 60 pending patent
applications in the United States relating to optical fiber
lasers, amplifiers, bulk optics, semiconductors, and laser and
telecommunications systems. We also have patents and patent
applications in certain other countries. In February 2008, we
purchased a portfolio of photonics patents from British
Telecommunications plc in the fields of optical fiber lasers and
amplifiers, semiconductor devices, integrated optics, fiber
gratings, high-speed systems and optical networking.
Intellectual property rights, including those
15
that we own and those of others, involve significant risks. See
Item 1A, Risk Factors-Our inability to Protect Our
Intellectual Property and Proprietary Technologies Could Result
in the Unauthorized Use of Our Technologies by Third Parties,
Hurt Our Competitive Position and Adversely Affect Our Operating
Results.
Competition
Our markets are competitive and characterized by rapidly
changing technology and continuously evolving customer
requirements. We believe that the primary competitive factors in
our markets are:
|
|
|
|
|
product performance and reliability;
|
|
|
|
quality and service support;
|
|
|
|
price and value to the customer;
|
|
|
|
ability to manufacture and deliver products on a timely basis;
|
|
|
|
ability to achieve qualification for and integration into OEM
systems;
|
|
|
|
ability to meet customer specifications; and
|
|
|
|
ability to respond quickly to market demand and technological
developments.
|
We believe we compete favorably with respect to these criteria.
In the materials processing market, the competition is
fragmented and includes a large number of competitors. We
compete with makers of high-power
CO2
and solid-state lasers, including Fanuc, Rofin-Sinar
Technologies, Inc. and Trumpf GmbH + Co. KG, and makers of mid
and low-power
CO2
and solid-state lasers such as Coherent, Inc., GSI Group Inc.,
Newport Corporation and Rofin-Sinar Technologies, Inc. We also
compete with fiber laser makers, including Rofin-Sinar
Technologies, Inc., Trumpf GmbH + Co. KG, GSI Group Inc.,
Coherent Inc., Newport Corporation, The Furukawa Electric Co.,
Ltd., Keopsys SA, Mitsubishi Cable Industries, Ltd., Miyachi
Unitek Corporation, MPB Communications Inc., and JDS Uniphase
Corporation. We believe that we compete favorably with other
makers of fiber lasers on price, service, installed base and
performance.. We currently have limited competition in
high-power fiber lasers, but recently some competitors
introduced fiber lasers or announced plans to introduce fiber
lasers that compete with our high power products. We also
compete in the materials processing, advanced and medical
applications markets with end users that produce their own
solid-state and gas lasers as well as with manufacturers of
non-laser methods and tools, such as resistance welding and
cutting dies in the materials processing market and scalpels in
the medical market.
In the communications market, our principal competitors are
manufacturers of mid-power fiber amplifiers and DWDM systems,
such as Oclaro Inc., the Scientific-Atlanta division of Cisco
Systems, Inc. (Scientific-Atlanta), Emcore Corporation, JDS
Uniphase Corporation, Huawei Corporation and MPB Communications
Inc. We believe that we compete favorably with other high-power
fiber amplifier producers with respect to price, product
performance and output power. The fiber amplifier market is more
established than the fiber laser market and technological change
has not occurred as rapidly as it has in the case of fiber
lasers.
Many of our competitors are larger than we are and have
substantially greater financial, managerial and technical
resources, more extensive distribution and service networks,
greater sales and marketing capacity, and larger installed
customer bases than we do.
Employees
As of December 31, 2010, we had approximately
1,760 full-time employees, including 140 in research and
development, 1,370 in manufacturing operations, 100 in sales,
service and marketing, and 150 in general and administrative
functions. Of our total full-time employees at our principal
facilities, approximately 490 were in the United States, 600
were in Germany, 500 were in Russia and 60 were in China. We
have never experienced a work stoppage and none of our employees
is subject to a collective bargaining agreement. We believe that
our current relations with our employees are good.
16
Government
Regulation
Regulatory
Compliance
The majority of our laser and amplifier products sold in the
United States are classified as Class IV Laser Products
under the applicable rules and regulations of the Center for
Devices and Radiological Health (CDRH) of the U.S. Food and
Drug Administration. The same classification system is applied
in the European markets. Safety rules are formulated with
Deutsche Industrie Norm (i.e., German Industrial
Standards) or ISO standards, which are internationally
harmonized.
CDRH regulations generally require a self-certification
procedure pursuant to which a manufacturer must submit a filing
to the CDRH with respect to each product incorporating a laser
device, make periodic reports of sales and purchases and comply
with product labeling standards, product safety and design
features and informational requirements. Our products
applications can result in injury to human tissue if directed at
an individual or otherwise misused. The CDRH is empowered to
seek fines and other remedies for violations of their
requirements. We believe that our products are in material
compliance with applicable laws and regulations relating to the
manufacture of laser devices.
Environmental
Regulation
Our operations are subject to various federal, state, local and
international laws governing the environment, including those
relating to the storage, use, discharge, disposal, product
composition and labeling of, and human exposure to, hazardous
and toxic materials. We believe that our operations are in
material compliance with applicable environmental protection
laws and regulations.
Although we believe that our safety procedures for using,
handling, storing and disposing of such materials comply with
the standards required by federal and state laws and
regulations, we cannot completely eliminate the risk of
accidental contamination or injury from these materials. In the
event of such an accident involving such materials, we could be
liable for damages and such liability could exceed the amount of
our liability insurance coverage and the resources of our
business.
Availability
of Reports
Our annual reports on
Form 10-K,
quarterly reports on
Form 10-Q,
current reports on
Form 8-K
and any amendments to such reports are available free of charge
on our web site at www.ipgphotonics.com as soon as
reasonably practicable after such reports are electronically
filed with, or furnished to, the Securities and Exchange
Commission (www.sec.gov). We will also provide electronic
or paper copies of such reports free of charge, upon request
made to our Corporate Secretary.
The factors described below are the principal risks that
could materially adversely affect our operating results and
financial condition. Other factors may exist that we do not
consider significant based on information that is currently
available. In addition, new risks may emerge at any time, and we
cannot predict those risks or estimate the extent to which they
may affect us.
Downturns
in the markets we serve, particularly materials processing,
could have a material adverse effect on our sales and
profitability.
Our business depends substantially upon capital expenditures by
our customers, particularly by manufacturers in the materials
processing market, which includes automotive, marking,
electronics and photovoltaic applications. Approximately 84% of
our revenues in 2010 were from customers in the materials
processing market. Although applications in this market are
broad, sales for these applications are cyclical and have
historically experienced sudden and severe downturns and periods
of oversupply, resulting in significantly reduced demand for
capital equipment, including the products that we manufacture
and market. In 2009, our sales decreased by approximately 25% in
the materials processing market as a result of the global
economic recession. In 2010, sales in this market rebounded with
a 79% increase. For the foreseeable future, our
17
operations will continue to depend upon capital expenditures by
customers in this market, which, in turn, depend upon the demand
for their products or services. Decreased demand for products
and services from customers for these applications during an
economic downturn may lead to decreased demand for our products,
which would reduce our sales and margins. We may not be able to
respond by decreasing our expenses quickly enough, due in part,
to our fixed overhead structure related to our
vertically-integrated operations and our commitments to
continuing investment in research and development.
Uncertainty
and adverse changes in the general economic conditions of
markets in which we participate negatively affect our
business.
Current and future conditions in the economy have an inherent
degree of uncertainty. As a result, it is difficult to estimate
the level of growth or contraction for the economy as a whole.
It is even more difficult to estimate growth or contraction in
various parts, sectors and regions of the economy, including the
materials processing, telecommunications, advanced and medical
markets and applications in which we participate. Because all
components of our budgeting and forecasting are dependent upon
estimates of growth or contraction in the markets and
applications we serve and demand for our products, the
prevailing economic uncertainties render estimates of future
income and expenditures very difficult to make. Adverse changes
have occurred and may occur in the future as a result of
declining or flat global or regional economic conditions,
fluctuations in currency and commodity prices, wavering
confidence, capital expenditure reductions, unemployment,
declines in stock markets, contraction of credit availability,
declines in real estate values, or other factors affecting
economic conditions generally. These changes may negatively
affect the sales of our lasers and amplifiers, increase exposure
to losses from bad debts, increase the cost and decrease the
availability of financing, increase the risk of loss on
investments, or increase costs associated with manufacturing and
distributing products. A prolonged economic downturn could have
a material adverse effect on our business, financial condition
and results of operations.
Our
sales depend upon our ability to penetrate new applications for
fiber lasers and increase our market share in existing
applications.
Our level of sales will depend on our ability to generate sales
of fiber lasers in applications where conventional lasers, such
as
CO2
and yttrium aluminum garnet (YAG) lasers, have been used or in
new and developing markets and applications for lasers where
they have not been used previously. To date, a significant
portion of our revenue growth has been derived from sales of
fiber lasers primarily for applications where
CO2
and YAG lasers historically have been used. In order to maintain
or increase market demand for our fiber laser products, we will
need to devote substantial resources to:
|
|
|
|
|
demonstrate the effectiveness of fiber lasers in new
applications;
|
|
|
|
increase our direct and indirect sales efforts;
|
|
|
|
effectively service and support our installed product base.
|
|
|
|
extend our product line to address new applications for our
products;
|
|
|
|
continue to reduce our manufacturing costs and enhance our
competitive position; and
|
If we are unable to implement our strategy to develop new
applications for our products, our revenues, operating results
and financial condition could be adversely affected. We cannot
assure you that we will be able to successfully implement our
business strategy. In addition, our newly developed or enhanced
products may not achieve market acceptance or may be rendered
obsolete or less competitive by the introduction of new products
by other companies.
If
fiber lasers do not achieve broader market acceptance or if
market penetration occurs more slowly than we expect, sales and
profitability may be negatively impacted.
Fiber lasers are relatively new when compared to conventional
lasers and our future success depends on the development and
broader acceptance of fiber lasers. Potential customers may be
reluctant to adopt fiber
18
lasers as an alternative to conventional lasers, such as
CO2
and YAG, and non-laser methods, such as mechanical tools. Such
potential customers may have substantial investments and
know-how related to their existing laser and non-laser
technologies, and may perceive risks relating to the
reliability, quality, usefulness and cost-effectiveness of fiber
lasers when compared to other laser or non-laser technologies
available in the market. Many of our target markets, such as the
automotive, machine tool and other manufacturing, communications
and medical industries, have historically adopted new
technologies slowly. These markets often require long test and
qualification periods or lengthy government approval processes
before adopting new technologies. As a result, we may expend
significant resources and time to qualify our products for a new
customer application, and we cannot assure that our products
will be qualified or approved for such markets. If acceptance of
fiber laser technology and of our fiber lasers in particular
does not continue to grow within the markets that we serve, then
the opportunities to maintain or increase our revenues and
profitability may be severely limited.
Our
vertically integrated business results in high levels of fixed
costs and inventory levels that may adversely impact our gross
profits and our operating results in the event that demand for
our products declines or we maintain excess inventory
levels.
We have a high fixed cost base due to our vertically integrated
business model, including the fact that approximately 78% of our
1,760 employees as of December 31, 2010 were employed
in our manufacturing operations. We may not adjust these fixed
costs quickly enough to adapt to rapidly changing market
conditions. Our gross profit, in absolute dollars and as a
percentage of net sales, is impacted by our sales volume, the
corresponding absorption of fixed manufacturing overhead
expenses and manufacturing yields. In addition, because we are a
vertically integrated manufacturer and design and manufacture
our key specialty components, insufficient demand for our
products may subject us to the risks of high inventory carrying
costs and increased inventory obsolescence. If our capacity and
production levels are not properly sized in relation to expected
demand, we may need to record write-downs for excess or obsolete
inventory. Because we are vertically integrated, the rate at
which we turn inventory has historically been low when compared
to our cost of sales. We do not expect this to change
significantly in the future and believe that we will have to
maintain a relatively high level of inventory compared to our
cost of sales. As a result, we continue to expect to have a
significant amount of working capital invested in inventory.
Changes in our level of inventory lead to an increase in cash
generated from our operations when inventory is sold or a
decrease in cash generated from our operations at times when the
amount of inventory increases.
Our
manufacturing capacity and operations may not be appropriate for
future levels of demand and may adversely affect our gross
margins.
In response to an increase in demand for our fiber lasers, we
added substantial manufacturing capacity at our facilities in
the United States, Germany and Russia in the period from 2005 to
2008. Beginning in 2010, we entered another phase of expanding
capacity at those manufacturing facilities. A significant
portion of our manufacturing facilities and production
equipment, such as our semiconductor production and processing
equipment, diode packaging equipment and diode burn-in stations,
are special-purpose in nature and cannot be adapted easily to
make other products. If the demand for fiber lasers or
amplifiers does not increase or decreases from current levels,
we may have significant excess manufacturing capacity and
under-absorption of our fixed costs, which could in turn
adversely affect our gross margins and profitability.
To maintain our competitive position as the leading developer
and manufacturer of fiber lasers and to meet anticipated demand
for our products, we invested significantly in the expansion of
our manufacturing and operations throughout the world and may do
so in the future. We incurred in the past and will incur
significant costs associated with the acquisition, build-out and
preparation of our facilities. We had capital expenditures of
$28.4 million and $10.5 million in 2010 and 2009,
respectively, and we expect to incur approximately $50 million
in capital expenditures, excluding acquisitions, in 2011. In
connection with these projects, we may incur cost overruns,
construction delays, labor difficulties or regulatory issues
which could cause our capital expenditures to be higher than
what we currently anticipate, possibly by a material amount,
which would in turn adversely impact our operating results.
Moreover, we may experience higher costs due to yield loss,
19
production inefficiencies and equipment problems until any
operational issues associated with the opening of new
manufacturing facilities are resolved.
The
laser and amplifier industries are experiencing declining
average selling prices, which could cause our gross margins to
decline and harm our operating results.
Products in the laser and amplifier industries generally, and
our products specifically, are experiencing and may in the
future continue to experience a decline in average selling
prices (ASPs) as a result of new product and technology
introductions, increased competition and price pressures from
significant customers. If the ASPs of our products decline
further and we are unable to increase our unit volumes,
introduce new or enhanced products with higher margins or reduce
manufacturing costs to offset anticipated decreases in the
prices of our existing products, our operating results may be
adversely affected. In addition, because of our significant
fixed costs, we are limited in our ability to reduce total costs
quickly in response to any revenue shortfalls. Because of these
factors, we have experienced and we may experience in the future
material adverse fluctuations in our operating results on a
quarterly or annual basis if the ASPs of our products continue
to decline.
Because
we lack long-term purchase commitments from our customers, our
sales can be difficult to predict, which could lead to excess or
obsolete inventory and adversely affect our operating
results.
We generally do not enter into long-term agreements with our
customers obligating them to purchase our fiber lasers or
amplifiers. Our business is characterized by short-term purchase
orders and shipment schedules and, in some cases, orders may be
cancelled or delayed without significant penalty. As a result,
it is difficult to forecast our revenues and to determine the
appropriate levels of inventory required to meet future demand.
In addition, due to the absence of long-term volume purchase
agreements, we forecast our revenues and plan our production and
inventory levels based upon the demand forecasts of our OEM
customers, end users, and distributors, which are highly
unpredictable and can fluctuate substantially. This could lead
to increased inventory levels and increased carrying costs and
risk of excess or obsolete inventory due to unanticipated
reductions in purchases by our customers. In this regard, we
recorded provisions for inventory totaling $2.7 million,
$5.3 million and $3.8 million in 2010, 2009 and 2008,
respectively. These provisions were recorded as a result of
changes in market prices of certain components, the value of
those inventories that was realizable through finished product
sales and uncertainties related to the recoverability of the
value of inventories due to technological changes and excess
quantities. If our OEM customers, end users or distributors fail
to accurately forecast the demand for our products, fail to
accurately forecast the timing of such demand, or are unable to
consistently negotiate acceptable purchase order terms with
customers, our results of operations may be adversely affected.
We may
experience lower than expected manufacturing yields, which would
adversely affect our gross margins.
The manufacture of semiconductor diodes and the packaging of
them is a highly complex process. Manufacturers often encounter
difficulties in achieving acceptable product yields from diode
and packaging operations. We have from time to time experienced
lower than anticipated manufacturing yields for our diodes and
packaged diodes. This occurs during the production of new
designs and the installation and
start-up of
new process technologies. If we do not achieve planned yields,
our product costs could increase resulting in lower gross
margins, and key component availability would decrease.
We are
subject to litigation alleging that we are infringing
third-party intellectual property rights. Intellectual property
claims could result in costly litigation and harm our
business.
In recent years, there has been significant litigation involving
intellectual property rights in many technology-based
industries, including our own. We face risks and uncertainties
in connection with such litigation, including the risk that
patents issued to others may harm our ability to do business;
that there could be existing patents of which we are unaware
that could be pertinent to our business; and that it is not
possible for us to know whether there are patent applications
pending that our products might infringe upon, since
20
patent applications often are not disclosed until a patent is
issued or published. Moreover, the frequency with which new
patents are granted and the diversity of jurisdictions in which
they are granted make it impractical and expensive for us to
monitor all patents that may be relevant to our business.
From time to time, we have been notified of allegations and
claims that we may be infringing patents or intellectual
property rights owned by third parties. In 2007, we settled two
patent infringement lawsuits filed against us and in 2010 we
settled another patent infringement lawsuit filed against us. We
are presently defending one patent infringement lawsuit.
In November 2006, IMRA America, Inc. filed an action against us
alleging that certain products we produce, including but not
limited to our continuous wave and pulsed fiber lasers and fiber
amplifiers, which account for a significant portion of our
revenues, infringe one U.S. patent allegedly owned by IMRA
America. IMRA America alleged willful infringement and sought
damages of at least $10 million, treble damages and
injunctive relief. IMRA America also alleged inducement of
infringement and contributory infringement. We filed an answer
in which we denied infringement and raised additional defenses
that the patent is invalid and unenforceable. In addition, we
filed declaratory judgment counterclaims based on these three
defenses. This lawsuit concerns products made, used, sold or
offered for sale in or imported into the United States and
therefore the lawsuit affects products that account for a
substantial portion of our revenues. This lawsuit does not
affect revenues that are derived from products that are not
made, used, sold or offered for sale in or imported into the
United States. In June 2008, the U.S. Patent and Trademark
Office (USPTO) ordered re-examination of the patent
claims asserted by IMRA America against the Company based on
several prior art references that we submitted in an ex parte
re-examination request. In July 2009, the USPTO confirmed the
patentability of all of the claims in the IMRA America patent
over the prior art cited in the re-examination, as well as of
new claims added during the re-examination. In August 2009, we
submitted an additional re-examination request, which was denied
by the USPTO. The USPTO issued a re-examination certificate in
October 2009. As a result, the U.S. District Court for the
Eastern District of Michigan lifted the stay on the litigation.
The District Court adopted the claim construction of IMRA on one
of the four claim terms, but did not decide the others. In March
2011, the District Court granted our motion for summary judgment
of no marking, precluding IMRA from seeking damages for any
alleged infringing products sold prior to November 16,
2006, the date the lawsuit was filed, with the exception of four
particular alleged infringing products, as to which IMRA is
precluded from seeking damages for sales prior to August 6,
2006. The District Court denied our motions for summary judgment
on non-infringement, invalidity, no willful infringement and
laches, and granted IMRAs for summary judgment on no
invalidity for derivation and no equitable misconduct. The trial
date has not been scheduled. IMRA America has informed us that
it has patents and applications in foreign jurisdictions
directed to similar subject matter as the patent subject to this
lawsuit, but has not asserted them against us. The Company has
filed oppositions to two IMRA patents in Japan and Germany. In
Japan, the patent office invalidated two claims and maintained
49 claims of the IMRA patent. The German opposition is still
pending.
There can be no assurance that we will be able to dispose
without a material effect the litigation with IMRA America,
claims or other allegations made against us and claims that may
be asserted in the future. The outcome of any litigation,
including the pending litigation, is uncertain. Even if we
ultimately are successful on the merits of any such litigation
or re-examination, legal and administrative proceedings related
to intellectual property are typically expensive and
time-consuming, generate negative publicity and divert financial
and managerial resources. Some litigants may have greater
financial resources than we have and may be able to sustain the
costs of complex intellectual property litigation more easily
than we can.
If we do not prevail in any intellectual property litigation
brought against us, including the lawsuits brought by IMRA
America, it could affect our ability to sell our products and
materially harm our business, financial condition and results of
operations. These developments could adversely affect our
ability to compete for customers and increase our revenues.
Plaintiffs in intellectual property cases often seek, and
sometimes obtain, injunctive relief. Intellectual property
litigation commenced against us, including the lawsuit brought
21
by IMRA America that we are presently defending, could force us
to take actions that could be harmful to our business,
competitive position, results of operations and financial
condition, including the following:
|
|
|
|
|
stop selling our products or using the technology that contains
the allegedly infringing intellectual property;
|
|
|
|
pay actual monetary damages, royalties, lost profits or
increased damages and the plaintiffs attorneys fees,
which individually or in the aggregate may be substantial;
|
|
|
|
attempt to obtain a license to use the relevant intellectual
property, which may not be available on reasonable terms or at
all; and
|
|
|
|
attempt to redesign the products that allegedly infringed upon
intellectual property of others, which may be costly or
impractical.
|
In addition, intellectual property lawsuits can be brought by
third parties against OEMs and end users that incorporate our
products into their systems or processes. In some cases, we
indemnify OEMs against third-party infringement claims relating
to our products and we often make representations affirming,
among other things, that our products do not infringe on the
intellectual property rights of others. As a result, we may
incur liabilities in connection with lawsuits against our
customers. Any such lawsuits, whether or not they have merit,
could be time-consuming to defend, damage our reputation or
result in substantial and unanticipated costs.
Our
inability to protect our intellectual property and proprietary
technologies could result in the unauthorized use of our
technologies by third parties, hurt our competitive position and
adversely affect our operating results.
We rely on patents, trade secret laws, contractual agreements,
technical know-how and other unpatented proprietary information
to protect our products, product development and manufacturing
activities from unauthorized copying by third parties. Although
we acquired a patent portfolio in 2008 and started a program in
2007 to increase the number of patent applications we file, our
patents do not cover all of our technologies, systems, products
and product components and may not prevent third parties from
unauthorized copying of our technologies, products and product
components. We seek to protect our proprietary technology under
laws affording protection for trade secrets. We also seek to
protect our trade secrets and proprietary information, in part,
by requiring employees to enter into agreements providing for
the maintenance of confidentiality and the assignment of rights
to inventions made by them while employed by us. We have
significant international operations and we are subject to
foreign laws which differ in many respects from U.S. laws.
Policing unauthorized use of our trade secret technologies
throughout the world and proving misappropriation of our
technologies are particularly difficult, especially due to the
number of our employees and operations in numerous foreign
countries. The steps that we take to acquire ownership of our
employees inventions and trade secrets in foreign
countries may not have been effective under all such local laws,
which could expose us to potential claims or the inability to
protect intellectual property developed by our employees.
Furthermore, any changes in, or unexpected interpretations of,
the trade secret and other intellectual property laws in any
country in which we operate may adversely affect our ability to
enforce our trade secret and intellectual property positions.
Costly and time-consuming litigation could be necessary to
determine the scope of our confidential information and trade
secret protection. We also enter into confidentiality agreements
with our consultants and other suppliers to protect our
confidential information that we deliver to them. However, there
can be no assurance that our confidentiality agreements will not
be breached, that we will be able to effectively enforce them or
that we will have adequate remedies for any breach.
Given our reliance on trade secret laws, others may
independently develop similar or alternative technologies or
duplicate our technologies and commercialize discoveries that we
have made. Therefore, our intellectual property efforts may be
insufficient to maintain our competitive advantage or to stop
other parties from commercializing similar products or
technologies. Many countries outside of the United States afford
little or no protection to trade secrets and other intellectual
property rights. Intellectual property litigation can be
time-consuming and expensive, and there is no guarantee that we
will have the resources to fully enforce our rights. If we are
unable to prevent misappropriation or infringement of our
intellectual property rights, or
22
the independent development or design of similar technologies,
our competitive position and operating results could suffer.
We
depend upon internal production and on outside single or
limited-source suppliers for many of our key components and raw
materials. Any interruption in the supply of these key
components and raw materials could adversely affect our results
of operations.
We rely exclusively on our own production capabilities to
manufacture certain of our key components, such as semiconductor
diodes, specialty optical fibers and optical components. We do
not have redundant production lines for some of our components,
such as our diodes and some other components, which are made at
a single manufacturing facility. These may not be readily
available from other sources at our current costs. If our
manufacturing activities were obstructed or hampered
significantly, it could take a considerable length of time, or
it could increase our costs, for us to resume manufacturing or
find alternative sources of supply. Many of the tools and
equipment we use are custom-designed, and it could take a
significant period of time to repair or replace them. Our three
major manufacturing facilities are located in Oxford,
Massachusetts; Burbach, Germany; and Fryazino, Russia. If, as a
result of a flood, fire, natural disaster, political unrest, act
of terrorism, war, outbreak of disease or other similar event,
any of our three major manufacturing facilities or equipment
should become inoperable, inaccessible, damaged or destroyed,
our business could be adversely affected to the extent that we
do not have redundant production capabilities.
Also, we purchase certain raw materials used to manufacture our
products and other components, such as semiconductor wafer
substrates, diode packages, modulators, micro-optics, bulk
optics and high-power beam delivery products, from single or
limited-source suppliers. In general, we have no long-term
contractual supply arrangements with these suppliers. Some of
our suppliers are also our competitors. Some of our suppliers
reduced their inventory levels and manufacturing capacity
because of the recent recession. As a result, we experienced and
may in the future experience longer lead times or delays in
fulfillment of our orders. Furthermore, other than our current
suppliers, there are a limited number of entities from whom we
could obtain these supplies. We do not anticipate that we would
be able to purchase these components or raw materials that we
require in a short period of time or at the same cost from other
sources in commercial quantities or that have our required
performance specifications. Any interruption or delay in the
supply of any of these components or materials, or the inability
to obtain these components and materials from alternate sources
at acceptable prices and within a reasonable amount of time,
could adversely affect our business. If our suppliers face
financial or other difficulties, if our suppliers do not
maintain sufficient inventory on hand or if there are
significant changes in demand for the components and materials
we obtain from them, they could limit the availability of these
components and materials to us, which in turn could adversely
affect our business.
We
rely on the significant experience and specialized expertise of
our senior management and scientific staff and if we are unable
to retain these key employees and attract other highly skilled
personnel necessary to grow our business successfully, our
business and results of operations could suffer.
Our future success is substantially dependent on the continued
service of our executive officers, particularly our founder and
chief executive officer, Dr. Valentin P. Gapontsev,
age 72, and the managing director of our German subsidiary
IPG Laser GmbH, Dr. Eugene Shcherbakov, age 63, our
highly trained team of scientists, many of whom have numerous
years of experience and specialized expertise in optical fibers,
semiconductors and optical component technology, and other key
engineering, sales, marketing, manufacturing and support
personnel, any of whom may leave, which could harm our business.
The members of our scientific staff who are expected to make
significant individual contributions to our business are also
members of our executive management team as disclosed under
Item 10, Directors, Executive Officers and Corporate
Governance below. Furthermore, our business requires
scientists and engineers with experience in several disciplines,
including physics, optics, materials sciences, chemistry and
electronics. We will need to continue to recruit and retain
highly skilled scientists and engineers for certain functions.
Our future success also depends on our ability to identify,
attract, hire, train, retain and motivate highly skilled
research and development, managerial, operations, sales,
marketing and customer service personnel. If we fail to attract,
integrate and retain the necessary personnel, our ability to
extend and maintain our scientific expertise and grow our
business could suffer significantly.
23
Failure
to effectively build and expand our direct field service and
support organization could have an adverse effect on our
business.
We believe that it will become increasingly important for us to
provide rapid, responsive service directly to our customers
throughout the world and to build and expand our own personnel
resources to provide these services. Any actual or perceived
lack of direct field service in the locations where we sell or
try to sell our products may negatively impact our sales efforts
and, consequently, our revenues. Accordingly, we have an ongoing
effort to develop our direct support systems worldwide. This
requires us to recruit and train additional qualified field
service and support personnel as well as maintain effective and
highly trained organizations that can provide service to our
customers in various countries. We may not be able to attract
and train additional qualified personnel to expand our direct
support operations successfully. We may not be able to find and
engage additional qualified third-party resources to supplement
and enhance our direct support operations. Further, we may incur
significant costs in providing these direct field and support
services. Failure to implement our direct support operation
effectively could adversely affect our relationships with our
customers, and our operating results may suffer.
A few
customers account for a significant portion of our sales, and if
we lose any of these customers or they significantly curtail
their purchases of our products, our results of operations could
be adversely affected.
We rely on a few customers for a significant portion of our
sales. In the aggregate, our top five customers accounted for
19%, 12% and 17% of our consolidated net sales in 2010, 2009 and
2008, respectively. Our largest customer accounted for 7%, 3%
and 7% of sales in 2010, 2009 and 2008, respectively. We
generally do not enter into agreements with our customers
obligating them to purchase our fiber lasers or amplifiers. Our
business is characterized by short-term purchase orders and
shipment schedules. If any of our principal customers
discontinues its relationship with us, replaces us as a vendor
for certain products or suffers downturns in its business, our
business and results of operations could be adversely affected.
We
have experienced, and expect to experience in the future,
fluctuations in our quarterly operating results. These
fluctuations may increase the volatility of our stock
price.
We have experienced, and expect to continue to experience,
fluctuations in our quarterly operating results. We believe that
fluctuations in quarterly results may cause the market price of
our common stock to fluctuate, perhaps substantially. Factors
which may have an influence on our operating results in a
particular quarter include:
|
|
|
|
|
the increase, decrease, cancellation or rescheduling of
significant customer orders;
|
|
|
|
the timing of revenue recognition based on the installation or
acceptance of certain products shipped to our customers;
|
|
|
|
seasonality attributable to different purchasing patterns and
levels of activity throughout the year in the areas where we
operate;
|
|
|
|
the timing of customer qualification of our products and
commencement of volume sales of systems that include our
products;
|
|
|
|
our ability to obtain export licenses for our products on a
timely basis or at all;
|
|
|
|
the rate at which our present and future customers and end users
adopt our technologies;
|
|
|
|
the gain or loss of a key customer;
|
|
|
|
product or customer mix;
|
|
|
|
competitive pricing pressures;
|
|
|
|
the relative proportions of our U.S. and international
sales;
|
|
|
|
our ability to design, manufacture and introduce new products on
a cost-effective and timely basis;
|
24
|
|
|
|
|
our ability to manage our inventory levels and any inventory
write-downs;
|
|
|
|
the incurrence of expenses to develop and improve application
and support capabilities, the benefits of which may not be
realized until future periods, if at all;
|
|
|
|
different capital expenditure and budget cycles for our
customers, which affect the timing of their spending;
|
|
|
|
foreign currency fluctuations; and
|
|
|
|
our ability to control expenses.
|
These factors make it difficult for us to accurately predict our
operating results. In addition, our ability to accurately
predict our operating results is complicated by the fact that
many of our products have long sales cycles, some lasting as
long as twelve months. Once a sale is made, our delivery
schedule typically ranges from four weeks to four months, and
therefore our sales will often reflect orders shipped in the
same quarter that they are received and will not enhance our
ability to predict our results for future quarters. In addition,
long sales cycles may cause us to incur significant expenses
without offsetting revenues since customers typically expend
significant effort in evaluating, testing and qualifying our
products before making a decision to purchase them. Moreover,
customers may cancel or reschedule shipments, and production
difficulties could delay shipments. Accordingly, our results of
operations are subject to significant fluctuations from quarter
to quarter, and we may not be able to accurately predict when
these fluctuations will occur.
Foreign
currency transaction risk may negatively affect our net sales,
cost of sales and operating margins and could result in exchange
losses.
We conduct our business and incur costs in the local currency of
most countries in which we operate. In 2010, our net sales
outside the United States represented a significant portion of
our total sales. We incur currency transaction risk whenever one
of our operating subsidiaries enters into either a purchase or a
sales transaction using a different currency from the currency
in which it receives revenues. Changes in exchange rates can
also affect our results of operations by changing the
U.S. dollar value of sales and expenses denominated in
foreign currencies. We cannot accurately predict the impact of
future exchange rate fluctuations on our results of operations.
Further, given the volatility of exchange rates, we may not be
able to effectively manage our currency transaction or
translation risks, and any volatility in currency exchange rates
may increase the price of our products in local currency to our
foreign customers, which may have an adverse effect on our
financial condition, cash flows and profitability.
We
depend on our OEM customers and system integrators and their
ability to incorporate our products into their
systems.
Our sales depend in part on our ability to maintain existing and
secure new OEM customers. Our revenues also depend in part upon
the ability of our current and potential OEM customers and
system integrators to develop and sell systems that incorporate
our laser and amplifier products. The commercial success of
these systems depends to a substantial degree on the efforts of
these OEM customers and system integrators to develop and market
products that incorporate our technologies. Relationships and
experience with traditional laser makers, limited marketing
resources, reluctance to invest in research and development and
other factors affecting these OEM customers and third-party
system integrators could have a substantial impact upon our
financial results. If OEM customers or integrators are not able
to adapt existing tools or develop new systems to take advantage
of the features and benefits of fiber lasers, then the
opportunities to increase our revenues and profitability may be
severely limited or delayed. Furthermore, if our OEM customers
or third-party system integrators experience financial or other
difficulties that adversely affect their operations, our
financial condition or results of operations may also be
adversely affected.
25
The
markets for our products are highly competitive and increased
competition could increase our costs, reduce our sales or cause
us to lose market share.
The industries in which we operate are characterized by
significant price and technological competition. Our fiber laser
and amplifier products compete with conventional laser
technologies and amplifier products offered by several
well-established companies, some of which are larger and have
substantially greater financial, managerial and technical
resources, more extensive distribution and service networks,
greater sales and marketing capacity, and larger installed
customer bases than we do. Also, we compete with widely used
non-laser production methods, such as resistance welding. We
believe that competition will be particularly intense from
makers of
CO2,
YAG and disc lasers, as these makers of conventional solutions
may lower prices to maintain current market share and have
committed significant research and development resources to
pursue opportunities related to these technologies.
In addition, we face competition from a growing number of fiber
laser makers, including Rofin-Sinar Technologies, Inc., Trumpf
GmbH + Co. KG, GSI Group Inc., Coherent Inc., Newport
Corporation, The Furukawa Electric Co., Ltd., Keopsys SA,
Mitsubishi Cable Industries, Ltd., Miyachi Unitek Corporation,
MPB Communications Inc. and JDS Uniphase Corporation.
Competition from other fiber laser makers has increased and some
have introduced fiber lasers or announced plans to introduce
fiber lasers that compete with our products. We may not be able
to successfully differentiate our current and proposed products
from our competitors products and current or prospective
customers may not consider our products to be superior to
competitors products. To maintain our competitive
position, we believe that we will be required to continue a high
level of investment in research and development, application
development and customer service and support, and to react to
market pricing conditions. We may not have sufficient resources
to continue to make these investments and we may not be able to
make the technological advances or price adjustments necessary
to maintain our competitive position. We also compete against
our OEM customers internal production of competitive laser
technologies.
Our
inability to manage risks associated with our international
customers and operations could adversely affect our
business.
Our have significant facilities in and our products aresold in
numerous countries. The United States, Germany, Japan, Russia
and China are our principal markets. A significant amount of our
revenues are derived from customers, and we have substantial
tangible assets, outside of the United States. We anticipate
that foreign sales will continue to account for a significant
portion of our revenues in the foreseeable future. Our
operations and sales in these markets are subject to risks
inherent in international business activities, including:
|
|
|
|
|
longer accounts receivable collection periods;
|
|
|
|
fluctuations in the values of foreign currencies;
|
|
|
|
changes in a specific countrys or regions economic
conditions, such as recession;
|
|
|
|
compliance with a wide variety of domestic and foreign laws and
regulations and unexpected changes in those laws and regulatory
requirements, including uncertainties regarding taxes, tariffs,
quotas, export controls, export licenses and other trade
barriers;
|
|
|
|
certification requirements;
|
|
|
|
environmental regulations;
|
|
|
|
less effective protection of intellectual property rights in
some countries;
|
|
|
|
potentially adverse tax consequences;
|
|
|
|
different capital expenditure and budget cycles for our
customers, which affect the timing of their spending;
|
26
|
|
|
|
|
political, legal and economic instability, foreign conflicts,
and the impact of regional and global infectious illnesses in
the countries in which we and our customers, suppliers,
manufacturers and subcontractors are located;
|
|
|
|
preference for locally produced products;
|
|
|
|
difficulties and costs of staffing and managing international
operations across different geographic areas and cultures;
|
|
|
|
seasonal reductions in business activities; and
|
|
|
|
fluctuations in freight rates and transportation disruptions.
|
Political and economic instability and changes in governmental
regulations could adversely affect both our ability to
effectively operate our foreign sales offices and the ability of
our foreign suppliers to supply us with required materials or
services. Any interruption or delay in the supply of our
required components, products, materials or services, or our
inability to obtain these components, materials, products or
services from alternate sources at acceptable prices and within
a reasonable amount of time, could impair our ability to meet
scheduled product deliveries to our customers and could cause
customers to cancel orders.
We are also subject to risks of doing business in Russia through
our subsidiary, NTO IRE-Polus, which provides components and
test equipment to us and sells finished fiber devices to
customers in Russia and neighboring countries. The results of
operations, business prospects and facilities of NTO IRE-Polus
are subject to the economic and political environment in Russia.
Recently, a Russian investor purchased a minority interest in
NTO IRE-Polus. As a minority investor, they have rights under
Russian law, as well as under our negotiated agreements with
them. Even though we control a supermajority of the shares and a
majority of the board, certain actions require unanimous
shareholder approval, including changes to capital, additional
investments, use of proceeds other than initially agreed to uses
and amounts, distributions, transactions in excess of agreed
upon amounts and related party transactions. In recent years
Russia has undergone substantial political, economic and social
change. As is typical of an emerging market, Russia does not
possess a well-developed business, legal and regulatory
infrastructure that would generally exist in a more mature free
market economy. In addition, the tax, currency and customs
legislation within Russia is subject to varying interpretations
and changes, which can occur frequently. The future economic
direction of Russia remains largely dependent upon the
effectiveness of economic, financial and monetary measures
undertaken by the government, together with tax, legal,
regulatory and political developments. Our failure to manage the
risks associated with NTO IRE-Polus and our other existing and
potential future international business operations could have a
material adverse effect upon our results of operations.
Our
products could contain defects, which may reduce sales of those
products, harm market acceptance of our fiber laser products or
result in claims against us.
The manufacture of our fiber lasers and amplifiers involves
highly complex and precise processes. Despite testing by us and
our customers, errors have been found, and may be found in the
future, in our products. These defects may cause us to incur
significant warranty, support and repair costs, incur additional
costs related to a recall, divert the attention of our
engineering personnel from our product development efforts and
harm our relationships with our customers. These problems could
result in, among other things, loss of revenues or a delay in
revenue recognition, loss of market share, harm to our
reputation or a delay or loss of market acceptance of our fiber
laser products. Defects, integration issues or other performance
problems in our fiber laser and amplifier products could also
result in personal injury or financial or other damages to our
customers, which in turn could damage market acceptance of our
products. Our customers could also seek damages from us for
their losses. A product liability claim brought against us, even
if unsuccessful, could be time-consuming and costly to defend.
27
We may
pursue acquisitions and investments in new businesses, products,
patents or technologies. These may involve risks which could
disrupt our business and may harm our financial
condition.
We currently have no binding commitments or agreements to make
any acquisitions and have limited experience in making
acquisitions. In the future, we may make acquisitions of and
investments in new businesses, products, patents, technologies
and geographic areas, or we may acquire operations, products or
technologies that expand our current capabilities. Acquisitions
present a number of potential risks and challenges that could,
if not met, disrupt our business operations, increase our
operating costs and reduce the value of the acquired company,
asset or technology to us. For example, if we identify an
acquisition candidate, we may not be able to successfully
negotiate or finance the acquisition on favorable terms. Even if
we are successful, we may not be able to integrate the acquired
businesses, products, patents or technologies into our existing
business and products. As a result of the rapid pace of
technological change in our industry, we may misjudge the
long-term potential of an acquired business, product, patent or
technology, or the acquisition may not be complementary to our
existing business. Furthermore, potential acquisitions and
investments, whether or not consummated, may divert our
managements attention and require considerable cash
outlays at the expense of our existing operations. In addition,
to complete future acquisitions, we may issue equity securities,
incur debt, assume contingent liabilities or have amortization
expenses and write-downs of acquired assets, which could
adversely affect our profitability and result in dilution to our
existing and future stockholders.
We are
subject to various environmental laws and regulations that could
impose substantial costs upon us and may adversely affect our
business, operating results and financial
condition.
Some of our operations use substances regulated under various
federal, state, local and international laws governing the
environment, including those relating to the storage, use,
discharge, disposal, product composition and labeling of, and
human exposure to, hazardous and toxic materials. We could incur
costs, fines and civil or criminal sanctions, third-party
property damage or personal injury claims, or could be required
to incur substantial investigation or remediation costs, if we
were to violate or become liable under environmental laws.
Liability under environmental laws can be joint and several and
without regard to comparative fault. Compliance with current or
future environmental laws and regulations could restrict our
ability to expand our facilities or require us to acquire
additional expensive equipment, modify our manufacturing
processes, or incur other significant expenses in order to
remain in compliance with such laws and regulations. At this
time, we do not believe the costs to maintain compliance with
current environmental laws to be material. Although we do not
currently anticipate that such costs will become material, if
such costs were to become material in the future, whether due to
unanticipated changes in environmental laws, unanticipated
changes in our operations or other unanticipated changes, we may
be required to dedicate additional staff or financial resources
in order to maintain compliance. There can be no assurance that
violations of environmental laws or regulations will not occur
in the future as a result of the lack of obtain permits, human
error, accident, equipment failure or other causes.
We are
subject to export control regulations that could restrict our
ability to increase our international sales and may adversely
affect our business.
A significant part of our business involves the export of our
products to other countries. The U.S. government has in
place a number of laws and regulations that control the export,
re-export or transfer of
U.S.-origin
products, software and technology. The governments of other
countries in which we do business have similar regulations
regarding products, software and technology originating in those
countries. These laws and regulations may require that we obtain
a license before we can export, re-export or transfer certain
products, software or technology. The requirement to obtain a
license could put us at a competitive disadvantage by
restricting our ability to sell products to customers in certain
countries or by giving rise to delays or expenses related to
obtaining a license. In applying for a license and responding to
questions from licensing authorities, we have experienced and,
in the future, may experience delays in obtaining export
licenses based on issues solely within the control of the
applicable government agency. Under the discretion of the
issuing government agency, an export license may permit the
export of one unit to a single customer or multiple units to one
or more customers. Licenses may also include conditions that
limit the use, resale, transfer, re-export,
28
modification, disassembly, or transfer of a product, software or
technology after it is exported without first obtaining
permission from the relevant government agency. Failure to
comply with these laws and regulations could result in
government sanctions, including substantial monetary penalties,
denial of export privileges, debarment from government contracts
and a loss of revenues. Delays in obtaining or failure to obtain
required export licenses may require us to defer shipments for
substantial periods or cancel orders. Any of these circumstances
could adversely affect our operations and, as a result, our
financial results could suffer.
Our
ability to access financial markets to finance a portion of our
working capital requirements and support our liquidity needs may
be adversely affected by factors beyond our control and could
negatively impact our ability to finance our operations, meet
certain obligations or implement our operating
strategy.
We occasionally borrow under our existing credit facilities to
fund operations, including working capital investments. Our
major credit lines in the U.S. and Germany expire in June
2015 and June 2012, respectively. Market disruptions such as
those currently being experienced in the United States and
abroad have materially impacted liquidity in the credit and debt
markets, making financing terms for borrowers less attractive,
and, in certain cases, have resulted in the unavailability of
certain types of financing. Continued uncertainty in the
financial markets may negatively impact our ability to access
additional financing or to refinance our existing credit
facilities or existing debt arrangements on favorable terms or
at all, which could negatively affect our ability to fund
current and future expansion as well as future acquisitions and
development. These disruptions may include turmoil in the
financial services industry, unprecedented volatility in the
markets where our outstanding securities trade, and general
economic downturns in the areas where we do business. If we are
unable to access funds at competitive rates, or if our
short-term or long-term borrowing costs increase, our ability to
finance our operations, meet our short-term obligations and
implement our operating strategy could be adversely affected.
Our
ability to raise capital in the future may be limited, and our
failure to raise capital when needed could prevent us from
growing.
We may in the future be required to raise capital through public
or private financing or other arrangements. Such financing may
not be available on acceptable terms, or at all, and our failure
to raise capital when needed could harm our business. Additional
equity financing may be dilutive to the holders of our common
stock, and debt financing, if available, may involve restrictive
covenants and could reduce our profitability. If we cannot raise
funds on acceptable terms, we may not be able to grow our
business or respond to competitive pressures.
Dr. Valentin
P. Gapontsev, our Chairman and Chief Executive Officer and two
trusts he created control approximately 42% of our voting power
and have a significant influence on the outcome of director
elections and other matters requiring stockholder approval,
including a change in corporate control.
Dr. Valentin P. Gapontsev, our Chairman and Chief Executive
Officer, and IP Fibre Devices (UK) Ltd. (IPFD), of which
Dr. Gapontsev is the managing director, together with two
trusts he created beneficially own approximately 42% of our
common stock. Trustees of the trusts are officers or employees
of the Company. Dr. Gapontsev and the trusts have a
significant influence on the outcome of matters requiring
stockholder approval, including:
|
|
|
|
|
election of our directors;
|
|
|
|
amendment of our certificate of incorporation or
by-laws; and
|
|
|
|
approval of mergers, consolidations or the sale of all or
substantially all of our assets.
|
Dr. Gapontsev and the trusts may vote their shares of our
common stock in ways that are adverse to the interests of other
holders of our common stock. These significant ownership
interests could delay, prevent or cause a change in control of
our company, any of which could adversely affect the market
price of our common stock.
29
Anti-takeover
provisions in our charter documents and Delaware law could
prevent or delay a change in control of our company, even if a
change in control would be beneficial to our
stockholders.
Provisions of our certificate of incorporation and by-laws,
including certain provisions that will take effect when
Dr. Valentin P. Gapontsev (together with his affiliates and
associates) ceases to beneficially own an aggregate of 25% or
more of our outstanding voting securities, may discourage, delay
or prevent a merger, acquisition or change of control, even if
it would be beneficial to our stockholders. The existence of
these provisions could also limit the price that investors might
be willing to pay in the future for shares of our common stock.
These provisions include:
|
|
|
|
|
authorizing the issuance of blank check preferred
stock;
|
|
|
|
establishing a classified board;
|
|
|
|
providing that directors may only be removed for cause;
|
|
|
|
prohibiting stockholder action by written consent;
|
|
|
|
limiting the persons who may call a special meeting of
stockholders;
|
|
|
|
establishing advance notice requirements for nominations for
election to the board of directors and for proposing matters to
be submitted to a stockholder vote; and
|
|
|
|
supermajority stockholder approval to change these provisions.
|
Provisions of Delaware law may also discourage, delay or prevent
someone from acquiring or merging with our company or obtaining
control of our company. Specifically, Section 203 of the
Delaware General Corporation Law, which will apply to our
company following such time as Dr. Gapontsev (together with
his affiliates and associates) ceases to beneficially own 25% or
more of the total voting power of our outstanding shares, may
prohibit business combinations with stockholders owning 15% or
more of our outstanding voting stock.
Substantial
sales of our common stock, including shares issued upon the
exercise of currently outstanding options or pursuant to our
universal shelf registration statement, could cause our stock
price to decline.
Sales of a substantial number of shares of common stock, or the
perception that sales could occur, could adversely affect the
market price of our common stock. As of December 31, 2010,
we had 46,988,566 shares of common stock outstanding and
approximately 2,736,000 shares subject to outstanding
options. We have registered all shares of common stock that we
may issue under our stock option plans and our employee stock
ownership plan. In addition, all of our unregistered shares of
our common stock are now eligible for sale under Rule 144,
or Rule 701. As these shares are issued, they may be freely
sold in the public market, and subject, in the case of any
awards under our stock-based compensation plans, to applicable
vesting requirements.
We currently have the ability to offer and sell common stock,
preferred stock, warrants, debt and convertible securities under
a currently effective universal shelf registration statement. In
the future, we may issue additional options, warrants or other
securities convertible into our common stock. Sales of
substantial amounts of shares of our common stock or other
securities under our universal shelf registration statement
could lower the market price of our common stock and impair our
ability to raise capital through the sale of equity securities.
If
securities analysts stop publishing research or reports about
our business, or if they downgrade our stock, the price of our
stock could decline.
The trading market for our common stock relies in part on the
research and reports that industry or financial analysts publish
about us. If one or more of these analysts who do cover us
downgrade our stock, our stock price would likely decline.
Further, if one or more of these analysts cease coverage of our
company, we could lose visibility in the market, which in turn
could cause our stock price to decline.
30
|
|
ITEM 1B.
|
UNRESOLVED
STAFF COMMENTS
|
None.
Our main facilities at December 31, 2010 include the
following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Owned or
|
|
Lease
|
|
|
Approximate
|
|
|
|
Location
|
|
Leased
|
|
Expiration
|
|
|
Size (sq. ft.)
|
|
|
Primary Activity
|
|
Oxford, Massachusetts
|
|
Owned
|
|
|
|
|
|
|
261,000
|
|
|
Diodes, components, complete device manufacturing, administration
|
Burbach, Germany
|
|
Owned
|
|
|
|
|
|
|
206,000
|
|
|
Optical fiber, components, final assembly, complete device
manufacturing, administration
|
Fryazino, Russia
|
|
Leased
|
|
|
|
|
|
|
69,000
|
|
|
Components, complete device
|
|
|
Owned
|
|
|
|
|
|
|
35,000
|
|
|
manufacturing, administration
|
Beijing, China
|
|
Owned
|
|
|
|
|
|
|
38,000
|
|
|
Administration, service
|
Novi, Michigan
|
|
Owned
|
|
|
|
|
|
|
16,000
|
|
|
Administration, service
|
Legnano, Italy
|
|
Leased
|
|
|
June 2011
|
|
|
|
12,000
|
|
|
Complete device manufacturing, administration
|
Yokohama, Japan
|
|
Leased
|
|
|
November 2011
|
|
|
|
22,000
|
|
|
Administration, service
|
|
|
|
* |
|
Subject to ongoing renewal discussions. |
We maintain our corporate headquarters in Oxford, Massachusetts,
and conduct research and development in Oxford, Massachusetts,
Burbach, Germany and Fryazino, Russia. We operate four
manufacturing facilities for lasers, amplifiers and components,
which are located in the United States, Germany, Russia and
Italy. We also manufacture certain optical components and
systems in India and China. We are committed to meeting
internationally recognized manufacturing standards. Our
facilities in the United States and Germany are ISO 9001
certified and we have ISO certification in Russia for specific
products. We have sales personnel at each of our manufacturing
facilities, and at offices in Novi, Michigan; Santa Clara,
California; London, England; Illkirch, France; Yokohama and
Chubu, Japan; Daejeon, South Korea; Bangalore, India; Beijing,
China; and Singapore.
We plan to expand our operations in Russia, Germany, China,
Italy and the United States to meet the demand for our products
and our sales and support needs. We believe that we will be able
to obtain additional land or commercial space as needed.
|
|
ITEM 3.
|
LEGAL
PROCEEDINGS
|
From time to time, we are party to various legal proceedings and
other disputes incidental to our business, including those
described below. For a discussion of the risks associated with
these legal proceedings and other disputes, see Item 1A.
Risk Factors We are subject to litigation
alleging that we are infringing third-party intellectual
property rights. Intellectual property claims could result in
costly litigation and harm our business.
In November 2006, IMRA America, Inc. filed an action against us
alleging that certain products we produce, including but not
limited to our continuous wave and pulsed fiber lasers and fiber
amplifiers, which account for a significant portion of our
revenues, infringe one U.S. patent allegedly owned by IMRA
America. IMRA America alleged willful infringement and sought
damages of at least $10 million, treble damages and
injunctive relief. IMRA America also alleged inducement of
infringement and contributory infringement. This lawsuit
concerns products made, used, sold or offered for sale in or
imported into the United States and therefore the lawsuit
affects products that account for a substantial portion of our
revenues. We filed an answer
31
in which we denied infringement and raised additional defenses
that the patent is invalid and unenforceable. In addition, we
filed declaratory judgment counterclaims based on these three
defenses. This lawsuit does not affect revenues that are derived
from products that are not made, used, sold or offered for sale
in or imported into the United States. IMRA America has informed
us that it has patents and applications in foreign jurisdictions
directed to similar subject matter as the patent subject to this
lawsuit, but has not asserted them against us. In June 2008, the
USPTO ordered re-examination of the patent claims asserted by
IMRA America, Inc. against the Company based on several prior
art references that we submitted in an ex parte re-examination
request. In July 2009, the USPTO confirmed the patentability of
all of the claims in the IMRA America Inc., patent over the
prior art cited in the re-examination, as well as of new claims
added during the re-examination. In August 2009, we submitted an
additional re-examination request, which was denied by the
USPTO. The USPTO issued a re-examination certificate in October
2009. As a result, the U.S. District Court for the Eastern
District of Michigan lifted the stay on the litigation. The
District Court adopted the claim construction of IMRA on one of
the four claim terms, but did not decide the others. In March
2011, the District Court granted our motion for summary judgment
of no marking, precluding IMRA from seeking damages for any
alleged infringing products sold prior to November 16,
2006, the date the lawsuit was filed, with the exception of four
particular alleged infringing products, as to which IMRA is
precluded from seeking damages for sales prior to August 6,
2006. The District Court denied our motions for summary judgment
on non-infringement, invalidity, no willful infringement and
laches, and granted IMRAs for summary judgment on no
invalidity for derivation and no equitable misconduct. The trial
date has not been scheduled. We intend to vigorously contest the
claims against us, but we cannot predict the outcome of the
proceeding.
|
|
ITEM 4.
|
[REMOVED
AND RESERVED]
|
PART II
|
|
ITEM 5.
|
MARKET
FOR THE REGISTRANTS COMMON EQUITY, RELATED STOCKHOLDER
MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
|
Price
Range of Common Stock
Our common stock is quoted on the Nasdaq Global Market under the
symbol IPGP. The following table sets forth the
quarterly high and low sale prices of our common stock as
reported on the Nasdaq Global Market.
|
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
|
|
Price
|
|
|
|
High
|
|
|
Low
|
|
|
First Quarter ended March 31, 2009
|
|
$
|
13.56
|
|
|
$
|
6.79
|
|
Second Quarter ended June 30, 2009
|
|
$
|
11.80
|
|
|
$
|
8.36
|
|
Third Quarter ended September 30, 2009
|
|
$
|
15.35
|
|
|
$
|
9.48
|
|
Fourth Quarter ended December 31, 2009
|
|
$
|
17.62
|
|
|
$
|
12.98
|
|
First Quarter ended March 31, 2010
|
|
$
|
17.42
|
|
|
$
|
13.32
|
|
Second Quarter ended June 30, 2010
|
|
$
|
19.20
|
|
|
$
|
14.57
|
|
Third Quarter ended September 30, 2010
|
|
$
|
25.29
|
|
|
$
|
13.93
|
|
Fourth Quarter ended December 31, 2010
|
|
$
|
33.43
|
|
|
$
|
19.87
|
|
As of March 8, 2011, there were 47,215,469 shares of
our common stock outstanding held by approximately 60 holders of
record, which does not include beneficial owners of common stock
whose shares are held in the names of various securities
brokers, dealers and registered clearing agencies.
32
Stock
Price Performance Graph
The following Stock Price Performance Graph and related
information includes comparisons required by the SEC. The Graph
does not constitute soliciting material and should
not be deemed filed or incorporated by reference
into any other filings under the Securities Act of 1933, as
amended, or the Securities Exchange Act of 1934, as amended,
except to the extent that we specifically incorporate this
information by reference into such filing.
The following graph presents the cumulative shareholder returns
for our Common Stock compared with the NASDAQ Composite Index
and the S&P Technology Sector Index. We selected these
comparative groups due to industry similarities and the fact
that they contain several direct competitors.
COMPARISON
OF CUMULATIVE TOTAL RETURN
AMONG THE COMPANY, THE NASDAQ COMPOSITE INDEX AND S&P
500
TECHNOLOGY SECTOR INDEX
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/13/2006
|
|
12/31/2006
|
|
12/31/2007
|
|
12/31/2008
|
|
12/31/2009
|
|
12/31/2010
|
|
IPG Photonics Corporation
|
|
$
|
100.00
|
|
|
$
|
93.75
|
|
|
$
|
78.09
|
|
|
$
|
51.48
|
|
|
$
|
65.35
|
|
|
$
|
123.52
|
|
Nasdaq Composite (U.S. & Foreign)
|
|
$
|
100.00
|
|
|
$
|
99.30
|
|
|
$
|
109.04
|
|
|
$
|
64.83
|
|
|
$
|
93.29
|
|
|
$
|
109.06
|
|
S&P 500 Technology Sector Index
|
|
$
|
100.00
|
|
|
$
|
99.74
|
|
|
$
|
113.91
|
|
|
$
|
66.14
|
|
|
$
|
98.14
|
|
|
$
|
107.53
|
|
The above graph represents and compares the value, through
December 31, 2010, of a hypothetical investment of $100
made at the closing price on December 13, 2006 (which was
the date that our common stock began trading on the Nasdaq
Global Market) in each of (i) our common stock,
(ii) the NASDAQ Composite Stock Index and (iii) the
S&P 500 Technology Sector Index, in each case assuming the
reinvestment of dividends. The stock price performance shown in
this graph is not necessarily indicative of, and not is intended
to suggest, future stock price performance.
33
Dividends
We have never declared or paid any cash dividends on our capital
stock. We anticipate that we will retain any future earnings to
support operations and to finance the growth and development of
our business. Therefore, we do not expect to pay cash dividends
in the foreseeable future. Our payment of any future dividends
will be at the discretion of our Board of Directors after taking
into account any business conditions, any contractual and legal
restrictions on our payment of dividends, and our financial
condition, operating results, cash needs and growth plans. In
addition, current agreements with certain of our lenders
contain, and future loan agreements may contain, restrictive
covenants that generally prohibit us from paying cash dividends,
making any distribution on any class of stock or making stock
repurchases.
Recent
Sales of Unregistered Securities; Use of Proceeds from
Registered Securities
During the past three years, we have sold and issued the
following unregistered securities:
1. In December 2008, we issued 50,680 unregistered shares
of common stock as partial payment of the purchase price for the
20% noncontrolling interest in IPG Photonics (Italy), S.r.l.
that we did not previously own. IPG Photonics (Italy), S.r.l. is
now 100% owned by us. The shares were valued at $13.05 per
share, the closing price on November 17, 2008.
2. In March 2009, we issued 293,146 unregistered shares of
common stock as payment of the purchase price for a 31.6%
noncontrolling interest in NTO IRE-Polus. The aggregate sale
price for the shares was $6,117,973.
3. In May 2009, we issued 75,000 unregistered shares of
common stock as partial payment of the purchase price for the
20% noncontrolling interest in IPG Photonics (Japan), Ltd. IPG
Photonics (Japan), Ltd. is now 100% owned by us. The aggregate
sale price for the shares was $848,000.
The sales of securities described above were deemed to be exempt
from registration pursuant to Section 4(2) of the
Securities Act and Regulation D promulgated thereunder as
transactions by an issuer not involving a public offering. Each
of these sales was to accredited investors, as such
term is defined in Rule 501 of Regulation D. Each of
the recipients of securities in the transactions deemed to be
exempt from registration pursuant to Section 4(2) of the
Securities Act received written disclosures that the securities
had not been registered under the Securities Act and that any
resale must be made pursuant to a registration or an available
exemption from such registration. None of the sales of the
securities described above involved the use of an underwriter,
and no commissions were paid in connection with the sale of any
of the securities that we issued. The sales of these securities
were made without general solicitation or advertising.
Issuer
Purchases of Equity Securities
During the quarter ended December 31, 2010, there were no
repurchases made by us or on our behalf, or by any
affiliated purchasers, of shares of our common stock.
34
Information
Regarding Equity Compensation Plans
The following table sets forth information with respect to
securities authorized for issuance under our equity compensation
plans as of December 31, 2010:
Equity
Compensation Plan Information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities
|
|
|
|
Number of Securities
|
|
|
|
|
|
Remaining Available
|
|
|
|
to be Issued upon
|
|
|
Weighted-Average
|
|
|
for Future Issuance
|
|
|
|
Exercise of
|
|
|
Exercise Price of
|
|
|
Under Equity
|
|
|
|
Outstanding
|
|
|
Outstanding
|
|
|
Compensation Plans
|
|
|
|
Options, Warrants
|
|
|
Options, Warrants
|
|
|
(Excluding Securities
|
|
|
|
and Rights
|
|
|
and Rights
|
|
|
Reflected in Column (a))
|
|
Plan Category
|
|
(a)
|
|
|
(b)
|
|
|
(c)
|
|
|
Equity Compensation Plans Approved by Security Holders
|
|
|
2,736,443
|
|
|
$
|
10.33
|
|
|
|
1,526,358
|
|
Equity Compensation Plans Not Approved by Security Holders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
2,736,443
|
|
|
|
|
|
|
|
1,526,358
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35
|
|
ITEM 6.
|
SELECTED
FINANCIAL DATA
|
The following selected consolidated financial data should be
read in conjunction with, and is qualified by reference to, our
consolidated financial statements and related notes and
Item 7, Managements Discussion and Analysis of
Financial Condition and Results of Operations included
elsewhere in this Annual Report on
Form 10-K.
The data as of December 31, 2010 and 2009, and for the
years ended December 31, 2010, 2009 and 2008, is derived
from our audited consolidated financial statements and related
notes included elsewhere in this Annual Report on
Form 10-K.
The data as of December 31, 2008, 2007 and 2006, and for
the years ended December 31, 2007 and 2006, is derived from
our audited consolidated financial statements and related notes
not included in this Annual Report on
Form 10-K.
Our historical results are not necessarily indicative of the
results for any future period.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands, except per share data)
|
|
|
Consolidated Statement of Operations Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
299,256
|
|
|
$
|
185,894
|
|
|
$
|
229,076
|
|
|
$
|
188,677
|
|
|
$
|
143,225
|
|
Cost of sales
|
|
|
152,798
|
|
|
|
121,626
|
|
|
|
121,776
|
|
|
|
103,695
|
|
|
|
79,931
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
146,458
|
|
|
|
64,268
|
|
|
|
107,300
|
|
|
|
84,982
|
|
|
|
63,294
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing
|
|
|
19,100
|
|
|
|
15,157
|
|
|
|
13,900
|
|
|
|
10,103
|
|
|
|
6,222
|
|
Research and development
|
|
|
19,160
|
|
|
|
18,543
|
|
|
|
15,804
|
|
|
|
9,527
|
|
|
|
6,544
|
|
General and administrative
|
|
|
28,645
|
|
|
|
20,489
|
|
|
|
23,198
|
|
|
|
20,203
|
|
|
|
13,757
|
|
(Gain) loss on foreign exchange
|
|
|
(848
|
)
|
|
|
1,022
|
|
|
|
(2,798
|
)
|
|
|
(1,175
|
)
|
|
|
765
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
66,057
|
|
|
|
55,211
|
|
|
|
50,104
|
|
|
|
38,658
|
|
|
|
27,288
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
80,401
|
|
|
|
9,057
|
|
|
|
57,196
|
|
|
|
46,324
|
|
|
|
36,006
|
|
Interest (expense) income, net
|
|
|
(1,188
|
)
|
|
|
(1,252
|
)
|
|
|
(777
|
)
|
|
|
674
|
|
|
|
(1,493
|
)
|
Fair value adjustment to series B warrants(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(7,444
|
)
|
Other income (expense), net
|
|
|
39
|
|
|
|
(36
|
)
|
|
|
145
|
|
|
|
612
|
|
|
|
1,050
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before (provision for) benefit from income taxes
|
|
|
79,252
|
|
|
|
7,769
|
|
|
|
56,564
|
|
|
|
47,610
|
|
|
|
28,119
|
|
(Provision for) benefit from income taxes
|
|
|
(24,900
|
)
|
|
|
(2,485
|
)
|
|
|
(18,111
|
)
|
|
|
(15,522
|
)
|
|
|
2,995
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
54,352
|
|
|
|
5,284
|
|
|
|
38,453
|
|
|
|
32,088
|
|
|
|
31,114
|
|
Less: Net income (loss) attributable to noncontrolling interests
|
|
|
361
|
|
|
|
(135
|
)
|
|
|
1,799
|
|
|
|
2,193
|
|
|
|
1,881
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to IPG Photonics Corporation
|
|
|
53,991
|
|
|
|
5,419
|
|
|
|
36,654
|
|
|
|
29,895
|
|
|
|
29,233
|
|
Accretion of series B preferred stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,994
|
)
|
Beneficial conversion feature
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(18,267
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to common shareholders
|
|
$
|
53,991
|
|
|
$
|
5,419
|
|
|
$
|
36,654
|
|
|
$
|
29,895
|
|
|
$
|
8,972
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.16
|
|
|
$
|
0.12
|
|
|
$
|
0.82
|
|
|
$
|
0.69
|
|
|
$
|
0.27
|
|
Diluted
|
|
$
|
1.13
|
|
|
$
|
0.12
|
|
|
$
|
0.79
|
|
|
$
|
0.65
|
|
|
$
|
0.26
|
|
Weighted-average shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
46,424
|
|
|
|
45,489
|
|
|
|
44,507
|
|
|
|
43,269
|
|
|
|
27,896
|
|
Diluted
|
|
|
47,594
|
|
|
|
46,595
|
|
|
|
46,223
|
|
|
|
45,749
|
|
|
|
33,005
|
|
|
|
|
(1) |
|
The change in value of the series B warrants is a non-cash
charge related to recording the increase or decrease in the fair
value of the warrants prior to their conversion in December
2006. The change in fair value for this derivative instrument
was directly related to the probability that the warrants would
be |
36
|
|
|
|
|
exercised prior to their expiration in April 2008. We used a
portion of the net proceeds from our IPO to repurchase the
series B warrants. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Consolidated Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
147,860
|
|
|
$
|
82,920
|
|
|
$
|
51,283
|
|
|
$
|
37,972
|
|
|
$
|
75,667
|
|
Working capital, excluding cash and cash equivalents
|
|
|
70,171
|
|
|
|
61,163
|
|
|
|
80,714
|
|
|
|
83,237
|
|
|
|
40,001
|
|
Total assets
|
|
|
441,855
|
|
|
|
312,636
|
|
|
|
313,218
|
|
|
|
263,321
|
|
|
|
232,492
|
|
Revolving
line-of-credit
facilities
|
|
|
6,841
|
|
|
|
6,007
|
|
|
|
19,769
|
|
|
|
11,218
|
|
|
|
2,603
|
|
Long-term debt, including current portion
|
|
|
16,977
|
|
|
|
18,000
|
|
|
|
19,330
|
|
|
|
20,000
|
|
|
|
38,367
|
|
Redeemable noncontrolling interests
|
|
|
24,903
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders equity
|
|
$
|
316,600
|
|
|
$
|
256,430
|
|
|
$
|
238,172
|
|
|
$
|
200,180
|
|
|
$
|
158,594
|
|
|
|
ITEM 7.
|
MANAGEMENTS
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
|
The following discussion and analysis of our financial
condition and results of operations should be read in
conjunction with Item 6, Selected Consolidated
Financial Data and our consolidated financial statements
and related notes included in this Annual Report of
Form 10-K.
This discussion contains forward-looking statements that involve
risks and uncertainties. Our actual results could differ
materially from those anticipated in these forward-looking
statements as a result of certain factors including, but not
limited to, those discussed under Item 1A, Risk
Factors.
Overview
We develop and manufacture a broad line of high-performance
fiber lasers for diverse applications in numerous markets. Fiber
lasers are a new generation of lasers that combine the long life
and high efficiency of semiconductor diodes with the high
amplification and precise beam qualities of specialty optical
fibers. Fiber lasers deliver superior performance, reliability
and usability at a generally lower total cost of ownership
compared to
CO2
and crystal lasers. Our products are displacing conventional
lasers in many current applications and also enable new
applications for lasers.
Our diverse lines of low, mid and high-power lasers and
amplifiers are used in materials processing, advanced,
communications and medical applications. We sell our products
globally to original equipment manufacturers, or OEMs, system
integrators and end users. We market our products
internationally primarily through our direct sales force and
also through agreements with independent sales representatives
and distributors. We have sales offices in the United States,
Germany, Italy, France, the United Kingdom, Japan, China, South
Korea, Singapore, India and Russia.
We are vertically integrated. We design and manufacture most key
components used in our finished products, including
semiconductor diodes, optical fiber preforms and cables,
finished fiber lasers and amplifiers. We also manufacture
certain complementary products used with our lasers including
optical heads, beam splitters and chillers. Our vertically
integrated operations allow us to reduce manufacturing costs,
ensure access to critical components, rapidly develop and
integrate advanced products and protect our proprietary
technology.
Since our formation in Russia in 1990, we have been focused on
developing and manufacturing high-power fiber lasers and
amplifiers. We established manufacturing and research operations
in Germany in 1994 and in the United States in 1998. In the
following years, we developed numerous OEM customer
relationships for our advanced, active fiber-based products and
generated a substantial majority of our sales from
37
communications companies. During 2001, 2002 and 2003, we
invested in developing and manufacturing our own semiconductor
diodes, one of our highest-cost components, rather than
purchasing them from third-party vendors. Also, we developed new
products with higher output levels, targeting new applications
and markets outside of the communications industry, particularly
materials processing, which is now the largest market for our
products.
Description
of Our Net Sales, Costs and Expenses
Net sales. We derive net sales primarily from
the sale of fiber lasers and amplifiers. We also sell diode
lasers, communications systems and complementary products. We
sell our products through our direct sales organization and our
network of distributors and sales representatives, as well as
system integrators. We sell our products to OEMs that supply
materials processing laser systems, communications systems and
medical laser systems to end users. We also sell our products to
end users that build their own systems which incorporate our
products or use our products as an energy or light source. Our
scientists and engineers work closely with OEMs and end users to
analyze their system requirements and match appropriate fiber
laser or amplifier specifications. Our sales cycle varies
substantially, ranging from a period of a few weeks to as long
as one year or more.
Sales of our products generally are recognized upon shipment,
provided that no obligations remain and collection of the
receivable is reasonably assured. Our sales typically are made
on a purchase order basis rather than through long-term purchase
commitments.
We develop our products to standard specifications and use a
common set of components within our product architectures. Our
major products are based upon a common technology platform. We
continually enhance these and other products by improving their
components as well as by developing new components. Although it
is difficult to predict the life cycles of our products and what
stage of the life cycle our products are in, we estimate that
our major products are in the early stages of their life cycles.
The average selling prices of our products generally decrease as
the products mature. These decreases result from factors such as
increased competition, the introduction of new products,
increases in unit volumes and market share considerations. In
the past, we have lowered our selling prices in order to
penetrate new markets and applications in which previously it
was not economically feasible for customers to deploy our
products. Furthermore, we offer volume discounts to customers
who buy multiple units. We cannot predict the timing and degree
of these price declines.
Cost of sales. Our cost of sales consists
primarily of the cost of raw materials and components, direct
labor expenses and manufacturing overhead. We are vertically
integrated and currently manufacture all critical components for
our products as well as assemble finished products. We believe
our vertical integration allows us to increase efficiencies,
leverage our scale and lower our cost of sales. Cost of sales
also includes personnel costs and overhead related to our
manufacturing and engineering operations, related occupancy and
equipment costs, shipping costs and reserves for inventory
obsolescence and for warranty obligations. Inventories are
written off and charged to cost of sales when identified as
excess or obsolete.
Due to our vertical integration strategy, we maintain a
relatively high fixed manufacturing overhead. We may not adjust
these fixed costs quickly enough to adapt to rapidly changing
market conditions. Our gross margin is therefore significantly
affected by our sales volume and the corresponding absorption of
fixed manufacturing overhead expenses. Additionally, because
many of our products are customized, we are frequently required
to devote significant engineering resources to the sales
process, which we also include in cost of product sales as
incurred.
Sales and marketing. Our sales and marketing
expense consists primarily of costs related to compensation,
trade shows, professional and technical conferences, travel,
facilities, depreciation of equipment used for demonstration
purposes and other marketing costs.
Research and development. Our research and
development expense consists primarily of compensation,
development expenses related to the design of our products and
certain components, and facilities costs. We
38
use a common research and development platform for our products.
Costs related to product development are recorded as research
and development expenses in the period in which they are
incurred.
General and administrative. Our general and
administrative expense consists primarily of compensation and
associated costs for executive management, finance, legal and
other administrative personnel, outside legal and professional
fees, allocated facilities costs and other corporate expenses.
Factors
and Trends That Affect Our Operations and Financial
Results
Management believes that the following factors and trends are
important in understanding our financial statements and overall
financial performance.
Net sales Our net sales grew from
$60.7 million in 2004 to $299.3 million in 2010,
representing a compound annual growth rate of approximately 30%.
Net sales growth was driven by (i) increasing demand for
our products, fueled by the decreasing average cost per watt of
output power and resulting increased cost competitiveness
compared to traditional lasers, (ii) the introduction of
new products, including our high-power lasers with higher output
power levels, (iii) the growing market acceptance of fiber
lasers and (iv) the development of new applications for our
products and new OEM customer relationships. Our annual revenue
growth rates have varied. Net Sales increased by 61% in 2010. In
2009, our net sales decreased by 19% primarily due to the global
economic downturn. Prior to 2009, our growth rates were 21% in
2008, 32% in 2007 and 49% in 2006.
Our business depends substantially upon capital expenditures by
our customers, particularly by manufacturers in the materials
processing market, which include automotive, marking,
electronics and photovoltaic applications. Approximately 84% of
our revenues in 2010 were from customers in the materials
processing market. Although applications in this market are
broad, the capital equipment market in general is cyclical and
historically has experienced sudden and severe downturns. For
the foreseeable future, our operations will continue to depend
upon capital expenditures by customers in the materials
processing market and will be subject to the broader
fluctuations of capital equipment spending.
Our net sales have historically fluctuated from quarter to
quarter. The increase or decrease in sales from a prior quarter
can be affected by the timing of orders received from customers,
the shipment, installation and acceptance of products at our
customers facilities, the mix of OEM orders and one-time
orders for products with large purchase prices, and seasonal
factors such as the purchasing patterns and levels of activity
throughout the year in the regions where we operate.
Historically, our net sales have been higher in the second half
of the year than in the first half of the year. Furthermore, net
sales can be affected by the time taken to qualify our products
for use in new applications in the end markets that we serve.
The adoption of our products by a new customer or qualification
in a new application can lead to an increase in net sales for a
period, which may then slow until we penetrate new markets or
obtain new customers.
Gross margin. Our total gross margin in any
period can be significantly affected by total net sales in any
period, by product mix, that is, the percentage of our revenue
in the period that is attributable to higher or lower-power
products, and by other factors, some of which are not under our
control.
Our product mix affects our margins because the selling price
per watt is generally higher for low and mid-power devices than
for high-power devices. The overall cost of high-power lasers
may be partially offset by improved absorption of fixed overhead
costs associated with sales of larger volumes of higher-power
products.
Due to our vertical integration, we have significant fixed costs
and our costs are difficult to adjust in response to changes in
demand. Significant decreases in net sales, such as those
experienced during 2009, will negatively affect gross margins.
Gross margin can also vary from quarter to quarter based on
changes in manufacturing activity levels, which may not be
consistent with changes in net sales. In periods where work in
process and finished goods levels increase, there is generally
greater absorption of manufacturing overhead relative to sales
volume, which can improve gross margins in those periods. In
periods where work in process and finished goods levels
decrease, there is generally less absorption of manufacturing
overhead relative to sales volume, which can reduce gross
margins in those periods.
39
We also regularly review our inventory for items that are
slow-moving, have been rendered obsolete or determined to be
excess. Any write-off of such slow-moving, obsolete or excess
inventory affects our gross margins. For example, we recorded
provisions for inventory totaling $2.7 million,
$5.3 million and $3.8 million in 2010, 2009 and 2008,
respectively.
The factors that can influence the gross margins derived from
sales of any individual product include the following:
|
|
|
|
|
factors that affect the prices we can charge, including the
features and performance of our products, their output power,
the nature of the end user and application, and competitive
pressures;
|
|
|
|
factors that affect the cost of our net sales, including the
cost of raw materials and components, manufacturing costs and
shipping costs;
|
|
|
|
production volumes and yields of specific product lines or
components; and
|
|
|
|
in the case of our OEM customers, the type of market that they
serve and the competitive pricing pressures faced by our OEM
customers.
|
Sales and marketing expense. We have expanded
our worldwide direct sales organization, opened applications
centers around the world, hired additional personnel involved in
marketing in our existing and new geographic locations,
increased the number of units used for demonstration purposes,
and otherwise increased expenditures on sales and marketing
activities in order to support the growth in our net sales. We
expect to continue to invest in our sales and marketing
resources and such costs may increase in the aggregate. However,
the rate of growth in such costs is not expected to be as high
as rates experienced in previous years.
Research and development expense. We plan to
continue to invest in research and development to improve our
existing components and products and develop new components and
products, such as diodes, gas lasers and visible lasers. The
amount of research and development expense we incur may vary
from period to period. Although, if net sales continue to
increase we would expect research and development expense to
increase in the aggregate.
General and administrative expense. We have
increased our general and administrative expenses and expanded
headcount to support the growth of our company and to comply
with public company reporting obligations and regulatory
requirements, incurred higher insurance expenses related to
directors and officers insurance and invested in our
financial reporting systems. In the future, we expect general
and administrative expenses to increase as we invest to support
the growth in net sales. In addition, the timing and amount of
litigation-related expenses may vary substantially from quarter
to quarter in response to the level of litigation activity and
other unforeseen circumstances and events.
Major customers. We have historically depended
on a few customers for a large percentage of our annual net
sales. The composition of this group can change from year to
year. Net sales derived from our five largest customers as a
percentage of our annual net sales were 19% in 2010, 12% in 2009
and 17% in 2008. Sales to our largest customer accounted for 7%,
3% and 7% of our net sales in 2010, 2009 and 2008, respectively.
We seek to add new customers and to expand our relationships
with existing customers. We anticipate that the composition of
our net sales to our significant customers will continue to
change. If any of our significant customers were to
substantially reduce their purchases from us, our results would
be adversely affected.
Critical
Accounting Policies and Estimates
The preparation of financial statements in conformity with
accounting principles generally accepted in the United States
requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of net sales
and expenses. By their nature, these estimates and judgments are
subject to an inherent degree of uncertainty. On an ongoing
basis we re-evaluate our judgments and estimates including those
related to inventories, income taxes and the fair value of
certain debt and equity instruments including stock-based
compensation. We base our estimates and judgments on our
historical experience and on
40
other assumptions that we believe are reasonable under the
circumstances, the results of which form the basis for making
the judgments about the carrying values of assets and
liabilities that are not readily apparent from other sources.
Actual results could differ from those estimates, which may
materially affect our operating results and financial position.
The accounting policies described below are those which, in our
opinion, involve the most significant application of judgment,
or involve complex estimation, and which could, if different
judgments or estimates were made, materially affect our reported
results of operations and financial position.
Revenue recognition. Our net sales are
generated from sales of fiber lasers, fiber amplifiers, diode
lasers and complementary products. Our products are used in a
wide range of applications by different types of end users or
used as components integrated into systems by OEMs or system
integrators. We also sell communications systems that include
our fiber lasers and amplifiers as components.
We recognize revenue when four basic criteria are met:
(i) persuasive evidence of an arrangement exists;
(ii) delivery has occurred or services have been rendered;
(iii) the fee is fixed or determinable; and
(iv) collectability is reasonably assured. Revenue from the
sale of our products is generally recognized upon shipment,
provided that the other revenue recognition criteria have been
met. We have no obligation to provide upgrades, enhancements or
customer support subsequent to the sale, other than warranty.
Revenue from orders with multiple deliverables is divided into
separate units of accounting when certain criteria are met. The
consideration for the arrangement is then allocated to the
separate units of accounting based on their relative fair
values. We defer the revenue on multiple element arrangements if
the fair values of all the undelivered elements are not known or
if customer acceptance is contingent on delivery of specified
items or performance conditions, if the performance conditions
cannot be satisfactorily tested prior to shipment or if we have
not met such conditions in the past. Applicable revenue
recognition criteria are then applied separately to each
separate unit of accounting.
Returns and customer credits are infrequent and are recorded as
a reduction to revenue. Rights of return are generally not
included in sales arrangements. We receive a customer purchase
order or contract as evidence of an arrangement and product
shipment terms are typically free on board (F.O.B.) shipping
point. Periodically, our revenue arrangements include customer
acceptance clauses. If an acceptance clause defines a
performance requirement in a process or application that we
cannot effectively test prior to delivery or that has not been
accepted previously, we defer recognition of revenue until the
performance requirement has been proved.
Inventory. Inventory is stated at the lower of
cost
(first-in,
first-out method) or market value. Inventory includes parts and
components that may be specialized in nature and subject to
rapid obsolescence. We maintain a reserve for inventory items to
provide for an estimated amount of excess or obsolete inventory.
The reserve is based upon a review of inventory materials on
hand, which we compare with estimated future usage and age. In
addition, we review the inventory and compare recorded costs
with estimates of current market value. Write-downs are recorded
to reduce the carrying value to the net realizable value with
respect to any part with costs in excess of current market
value. Estimating demand and current market values is inherently
difficult, particularly given that we make unique components and
products. We determine the valuation of excess and obsolete
inventory by making our best estimate considering the current
quantities of inventory on hand and our forecast of the need for
this inventory to support future sales of our products. We often
have limited information on which to base our forecasts. If
future sales differ from these forecasts, the valuation of
excess and obsolete inventory may change and additional
inventory provisions may be required. Because of our vertical
integration, a significant or sudden decrease in sales could
result in a significant change in the estimates of excess or
obsolete inventory. We recorded inventory charges of
$2.7 million, $5.3 million and $3.8 million in
2010, 2009 and 2008, respectively.
41
Stock-based compensation. Stock-based
compensation is included in the following financial statement
captions as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In thousands)
|
|
|
Cost of sales
|
|
$
|
727
|
|
|
$
|
578
|
|
|
$
|
328
|
|
Sales and marketing
|
|
|
801
|
|
|
|
727
|
|
|
|
407
|
|
Research and development
|
|
|
446
|
|
|
|
344
|
|
|
|
490
|
|
General and administrative
|
|
|
1,222
|
|
|
|
1,118
|
|
|
|
849
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
3,196
|
|
|
$
|
2,767
|
|
|
$
|
2,074
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
We allocate and record stock-based compensation expense on a
straight-line basis over the requisite service period.
We calculate the fair value of stock option grants using the
Black-Scholes option pricing model. Determining the appropriate
fair value model and calculating the fair value of stock-based
payment awards require the use of highly subjective assumptions,
including the expected life of the stock-based payment awards
and stock price volatility. The assumptions used to calculate
the fair value of stock-based payment awards represent
managements best estimates, but the estimates involve
inherent uncertainties and the application of management
judgment. As a result, if factors change and we use different
assumptions, our stock-based compensation expense could be
materially different in the future. The weighted average
assumptions used in the Black-Scholes model or the calculation
of compensation were as follows:
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
2010
|
|
2009
|
|
2008
|
|
Expected Term
|
|
2.9-5.9 years
|
|
1.74-7.10 years
|
|
4.33-7.23 years
|
Volatility
|
|
42%-48%
|
|
46%-65%
|
|
39%-65%
|
Risk Free Rate of Return
|
|
0.34%-2.68%
|
|
0.56%-2.78%
|
|
2.51%-5.20%
|
Dividend Yield
|
|
0%
|
|
0%
|
|
0%
|
Forfeiture Rate
|
|
0%-5.0%
|
|
2%-6.6%
|
|
2%-5%
|
For options granted with an expected term shorter than the
history of Company-specific trading data, the Company-specific
historical and implied volatility was used to calculate expected
volatility. For options granted with an expected term longer
than the available history of Company-specific trading data, the
trading data of similar entities whose share prices are publicly
available was used to calculate expected volatility. We used the
following factors to identify similar public entities: industry,
stage of life cycle, size and profitability. We intend to
continue to consistently apply this process using the same or
similar entities until a sufficient amount of historical
information regarding the volatility of its own share price
becomes available, or unless circumstances change such that the
identified entities are no longer similar to us. In this latter
case, more suitable, similar entities whose share prices are
publicly available would be utilized in the calculation.
As stock-based compensation expense recorded in our statements
of operations is based on options ultimately expected to vest,
it has been reduced for estimated forfeitures. We estimate
forfeitures at the time of grant and revise these estimates, if
necessary, in subsequent periods if actual forfeitures differ
from the estimates.
We have offered an employee stock purchase plan covering our
U.S. and German employees. The plan allows employees who
participate to purchase shares of common stock through payroll
deductions at a 15% discount to the lower of the stock price on
the first day or last day of the six-month purchase period.
Payroll deductions may not exceed 10% of the employees
compensation. Compensation expense related to the employee stock
purchase plan for the years ended December 31, 2010 and
2009, was approximately $206,000 and $205,000, respectively.
42
Income Taxes and Deferred Taxes. Our annual
tax rate is based on our income, statutory tax rates and tax
planning opportunities available to us in the various
jurisdictions in which we operate.
We file federal and state income tax returns in the United
States and tax returns in nine international jurisdictions. We
must estimate our income tax expense after considering, among
other factors, intercompany transactions on an arms length
basis, differing tax rates between jurisdictions, allocation
factors, tax credits, nondeductible items and changes in enacted
tax rates. Significant judgment is required in determining our
annual tax expense and in evaluating our tax positions. As we
continue to expand globally, there is a risk that, due to
complexity within and diversity among the various jurisdictions
in which we do business, a governmental agency may disagree with
the manner in which we have computed our taxes. Additionally,
due to the lack of uniformity among all of the foreign and
domestic taxing authorities, there may be situations where the
tax treatment of an item in one jurisdiction is different from
the tax treatment in another jurisdiction or that the
transaction causes a tax liability to arise in another
jurisdiction.
Deferred taxes arise because of the different treatment between
financial statement accounting and tax accounting, known as
temporary differences. The tax effects of these
temporary differences are recorded as deferred tax assets and
deferred tax liabilities on the consolidated balance sheet. At
December 31, 2010, we recorded a net deferred tax asset of
$9,692,000. If insufficient evidence of our ability to generate
future taxable income arises, we may be required to record a
valuation allowance against these assets, which will result in
additional income tax expense. On a quarterly basis, we evaluate
whether the deferred tax assets may be realized in the future
and assess the need for a valuation allowance.
We provide reserves for potential payments of tax to various tax
authorities related to uncertain tax positions and other issues.
Reserves recorded are based on a determination of whether and
how much of a tax benefit taken by us in our tax filings or
positions is more likely than not to be realized
following resolution of any potential contingencies present
related to the tax benefit, assuming that the matter in question
will be raised by the tax authorities. Potential interest and
penalties associated with such uncertain tax positions is
recorded as a component of income tax expense. At
December 31, 2010, we had unrecognized tax benefits of
approximately $2,951,000 that, if recognized, would be recorded
as a reduction in income tax expense.
Deferred tax liabilities are not recorded for undistributed
earnings of a foreign subsidiary that are deemed to be
indefinitely reinvested in the foreign jurisdiction. We have
formulated a specific plan for reinvestment of undistributed
earnings of our foreign subsidiaries which demonstrates that
such earnings will be indefinitely reinvested in the applicable
tax jurisdictions.
43
Results
of Operations
The following table sets forth selected statement of operations
data for the periods indicated in dollar amounts and expressed
as a percentage of net sales.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In thousands, except percentages and per share data)
|
|
|
Net sales
|
|
$
|
299,256
|
|
|
|
100.0
|
%
|
|
$
|
185,894
|
|
|
|
100.0
|
%
|
|
$
|
229,076
|
|
|
|
100.0
|
%
|
Cost of sales
|
|
|
152,798
|
|
|
|
51.1
|
|
|
|
121,626
|
|
|
|
65.4
|
|
|
|
121,776
|
|
|
|
53.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
146,458
|
|
|
|
48.9
|
|
|
|
64,268
|
|
|
|
34.6
|
|
|
|
107,300
|
|
|
|
46.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing
|
|
|
19,100
|
|
|
|
6.4
|
|
|
|
15,157
|
|
|
|
8.2
|
|
|
|
13,900
|
|
|
|
6.1
|
|
Research and development
|
|
|
19,160
|
|
|
|
6.4
|
|
|
|
18,543
|
|
|
|
10.0
|
|
|
|
15,804
|
|
|
|
6.9
|
|
General and administrative
|
|
|
28,645
|
|
|
|
9.6
|
|
|
|
20,489
|
|
|
|
11.0
|
|
|
|
23,198
|
|
|
|
10.1
|
|
(Gain) loss on foreign exchange
|
|
|
(848
|
)
|
|
|
(0.3
|
)
|
|
|
1,022
|
|
|
|
0.5
|
|
|
|
(2,798
|
)
|
|
|
(1.2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
66,057
|
|
|
|
22.1
|
|
|
|
55,211
|
|
|
|
29.7
|
|
|
|
50,104
|
|
|
|
21.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
80,401
|
|
|
|
26.9
|
|
|
|
9,057
|
|
|
|
4.9
|
|
|
|
57,196
|
|
|
|
25.0
|
|
Interest expense, net
|
|
|
(1,188
|
)
|
|
|
(0.4
|
)
|
|
|
(1,252
|
)
|
|
|
(0.7
|
)
|
|
|
(777
|
)
|
|
|
(0.3
|
)
|
Other income (expense), net
|
|
|
39
|
|
|
|
0.0
|
|
|
|
(36
|
)
|
|
|
(0.0
|
)
|
|
|
145
|
|
|
|
0.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before provision for income taxes
|
|
|
79,252
|
|
|
|
26.5
|
|
|
|
7,769
|
|
|
|
4.2
|
|
|
|
56,564
|
|
|
|
24.7
|
|
Provision for income taxes
|
|
|
(24,900
|
)
|
|
|
(8.3
|
)
|
|
|
(2,485
|
)
|
|
|
(1.3
|
)
|
|
|
(18,111
|
)
|
|
|
(7.9
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
54,352
|
|
|
|
18.2
|
|
|
|
5,284
|
|
|
|
2.8
|
|
|
|
38,453
|
|
|
|
16.8
|
|
Less: Net income (loss) attributable to noncontrolling interests
|
|
|
361
|
|
|
|
0.1
|
|
|
|
(135
|
)
|
|
|
(0.1
|
)
|
|
|
1,799
|
|
|
|
0.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to IPG Photonics Corporation
|
|
$
|
53,991
|
|
|
|
18.0
|
%
|
|
$
|
5,419
|
|
|
|
2.9
|
%
|
|
$
|
36,654
|
|
|
|
16.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to IPG Photonics Corporation per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.16
|
|
|
|
|
|
|
$
|
0.12
|
|
|
|
|
|
|
$
|
0.82
|
|
|
|
|
|
Diluted
|
|
$
|
1.13
|
|
|
|
|
|
|
$
|
0.12
|
|
|
|
|
|
|
$
|
0.79
|
|
|
|
|
|
Weighted-average shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
46,424
|
|
|
|
|
|
|
|
45,489
|
|
|
|
|
|
|
|
44,507
|
|
|
|
|
|
Diluted
|
|
|
47,594
|
|
|
|
|
|
|
|
46,595
|
|
|
|
|
|
|
|
46,223
|
|
|
|
|
|
Comparison
of Year Ended December 31, 2010 to Year Ended
December 31, 2009
Net sales. Net sales increased by
$113.4 million, or 61.0%, to $299.3 million in 2010
from $185.9 million in 2009. The table below sets forth
sales by application (in thousands, except for percentages):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
|
|
|
Year Ended
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
% of
|
|
|
December 31,
|
|
|
% of
|
|
|
|
|
|
|
|
Market
|
|
2010
|
|
|
Total
|
|
|
2009
|
|
|
Total
|
|
|
Change
|
|
|
%
|
|
|
Materials Processing
|
|
$
|
252,014
|
|
|
|
84.2
|
%
|
|
$
|
140,864
|
|
|
|
75.8
|
%
|
|
$
|
111,150
|
|
|
|
78.9
|
%
|
Telecommunications
|
|
|
14,020
|
|
|
|
4.7
|
%
|
|
|
10,867
|
|
|
|
5.8
|
%
|
|
|
3,153
|
|
|
|
29.0
|
%
|
Medical
|
|
|
8,026
|
|
|
|
2.7
|
%
|
|
|
7,606
|
|
|
|
4.1
|
%
|
|
|
420
|
|
|
|
5.5
|
%
|
Advanced Applications
|
|
|
25,196
|
|
|
|
8.4
|
%
|
|
|
26,557
|
|
|
|
14.3
|
%
|
|
|
(1,361
|
)
|
|
|
(5.1
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
299,256
|
|
|
|
|
|
|
$
|
185,894
|
|
|
|
|
|
|
$
|
113,362
|
|
|
|
61.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
44
Sales for materials processing applications increased due to
substantially increased sales of pulsed lasers used in marking
and engraving applications and high power lasers used in cutting
and welding applications. Sales for communications applications
increased due to increased sales of amplifiers in Russia. Sales
for medical applications increased due to increased demand from
our established customer in the United States and sales to new
customers in Europe and Asia. The decrease in sales of advanced
applications was due to lower sales of high-power lasers used in
government applications partially offset by increased sales for
optical pumping and research and development applications.
Cost of sales and gross margin. Cost of sales
increased by $31.2 million, or 25.6%, to
$152.8 million in 2010 from $121.6 million in 2009.
Our gross margin increased to 48.9% in 2010 from 34.6% in 2009.
The increase in gross margin was the result of an increase in
net sales and more favorable absorption of our fixed
manufacturing costs due to an increase in production volume. In
addition, cost of sales benefited from a reduction in the cost
per watt of our diodes and lower costs associated with greater
use of internally manufactured components and accessories.
Expenses related to inventory reserves and other valuation
adjustments decreased by $2.6 million to $2.7 million,
or 0.9% of sales, for the year ended December 31, 2010, as
compared to $5.3 million, or 2.9% of sales, for the year
ended December 31, 2009.
Sales and marketing expense. Sales and
marketing expense increased by $3.9 million, or 26.0%, to
$19.1 million in 2010 from $15.2 million in 2009,
primarily as a result of an increase in personnel costs due to
an increase in headcount and bonus accruals. As a percentage of
sales, sales and marketing expense decreased to 6.4% in 2010
from 8.2% in 2009. As we continue to expand our worldwide sales
organization, we expect expenditures on sales and marketing to
continue to increase in the aggregate.
Research and development expense. Research and
development expense increased by $0.7 million, or 3.3%, to
$19.2 million in 2010 from $18.5 million in 2009. This
increase was primarily the result of an increase in personnel
and consultant costs, partially offset by a decrease in
materials used in research and development activities. The
increase in personnel costs was driven primarily by bonus
accruals. Research and development activity continues to focus
on enhancing the performance of our internally manufactured
components, refining production processes to improve
manufacturing yields, developing new products operating at
different wavelengths and higher output powers and new
complementary accessories used with our products. As a
percentage of sales, research and development expense decreased
to 6.4% in 2010 from 10.0% in 2009. We expect that research and
development expenses will increase moderately in 2011.
General and administrative expense. General
and administrative expense increased by $8.1 million, or
39.8%, to $28.6 million in 2010 from $20.5 million in
2009, primarily due to a $3.6 million increase in personnel and
contractor expenses attributable to higher bonuses and
$2.5 million increase in accounting and legal fees related
to defending a patent infringement action brought against us.
The amount and timing of legal expenses we will incur in future
quarters will depend on the outcome and timing of court motions
and the trial. As a percentage of sales, general and
administrative expense decreased to 9.6% in 2010 from 11.0% in
2009. In the future, we expect general and administrative
expenses to increase as we invest to support the growth in net
sales.
Effect of exchange rates on sales, gross margin and operating
expenses. We estimate that if exchange rates had
been the same as one year ago, sales in 2010 would have been
$4.5 million higher, gross margin would have been
$1.6 million higher and operating expenses in total would
have been $0.3 million higher. The measures that assume
constant exchange rates between fiscal year 2010 and fiscal year
2009 are calculated using the average exchange rates for the
twelve-month period ended December 31, 2009 for the
respective currencies, which were Euro 1=US$1.39, Japanese
Yen 1= US$0.01 and Russian Ruble 1=US$0.03.
Gain (loss) on foreign exchange. We incurred a
foreign exchange gain of $0.8 million in 2010 as compared
to a loss of $1.0 million in 2009. The change was primarily
attributable to the depreciation of the Euro against the
U.S. Dollar and Japanese Yen.
Interest expense net. Interest expense, net
was $1.2 million in 2010 compared to $1.3 million in
2009.
Provision for income taxes. Provision for
income taxes was $24.9 million in 2010 compared to
$2.5 million in 2009, representing an effective tax rate of
31.4% in 2010 and 32.0% 2009. The increase in the
45
provision for income taxes was due to an increase in income
before the provision for income taxes, while the decrease in the
effective rate was due to the proportion of income earned in
countries with lower enacted tax rates.
Net income. Net income attributable to IPG
Photonics Corporation increased by $48.6 million to
$54.0 million in 2010 from $5.4 million in 2009. Net
income attributable to IPG Photonics Corporation as a percentage
of our net sales increased by 15.1 percentage points to
18.0% in 2010 from 2.9% in 2009 due to the factors described
above.
Comparison
of Year Ended December 31, 2009 to Year Ended
December 31, 2008
Net sales. Net sales decreased by
$43.2 million, or 18.9%, to $185.9 million in 2009
from $229.1 million in 2008. The table below sets forth
sales by application (in thousands, except for percentages):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
|
|
|
Year Ended
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
% of
|
|
|
December 31,
|
|
|
% of
|
|
|
|
|
|
|
|
Market
|
|
2009
|
|
|
Total
|
|
|
2008
|
|
|
Total
|
|
|
Change
|
|
|
%
|
|
|
Materials Processing
|
|
$
|
140,864
|
|
|
|
75.8
|
%
|
|
$
|
187,720
|
|
|
|
81.9
|
%
|
|
$
|
(46,856
|
)
|
|
|
(25.0
|
)%
|
Telecommunications
|
|
|
10,867
|
|
|
|
5.8
|
%
|
|
|
12,904
|
|
|
|
5.6
|
%
|
|
|
(2,037
|
)
|
|
|
(15.8
|
)%
|
Medical
|
|
|
7,606
|
|
|
|
4.1
|
%
|
|
|
3,782
|
|
|
|
1.7
|
%
|
|
|
3,824
|
|
|
|
101.1
|
%
|
Advanced Applications
|
|
|
26,557
|
|
|
|
14.3
|
%
|
|
|
24,670
|
|
|
|
10.8
|
%
|
|
|
1,887
|
|
|
|
7.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
185,894
|
|
|
|
|
|
|
$
|
229,076
|
|
|
|
|
|
|
$
|
(43,182
|
)
|
|
|
(18.9
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The decrease in materials processing applications sales resulted
from substantially decreased sales of pulsed lasers and
medium-power lasers used in marking, engraving and drilling
applications due to the global economic downturn. The decrease
in communications applications sales resulted primarily from
decreased sales of amplifiers, particularly in Russia. The
increase in medical application sales was due to the increased
demand from our established customers in the United States and
new OEM customers. The increase in sales of advanced
applications was due to higher sales of high-power lasers used
in government and defense research and pulsed and low-power
lasers used for sensing and optical pumping applications.
Cost of sales and gross margin. Cost of sales
decreased by $0.2 million, or 0.1%, to $121.6 million
in 2009 from $121.8 million in 2008. Our gross margin
decreased to 34.6% in 2009 from 46.8% in 2008. The decrease in
gross margin was the result of less favorable absorption of our
fixed manufacturing costs due to a decline in sales volume, less
favorable product mix due to proportionately lower sales of
medium-power lasers, a reduction in inventory, increases in
charges related to inventory write-downs and lower prices due to
pricing pressure caused by the industry-wide reduction in
demand. These costs of sales increases were offset partially by
a reduction in manufacturing expenses in the period, primarily
related to reduced salary and benefits expense and lower costs
for other manufacturing supplies. Expenses related to inventory
reserves and other valuation adjustments increased by
$1.5 million to $5.3 million, or 2.9% of sales, in
2009 as compared to $3.8 million, or 1.7% of sales, in
2008. The increase in inventory reserves in 2009 was due in part
to the decline in sales and corresponding usage of inventory as
well as to the impact of a new generation of diodes on usage
levels of the previous generation.
Sales and marketing expense. Sales and
marketing expense increased by $1.3 million, or 9.0%, to
$15.2 million in 2009 from $13.9 million in 2008,
primarily as a result of an increase in depreciation costs of
products used for demonstration purposes and travel expenses. As
a percentage of sales, sales and marketing expense increased to
8.2% in 2009 from 6.1% in 2008.
Research and development expense. Research and
development expense increased by $2.7 million, or 17.3%, to
$18.5 million in 2009 from $15.8 million in 2008. This
increase was primarily due to increases of $1.5 million in
material costs, $0.5 million in salaries and benefits and
$0.5 million in depreciation. As a percentage of sales,
research and development expense increased to 10.0% in 2009 from
6.9% in 2008.
General and administrative expense. General
and administrative expense decreased by $2.7 million, or
11.7%, to $20.5 million in 2009 from $23.2 million in
2008, primarily due to a $0.6 million decrease in
46
accounting and legal defense fees and a $1.6 million
decrease in personnel and contractor expenses primarily
attributable to lower incentive compensation. As a percentage of
sales, general and administrative expense increased to 11.0% in
2009 from 10.1% in 2008.
Effect of exchange rates on sales, gross margin and operating
expenses. We estimate that if exchange rates had
been the same in 2009 as in 2008, sales in 2009 would have been
$1.5 million higher, gross margin would have been
$2.1 million higher and operating expenses in total would
have been $0.9 million higher. The measures that assume
constant exchange rates between fiscal year 2009 and fiscal year
2008 are calculated using the average exchange rates for the
twelve-month period ended December 31, 2008 for the
respective currencies, which were Euro 1=US$1.47, Japanese
Yen 1= US$0.01 and Russian Ruble 1=US$0.04.
Gain (loss) on foreign exchange. We incurred a
foreign exchange loss of $1.0 million in 2009 as compared
to a gain of $2.8 million in 2008. The change was primarily
attributable to the appreciation of the Euro against the
U.S. Dollar.
Interest expense, net. Interest expense, net
was $1.3 million in 2009 compared to $0.8 million in
2008. Interest expense increased in 2009 because of higher
drawings on our credit lines, particularly during the first half
of the year.
Provision for income taxes. Provision for
income taxes was $2.5 million in 2009 compared to
$18.1 million in 2008, representing an effective tax rate
of 32.0% in both 2009 and 2008.
Net income. Net income attributable to IPG
Photonics Corporation decreased by $31.3 million to
$5.4 million in 2009 from $36.7 million in 2008. Net
income attributable to IPG Photonics Corporation as a percentage
of our net sales decreased by 13.0 percentage points to
3.0% in 2009 from 16.0% in 2008 due to the factors described
above.
Liquidity
and Capital Resources
Our principal sources of liquidity as of December 31, 2010
consisted of cash and cash equivalents of $147.9 million,
unused credit lines and overdraft facilities of
$51.5 million and working capital (excluding cash) of
$70.2 million. This compares to cash and cash equivalents
of $82.9 million, unused credit lines and overdraft
facilities of $53.8 million and working capital (excluding
cash) of $61.2 million as of December 31, 2009. The
increase in cash and cash equivalents of $65.0 million from
December 31, 2009 relates primarily to cash provided by
operating activities in 2010 of $63.4 million and a
non-controlling equity investment of $25.0 million in our
Russian subsidiary by The Russian Corporation of
Nanotechnologies (Rusnano), offset by capital
expenditures of $28.4 million. Cash provided by the Rusnano
investment will be used to fund the anticipated expansion of our
business in Russia, including operating expenses, investments in
working capital and capital expenditures. This funding is not
available for use outside of Russia. Terms of this investment
are more fully described below.
Our long-term debt consists of an $18.0 million secured
variable-rate note that matures in June 2015. The outstanding
balance of this note as of December 31, 2010 was
$16.7 million. The note is secured by a mortgage on real
estate and buildings that we own in Massachusetts.
We expect that the existing cash and marketable securities, our
cash flows from operations and our existing lines of credit will
be sufficient to meet our liquidity and capital needs for the
foreseeable future. Our future long-term capital requirements
depend on many factors including our level of sales, the impact
of economic recessions on our sales levels, the timing and
extent of spending to support development efforts, the expansion
of our sales and marketing activities, the timing and
introductions of new products, the need to ensure access to
adequate manufacturing capacity and the continuing market
acceptance of our products. We
47
have made no arrangements to obtain additional financing, and
there is no assurance that such additional financing, if
required or desired, will be available in amounts or on terms
acceptable to us, if at all.
The following table details our
line-of-credit
facilities as of December 31, 2010:
|
|
|
|
|
|
|
|
|
|
|
Available
|
|
|
|
|
|
|
Description
|
|
Principal
|
|
Interest Rate
|
|
Maturity
|
|
Security
|
|
U.S. Revolving Line of Credit(1)
|
|
Up to $35.0 million
|
|
LIBOR plus 1.125% to 1.625%, depending on our performance
|
|
June 2015
|
|
Unsecured
|
Euro Credit Facility (Germany)(2)
|
|
Euro 15.0 million ($19.9 million)
|
|
Euribor + 0.85% or EONIA + 1.2%
|
|
June 2012
|
|
Unsecured, guaranteed by parent company
|
Euro Overdraft Facilities
|
|
Euro 2.6 million ($3.4 million)
|
|
2.5%-6.5%
|
|
September 2011
|
|
Common pool of assets of German and Italian subsidiaries
|
|
|
|
(1) |
|
$12.0 million of this credit facility is available to our
foreign subsidiaries including those in India, China, Japan and
South Korea. Total drawings at December 31, 2010 were
$5.0 million with a weighted average interest rate of 1.9%. |
|
(2) |
|
$4.0 million of this credit facility is available to our
Russian subsidiary and $4.0 million is available to our
Italian subsidiary. |
Our largest committed credit lines are with Bank of America and
Deutsche Bank in the amounts of $35.0 million and
$19.9 million, respectively, and neither of them is
syndicated.
We are required to meet certain financial covenants associated
with our U.S. revolving line of credit and long-term debt
facilities. These covenants, tested quarterly, include a debt
service coverage ratio and a funded debt to earnings before
interest, taxes, depreciation and amortization
(EBITDA) ratio. The debt service coverage covenant
requires that we maintain a trailing twelve month ratio of cash
flow to debt service that is greater than 1.5:1. Debt service is
defined as required principal and interest payments during the
period. Cash flow is defined as EBITDA less unfunded capital
expenditures. The funded debt to EBITDA covenant requires that
the sum of all indebtedness for borrowed money on a consolidated
basis be less than two times our trailing twelve-month EBITDA.
We were in compliance with all such financial covenants as of
and for the year ended December 31, 2010.
The financial covenants in our loan documents may cause us to
not take or to delay investments and actions that we might
otherwise undertake because of limits on capital expenditures
and amounts that we can borrow or lease. In the event that we do
not comply with any of these covenants, we would be in default
under the loan agreement or loan agreements, which may result in
acceleration of the debt, cross-defaults on other debt or a
reduction in available liquidity, any of which could harm our
results of operations and financial condition.
In January 2010, we completed the acquisition of Photonics
Innovations, Inc., a maker of active and passive laser materials
and tunable lasers for scientific, biomedical, technological and
eye-safe range-finding applications. The acquisition of
Photonics Innovations, Inc. was not material to our liquidity,
financial position or results of operations.
In April 2010, we completed the acquisition of Cosytronic KG, a
German developer and manufacturer of automated welding turnkey
solutions. The acquisition of Cosytronic KG was not material to
our liquidity, financial position or results of operations.
In December 2010, we completed the sale of a 12.5% minority
interest of our Russian subsidiary, NTO IRE-Polus, to Rusnano
for $25,000,000. This sale contributed to the cash increase
during the year. Terms of the investment allow Rusnano to put
the investment to IPG for redemption in either cash or our
stock, at the
48
option of Rusnano, from December 2015 to December 2017. The
Company also has certain rights to call the investment from
December 2013 to December 2017. In addition, the Company has
rights to call the investment at any time if the Company no
longer is permitted to consolidate under U.S. generally
accepted accounting principle the financial results of NTO
IRE-Polus, we are required to account for the put rights on our
balance sheet as a liability or other than permanent equity or
Rusnano owns less than 10.01% of NTO IRE-Polus. Rusnano can
purchase up to an additional 12.5% of our Russian subsidiary if
NTO IRE-Polus attains certain minimum revenue thresholds for an
additional $25 million and these additional investments
would also be subject to the put and call provisions described
above. See Note 7 in Notes to Consolidated Financial
Statements.
Operating activities. Net cash provided by
operating activities increased by $9.0 million to
$63.4 million in 2010 from $54.4 million in 2009,
primarily resulting from:
|
|
|
|
|
An increase in cash provided by net income after adding back
non-cash charges of $56.0 million in 2010 as compared to
2009;
|
|
|
|
An increase in accrued expenses and other liabilities of
$22.1 million in 2010 compared to a decrease of
$0.1 million in 2009 primarily related to customer deposits
and deferred revenue, accrued compensation and accrued warranty;
partially offset by
|
|
|
|
An increase in inventory of $27.0 million in 2010 compared
to a decrease of inventory of $5.6 million in 2009; and
|
|
|
|
An increase in accounts receivable of $27.3 million in 2010
compared to a decrease of $9.3 million in 2009.
|
Given our vertical integration, rigorous and time-consuming
testing procedures for both internally manufactured and
externally purchased components and the lead time required to
manufacture components used in our finished products, the rate
at which we turn inventory has historically been low when
compared to our cost of sales. Also, our historic growth rates
required investment in inventories to support future sales and
enable us to quote short delivery times to our customers,
providing what we believe is a competitive advantage.
Furthermore, if there was a disruption to the manufacturing
capacity of any of our key technologies, our inventories of
components should enable us to continue to build finished
products for a period of time. We believe that we will continue
to maintain a relatively high level of inventory compared to our
cost of sales. As a result, we expect to have a significant
amount of working capital invested in inventory. A reduction in
our level of net sales or the rate of growth of our net sales
from their current levels would mean that the rate at which we
are able to convert our inventory into cash would decrease.
Investing activities. Net cash used in
investing activities was $32.6 million and
$10.6 million in 2010 and 2009, respectively. The cash used
in investing activities in 2010 related to the purchase of a new
building in South Korea to house a new laser application center,
the acquisitions of Photonics Innovations, Inc. and Cosytronic,
KG and purchases of equipment primarily in the United States and
Germany. The cash used in 2009 was primarily related to capital
expenditures on property, plant and equipment.
We expect to incur approximately $50 million in capital
expenditures, excluding acquisitions, in 2011. The timing and
extent of any capital expenditures in and between periods can
have a significant effect on our cash flow. Many of the capital
expenditure projects that we undertake have long lead times and
are difficult to cancel or defer to a later period.
Financing activities. Net cash provided by
financing activities was $37.8 million in 2010 as compared
to net cash used in financing activities of $12.3 million
in 2009. The cash provided by financing activities in 2010 was
primarily related to cash received from Rusnano for a 12.5%
interest in our Russian subsidiary and cash provided by the
exercise of stock options. The cash used in financing activities
in 2009 was primarily related to the repayment of credit lines
and long-term debt.
49
Contractual
Obligations
The following table describes our contractual obligations as of
December 31, 2010 (in thousands).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments Due in
|
|
|
|
|
|
|
Less Than
|
|
|
|
|
|
|
|
|
More Than
|
|
|
|
Total
|
|
|
1 Year
|
|
|
1-3 Years
|
|
|
3-5 Years
|
|
|
5 Years
|
|
|
Operating lease obligations
|
|
$
|
7,979
|
|
|
$
|
3,152
|
|
|
$
|
3,013
|
|
|
$
|
717
|
|
|
$
|
1,097
|
|
Purchase obligations(1)
|
|
|
6,911
|
|
|
|
6,911
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt obligations (including interest)(2)
|
|
|
16,666
|
|
|
|
1,333
|
|
|
|
2,667
|
|
|
|
12,666
|
|
|
|
|
|
Other notes payable
|
|
|
311
|
|
|
|
|
|
|
|
|
|
|
|
311
|
|
|
|
|
|
Contingent consideration
|
|
|
685
|
|
|
|
164
|
|
|
|
125
|
|
|
|
396
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total(3)
|
|
$
|
32,552
|
|
|
|
11,560
|
|
|
|
5,805
|
|
|
|
14,090
|
|
|
|
1,097
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Represents minimum purchase commitments for property, plant and
equipment and it excludes $2.0 million obligation for the
purchase of land by IRE Polus which was included in Accrued
expenses and other liabilities at December 31, 2010. |
|
(2) |
|
Interest for long-term debt obligations was calculated including
the effect of our interest rate swap. The effect of the interest
rate swap, which is accounted for as a cash flow hedge, is to
fix the LIBOR component of the interest rate of the underlying
floating rate loan at 4.9% for the term of the debt. |
|
(3) |
|
Excludes obligations related to FIN 48 because we are
unable to provide a reasonable estimate of the timing of future
payments relating to the remainder of these obligations. See
Note 13 to our consolidated financial statements. |
Recent
Accounting Pronouncements
In October 2009, an update was issued to the accounting guidance
related to the separation criteria used to determine the unit of
accounting for multiple element arrangements. This update
removes the
objective-and-reliable-evidence-of-fair-value
criterion from the separation criteria used to determine whether
an arrangement involving multiple deliverables contains more
than one unit of accounting, replaces references to fair
value with selling price to distinguish from
the fair value measurements required under the Fair Value
Measurements and Disclosures guidance, provides a hierarchy
that entities must use to estimate the selling price, eliminates
the use of the residual method for allocation and expands the
ongoing disclosure requirements. This guidance is effective for
us beginning January 1, 2011, although early adoption is
permitted, and adoption can be applied prospectively or
retrospectively. We are evaluating the effect that
implementation of this update will have, if any, on our
consolidated financial position and results of operations.
Effective June 30, 2009, we adopted a new FASB standard on
disclosure related to financial instruments, FASB ASC 825,
Financial Instruments, which requires disclosures about
fair value of financial instruments in interim reporting periods
as well as in annual financial statements. The adoption of the
new standard required us to provide additional disclosures.
|
|
ITEM 7A.
|
QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
We are exposed to market risk in the ordinary course of
business, which consists primarily of interest rate risk
associated with our cash and cash equivalents and our debt and
foreign exchange rate risk.
Interest rate risk. Our investments have
limited exposure to market risk. To minimize this risk, we
maintain a portfolio of cash, cash equivalents and short-term
investments, consisting primarily of bank deposits, money market
funds and short-term government funds. The interest rates are
variable and fluctuate with current market conditions. Because
of the short-term nature of these instruments, a sudden change
in market interest rates would not be expected to have a
material impact on our financial condition or results of
operations.
50
Our exposure to market risk also relates to the increase or
decrease in the amount of interest expense we must pay on our
bank debt and borrowings on our bank credit facilities. The
interest rate on our existing bank debt is effectively fixed
except for our U.S. revolving line of credit. The rates on
our Euro overdraft facilities in Germany and Italy and our
Japanese Yen overdraft facility are fixed for twelve-month
periods. Approximately 71% of our outstanding debt had a fixed
rate of interest as of December 31, 2010. We do not believe
that a 10% change in market interest rates would have a material
impact on our financial position or results of operations.
Exchange rates. Due to our international
operations, a significant portion of our net sales, cost of
sales and operating expenses are denominated in currencies other
than the U.S. dollar, principally the Euro, the Japanese
Yen and the Russian Ruble. As a result, our international
operations give rise to transactional market risk associated
with exchange rate movements of the U.S. dollar, the Euro,
the Japanese Yen and the Russian Ruble. Gains and losses on
foreign exchange transactions totaled a $0.8 million gain
in 2010 and a $1.0 million loss in 2009. Management
believes that the use of foreign currency financial instruments
reduces the risks of certain foreign currency transactions;
however, these instruments provide only limited protection. We
will continue to analyze our exposure to currency exchange rate
fluctuations and may engage in additional financial hedging
techniques in the future to attempt to minimize the effect of
these potential fluctuations. Exchange rate fluctuations may
adversely affect our financial results in the future. No foreign
currency derivative instruments were outstanding at
December 31, 2010.
|
|
ITEM 8.
|
FINANCIAL
STATEMENTS AND SUPPLEMENTARY DATA
|
This information is incorporated by reference from pages F-1
through F-[25] of this report.
|
|
ITEM 9.
|
CHANGES
IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE
|
None.
|
|
ITEM 9A.
|
CONTROLS
AND PROCEDURES
|
Evaluation
of Disclosure Controls and Procedures
Under the supervision of our Chief Executive Officer and our
Chief Financial Officer, our management has evaluated the
effectiveness of the design and operation of our
disclosure controls and procedures (as defined in
Rules 13a-15(e)
and
15d-15(e)
promulgated under the Securities Exchange Act of 1934, as
amended (the Exchange Act)), as of the end of the
period covered by this Annual Report on
Form 10-K
(the Evaluation Date). Based upon that evaluation,
our chief executive officer and our chief financial officer have
concluded that, as of the Evaluation Date, our disclosure
controls and procedures are effective to ensure that information
we are required to disclose in reports that we file or submit
under the Exchange Act is recorded, processed, summarized and
reported within the time periods specified in the Securities and
Exchange Commissions rules and forms.
Managements
Annual Report on Internal Control Over Financial
Reporting
Our management, including our Chief Executive Officer and Chief
Financial Officer, is responsible for establishing and
maintaining adequate internal control over financial reporting
(as defined in Exchange Act
Rules 13a-15(f)
and
15d-15(f))
for the Company and its subsidiaries. Internal control over
financial reporting is a process designed to provide reasonable
assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes in
accordance with generally accepted accounting principles. Our
management conducted an assessment of the effectiveness of our
internal control over financial reporting as of the Evaluation
Date based on criteria established in Internal
Control Integrated Framework issued by the
Committee of Sponsoring Organizations of the Treadway Commission
(COSO). Based on this assessment, our management concluded that,
as of the Evaluation Date, our internal control over financial
reporting was effective.
51
Our independent registered public accounting firm,
Deloitte & Touche LLP, has audited our internal
control over financial reporting, as stated in their report
below.
Changes
in Internal Controls
There was no change in our internal control over financial
reporting (as defined in
Rule 13a-15(f)
under the Exchange Act) that occurred during the last fiscal
quarter that has materially affected, or is reasonably likely to
materially affect, our internal control over financial reporting.
Limitations
on Effectiveness of Controls
Our management (including our Chief Executive Officer and Chief
Financial Officer) does not expect that the disclosure controls
and procedures or internal controls over financial reporting
will prevent or detect all error and all fraud. A control
system, no matter how well designed and operated, can provide
only reasonable, not absolute, assurance that the objectives of
the control system are met. Further, the design of a control
system must reflect the fact that there are resource
constraints, and the benefits of controls must be considered
relative to their costs. Due to the inherent limitations in all
control systems, no evaluation of controls can provide absolute
assurance that all control issues, errors and instances of
fraud, if any, within the company have been or will be detected.
52
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of
IPG Photonics Corporation
Oxford, MA
We have audited the internal control over financial reporting of
IPG Photonics Corporation and subsidiaries (the
Company) as of December 31, 2010, based on
criteria established in Internal Control
Integrated Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission. The Companys
management is responsible for maintaining effective internal
control over financial reporting and for its assessment of the
effectiveness of internal control over financial reporting,
included in the accompanying Managements Annual Report on
Internal Control Over Financial Reporting. Our responsibility is
to express an opinion on the Companys internal control
over financial reporting based on our audit.
We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether effective internal control
over financial reporting was maintained in all material
respects. Our audit included obtaining an understanding of
internal control over financial reporting, assessing the risk
that a material weakness exists, testing and evaluating the
design and operating effectiveness of internal control based on
the assessed risk, and performing such other procedures as we
considered necessary in the circumstances. We believe that our
audit provides a reasonable basis for our opinion.
A companys internal control over financial reporting is a
process designed by, or under the supervision of, the
companys principal executive and principal financial
officers, or persons performing similar functions, and effected
by the companys board of directors, management, and other
personnel to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
generally accepted accounting principles. A companys
internal control over financial reporting includes those
policies and procedures that (1) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the
company; (2) provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of
management and directors of the company; and (3) provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the
companys assets that could have a material effect on the
financial statements.
Because of the inherent limitations of internal control over
financial reporting, including the possibility of collusion or
improper management override of controls, material misstatements
due to error or fraud may not be prevented or detected on a
timely basis. Also, projections of any evaluation of the
effectiveness of the internal control over financial reporting
to future periods are subject to the risk that the controls may
become inadequate because of changes in conditions, or that the
degree of compliance with the policies or procedures may
deteriorate.
In our opinion, the Company maintained, in all material
respects, effective internal control over financial reporting as
of December 31, 2010, based on the criteria established in
Internal Control Integrated Framework issued
by the Committee of Sponsoring Organizations of the Treadway
Commission.
We have also audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
consolidated financial statements as of and for the year ended
December 31, 2010 of the Company and our report dated
March 15, 2011 expressed an unqualified opinion on those
financial statements.
/s/ Deloitte &
Touche LLP
Boston, MA
March 15, 2011
53
|
|
ITEM 9B.
|
OTHER
INFORMATION
|
None.
PART III
|
|
ITEM 10.
|
DIRECTORS,
EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
|
The information required hereunder is incorporated herein by
reference to our definitive Proxy Statement to be filed pursuant
to Regulation 14A, which Proxy Statement is anticipated to
be filed with the Securities and Exchange Commission within
120 days after December 31, 2010.
|
|
ITEM 11.
|
EXECUTIVE
COMPENSATION
|
The information required hereunder is incorporated herein by
reference to our definitive Proxy Statement to be filed pursuant
to Regulation 14A, which Proxy Statement is anticipated to
be filed with the Securities and Exchange Commission within
120 days after December 31, 2010.
|
|
ITEM 12.
|
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND
RELATED STOCKHOLDER MATTERS
|
The information required hereunder is incorporated herein by
reference to our definitive Proxy Statement to be filed pursuant
to Regulation 14A, which Proxy Statement is anticipated to
be filed with the Securities and Exchange Commission within
120 days after December 31, 2010, with the exception
of the information regarding securities authorized for issuance
under our equity compensation plans, which is set forth in
Item 5, Market for the Registrants Common Equity,
Related Stockholder Matters and Issuer Purchases of Equity
Securities, Information Regarding Equity Compensation
Plans and is incorporated herein by reference.
|
|
ITEM 13.
|
CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
INDEPENDENCE
|
The information required hereunder is incorporated herein by
reference to our definitive Proxy Statement to be filed pursuant
to Regulation 14A, which Proxy Statement is anticipated to
be filed with the Securities and Exchange Commission within
120 days after December 31, 2010.
|
|
ITEM 14.
|
PRINCIPAL
ACCOUNTING FEES AND SERVICES
|
The information required hereunder is incorporated herein by
reference to our definitive Proxy Statement to be filed pursuant
to Regulation 14A, which Proxy Statement is anticipated to
be filed with the Securities and Exchange Commission within
120 days after December 31, 2010.
PART IV
|
|
ITEM 15.
|
EXHIBITS AND
FINANCIAL STATEMENT SCHEDULES
|
(a) The following documents are filed as part of this
Annual Report on
Form 10-K:
|
|
|
|
(1)
|
Financial Statements.
|
See Index to Financial Statements on
page F-1.
|
|
|
|
(2)
|
Financial Statement Schedules.
|
All schedules are omitted because they are not applicable or the
required information is shown on the financial statements or
notes thereto.
54
|
|
|
|
(3)
|
The exhibits listed on the Index to Exhibits
preceding the Exhibits attached hereto are filed with this
Form 10-K
or incorporated by reference as set forth therein.
|
(b) Exhibits.
See (a)(3) above.
(c) Additional Financial Statement Schedules.
All schedules are omitted because they are not applicable or the
required information is shown on the financial statements or
notes thereto.
55
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the Registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereunto duly authorized, on March 15, 2011.
IPG Photonics Corporation
|
|
|
|
By:
|
/s/ Valentin
P. Gapontsev
|
Valentin P. Gapontsev
Chief Executive Officer and
Chairman of the Board
Pursuant to the requirements of the Securities Exchange Act of
1934, this report has been signed below by the following persons
on behalf of the Registrant and in the capacities and on the
dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
|
|
|
|
|
|
|
/s/ Valentin
P. Gapontsev
Valentin
P. Gapontsev
|
|
Chief Executive Officer, Chairman of the Board and Director
(Principal Executive Officer)
|
|
March 15, 2011
|
|
|
|
|
|
/s/ Timothy
P.V. Mammen
Timothy
P.V. Mammen
|
|
Chief Financial Officer (Principal Financial Officer and
Principal Accounting Officer)
|
|
March 15, 2011
|
|
|
|
|
|
/s/ Robert
A. Blair
Robert
A. Blair
|
|
Director
|
|
March 15, 2011
|
|
|
|
|
|
/s/ Michael
C. Child
Michael
C. Child
|
|
Director
|
|
March 15, 2011
|
|
|
|
|
|
/s/ John
H. Dalton
John
H. Dalton
|
|
Director
|
|
March 15, 2011
|
|
|
|
|
|
/s/ Henry
E. Gauthier
Henry
E. Gauthier
|
|
Director
|
|
March 15, 2011
|
|
|
|
|
|
/s/ William
S. Hurley
William
S. Hurley
|
|
Director
|
|
March 15, 2011
|
|
|
|
|
|
/s/ William
F. Krupke
William
F. Krupke
|
|
Director
|
|
March 15, 2011
|
|
|
|
|
|
/s/ Eugene
Shcherbakov
Eugene
Shcherbakov
|
|
Director
|
|
March 15, 2011
|
|
|
|
|
|
/s/ Igor
Samartsev
Igor
Samartsev
|
|
Director
|
|
March 15, 2011
|
56
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of
IPG Photonics Corporation
Oxford, Massachusetts
We have audited the accompanying consolidated balance sheets of
IPG Photonics Corporation and subsidiaries (the
Company) as of December 31, 2010 and 2009, and
the related consolidated statements of operations, equity,
comprehensive income, and cash flows for each of the three years
in the period ended December 31, 2010. These financial
statements are the responsibility of the Companys
management. Our responsibility is to express an opinion on the
financial statements based on our audits.
We conducted our audits in accordance with standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by
management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, such consolidated financial statements present
fairly, in all material respects, the financial position of the
Company as of December 31, 2010 and 2009, and the results
of their operations and their cash flows for each of the three
years in the period ended December 31, 2010, in conformity
with accounting principles generally accepted in the United
States of America.
We have also audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
Companys internal control over financial reporting as of
December 31, 2010, based on the criteria established in
Internal Control Integrated Framework issued
by the Committee of Sponsoring Organizations of the Treadway
Commission and our report dated March 15, 2011 expressed an
unqualified opinion on the Companys internal control over
financial reporting.
/s/ Deloitte &
Touche LLP
Boston, Massachusetts
March 15, 2011
F-2
IPG
PHOTONICS CORPORATION
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
|
(In thousands, except share and per share data)
|
|
|
ASSETS
|
CURRENT ASSETS:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
147,860
|
|
|
$
|
82,920
|
|
Accounts receivable, net
|
|
|
55,399
|
|
|
|
30,356
|
|
Inventories, net
|
|
|
72,470
|
|
|
|
52,869
|
|
Income taxes receivable
|
|
|
2,663
|
|
|
|
2,558
|
|
Prepaid expenses and other current assets
|
|
|
13,816
|
|
|
|
4,653
|
|
Deferred income taxes
|
|
|
8,593
|
|
|
|
7,558
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
300,801
|
|
|
|
180,914
|
|
DEFERRED INCOME TAXES
|
|
|
4,489
|
|
|
|
4,313
|
|
INTANGIBLE ASSETS
|
|
|
7,131
|
|
|
|
3,771
|
|
PROPERTY, PLANT AND EQUIPMENT, Net
|
|
|
120,683
|
|
|
|
111,453
|
|
OTHER ASSETS
|
|
|
8,751
|
|
|
|
12,185
|
|
|
|
|
|
|
|
|
|
|
TOTAL
|
|
$
|
441,855
|
|
|
$
|
312,636
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY
|
CURRENT LIABILITIES:
|
|
|
|
|
|
|
|
|
Revolving
line-of-credit
facilities
|
|
$
|
6,841
|
|
|
$
|
6,007
|
|
Current portion of long-term debt
|
|
|
1,333
|
|
|
|
1,333
|
|
Accounts payable
|
|
|
9,510
|
|
|
|
5,620
|
|
Accrued expenses and other liabilities
|
|
|
50,105
|
|
|
|
21,189
|
|
Deferred income taxes
|
|
|
3,387
|
|
|
|
503
|
|
Income taxes payable
|
|
|
11,594
|
|
|
|
2,179
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
82,770
|
|
|
|
36,831
|
|
DEFERRED INCOME TAXES AND OTHER LONG-TERM LIABILITIES
|
|
|
1,735
|
|
|
|
2,567
|
|
LONG-TERM DEBT
|
|
|
15,644
|
|
|
|
16,667
|
|
REDEEMABLE NONCONTROLLING INTERESTS
|
|
|
24,903
|
|
|
|
|
|
COMMITMENTS AND CONTINGENCIES
|
|
|
|
|
|
|
|
|
IPG PHOTONICS CORPORATION STOCKHOLDERS EQUITY:
|
|
|
|
|
|
|
|
|
Common stock, $0.0001 par value, 175,000,000 shares
authorized;
|
|
|
|
|
|
|
|
|
46,988,566 and 46,076,472 shares issued and outstanding at
December 31, 2010 and 2009, respectively
|
|
|
5
|
|
|
|
5
|
|
Additional paid-in capital
|
|
|
310,218
|
|
|
|
293,743
|
|
Retained earnings (accumulated deficit)
|
|
|
5,567
|
|
|
|
(48,424
|
)
|
Accumulated other comprehensive income
|
|
|
810
|
|
|
|
11,106
|
|
|
|
|
|
|
|
|
|
|
Total IPG Photonics Corporation stockholders equity
|
|
|
316,600
|
|
|
|
256,430
|
|
NONCONTROLLING INTERESTS
|
|
|
203
|
|
|
|
141
|
|
|
|
|
|
|
|
|
|
|
Total equity
|
|
|
316,803
|
|
|
|
256,571
|
|
|
|
|
|
|
|
|
|
|
TOTAL
|
|
$
|
441,855
|
|
|
$
|
312,636
|
|
|
|
|
|
|
|
|
|
|
See notes to consolidated financial statements.
F-3
IPG
PHOTONICS CORPORATION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In thousands, except per share data)
|
|
|
NET SALES
|
|
$
|
299,256
|
|
|
$
|
185,894
|
|
|
$
|
229,076
|
|
COST OF SALES
|
|
|
152,798
|
|
|
|
121,626
|
|
|
|
121,776
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GROSS PROFIT
|
|
|
146,458
|
|
|
|
64,268
|
|
|
|
107,300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES:
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing
|
|
|
19,100
|
|
|
|
15,157
|
|
|
|
13,900
|
|
Research and development
|
|
|
19,160
|
|
|
|
18,543
|
|
|
|
15,804
|
|
General and administrative
|
|
|
28,645
|
|
|
|
20,489
|
|
|
|
23,198
|
|
(Gain) loss on foreign exchange
|
|
|
(848
|
)
|
|
|
1,022
|
|
|
|
(2,798
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
66,057
|
|
|
|
55,211
|
|
|
|
50,104
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING INCOME
|
|
|
80,401
|
|
|
|
9,057
|
|
|
|
57,196
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OTHER EXPENSE, Net:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense, net
|
|
|
(1,188
|
)
|
|
|
(1,252
|
)
|
|
|
(777
|
)
|
Other income (expense), net
|
|
|
39
|
|
|
|
(36
|
)
|
|
|
145
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other expense
|
|
|
(1,149
|
)
|
|
|
(1,288
|
)
|
|
|
(632
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INCOME BEFORE PROVISION FOR INCOME TAXES
|
|
|
79,252
|
|
|
|
7,769
|
|
|
|
56,564
|
|
PROVISION FOR INCOME TAXES
|
|
|
(24,900
|
)
|
|
|
(2,485
|
)
|
|
|
(18,111
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET INCOME
|
|
|
54,352
|
|
|
|
5,284
|
|
|
|
38,453
|
|
LESS: NET INCOME (LOSS) ATTRIBUTABLE TO NONCONTROLLING INTERESTS
|
|
|
361
|
|
|
|
(135
|
)
|
|
|
1,799
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET INCOME ATTRIBUTABLE TO IPG PHOTONICS CORPORATION
|
|
$
|
53,991
|
|
|
$
|
5,419
|
|
|
$
|
36,654
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET INCOME ATTRIBUTABLE TO IPG PHOTONICS CORPORATION PER SHARE:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
1.16
|
|
|
$
|
0.12
|
|
|
$
|
0.82
|
|
Diluted
|
|
$
|
1.13
|
|
|
$
|
0.12
|
|
|
$
|
0.79
|
|
WEIGHTED AVERAGE SHARES OUTSTANDING:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
46,424
|
|
|
|
45,489
|
|
|
|
44,507
|
|
Diluted
|
|
|
47,594
|
|
|
|
46,595
|
|
|
|
46,223
|
|
See notes to consolidated financial statements.
F-4
IPG
PHOTONICS CORPORATION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
|
(In thousands, except share and per share data)
|
|
|
COMMON STOCK
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, beginning of year
|
|
|
46,076,472
|
|
|
$
|
5
|
|
|
|
44,965,960
|
|
|
$
|
4
|
|
|
|
44,012,341
|
|
|
$
|
4
|
|
Exercise of stock options
|
|
|
865,123
|
|
|
|
|
|
|
|
684,838
|
|
|
|
1
|
|
|
|
885,277
|
|
|
|
|
|
Common stock issued under employee stock purchase plan
|
|
|
46,971
|
|
|
|
|
|
|
|
57,528
|
|
|
|
|
|
|
|
17,662
|
|
|
|
|
|
Common stock issued in purchase of NCI
|
|
|
|
|
|
|
|
|
|
|
368,146
|
|
|
|
|
|
|
|
50,680
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, end of period
|
|
|
46,988,566
|
|
|
|
5
|
|
|
|
46,076,472
|
|
|
|
5
|
|
|
|
44,965,960
|
|
|
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ADDITIONAL PAID-IN CAPITAL
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, beginning of year
|
|
|
|
|
|
|
293,743
|
|
|
|
|
|
|
|
283,217
|
|
|
|
|
|
|
|
275,506
|
|
Stock-based compensation
|
|
|
|
|
|
|
3,196
|
|
|
|
|
|
|
|
2,767
|
|
|
|
|
|
|
|
2,074
|
|
Exercise of stock options and related tax benefit from exercise
|
|
|
|
|
|
|
13,138
|
|
|
|
|
|
|
|
2,871
|
|
|
|
|
|
|
|
4,761
|
|
Common stock issued under employee stock purchase plan
|
|
|
|
|
|
|
603
|
|
|
|
|
|
|
|
545
|
|
|
|
|
|
|
|
198
|
|
Common stock issued in purchase of NCI
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,027
|
|
|
|
|
|
|
|
678
|
|
Sale of redeemable noncontrolling interest
|
|
|
|
|
|
|
15,892
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase redeemable NCI to initial redemption value
|
|
|
|
|
|
|
(16,285
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount on purchase of NCI
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,028
|
|
|
|
|
|
|
|
|
|
Premium on purchase of NCI
|
|
|
|
|
|
|
(69
|
)
|
|
|
|
|
|
|
(712
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, end of period
|
|
|
|
|
|
|
310,218
|
|
|
|
|
|
|
|
293,743
|
|
|
|
|
|
|
|
283,217
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RETAINED EARNINGS (ACCUMULATED DEFICIT)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, beginning of year
|
|
|
|
|
|
|
(48,424
|
)
|
|
|
|
|
|
|
(53,843
|
)
|
|
|
|
|
|
|
(90,497
|
)
|
Net income attributable to IPG Photonics Corporation
|
|
|
|
|
|
|
53,991
|
|
|
|
|
|
|
|
5,419
|
|
|
|
|
|
|
|
36,654
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, end of period
|
|
|
|
|
|
|
5,567
|
|
|
|
|
|
|
|
(48,424
|
)
|
|
|
|
|
|
|
(53,843
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ACCUMULATED OTHER COMPREHENSIVE INCOME
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, beginning of year
|
|
|
|
|
|
|
11,106
|
|
|
|
|
|
|
|
8,794
|
|
|
|
|
|
|
|
15,167
|
|
Translation adjustments
|
|
|
|
|
|
|
(10,662
|
)
|
|
|
|
|
|
|
1,962
|
|
|
|
|
|
|
|
(5,327
|
)
|
Unrealized (loss) gain on derivatives, net of tax
|
|
|
|
|
|
|
(27
|
)
|
|
|
|
|
|
|
350
|
|
|
|
|
|
|
|
(1,046
|
)
|
Attribution to redeemable NCI
|
|
|
|
|
|
|
393
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, end of period
|
|
|
|
|
|
|
810
|
|
|
|
|
|
|
|
11,106
|
|
|
|
|
|
|
|
8,794
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL IPG PHOTONICS CORPORATION STOCKHOLDERS EQUITY
|
|
|
|
|
|
|
316,600
|
|
|
|
|
|
|
|
256,430
|
|
|
|
|
|
|
|
238,172
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NONCONTROLLING INTERESTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, beginning of year
|
|
|
|
|
|
|
141
|
|
|
|
|
|
|
|
5,127
|
|
|
|
|
|
|
|
4,455
|
|
Net income (loss) attributable to NCI
|
|
|
|
|
|
|
361
|
|
|
|
|
|
|
|
(135
|
)
|
|
|
|
|
|
|
1,799
|
|
Purchase of NCI
|
|
|
|
|
|
|
(92
|
)
|
|
|
|
|
|
|
(3,535
|
)
|
|
|
|
|
|
|
(2,575
|
)
|
Net income attributable to redeemable NCI
|
|
|
|
|
|
|
(276
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premium on purchase of NCI
|
|
|
|
|
|
|
69
|
|
|
|
|
|
|
|
712
|
|
|
|
|
|
|
|
1,448
|
|
Discount on purchase of NCI
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,028
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, end of period
|
|
|
|
|
|
|
203
|
|
|
|
|
|
|
|
141
|
|
|
|
|
|
|
|
5,127
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL EQUITY
|
|
|
|
|
|
$
|
316,803
|
|
|
|
|
|
|
$
|
256,571
|
|
|
|
|
|
|
$
|
243,299
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COMPREHENSIVE INCOME
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
$
|
54,352
|
|
|
|
|
|
|
$
|
5,284
|
|
|
|
|
|
|
$
|
38,453
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Translation adjustments
|
|
|
|
|
|
|
(10,662
|
)
|
|
|
|
|
|
|
1,962
|
|
|
|
|
|
|
|
(5,327
|
)
|
Unrealized (loss) gain on derivatives, net of tax
|
|
|
|
|
|
|
(27
|
)
|
|
|
|
|
|
|
350
|
|
|
|
|
|
|
|
(1,046
|
)
|
Change in cumulative translation adjustment attributable to
redeemable NCI
|
|
|
|
|
|
|
393
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
$
|
44,056
|
|
|
|
|
|
|
$
|
7,596
|
|
|
|
|
|
|
$
|
32,080
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See notes to consolidated financial statements.
F-5
IPG
PHOTONICS CORPORATION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In thousands)
|
|
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
54,352
|
|
|
$
|
5,284
|
|
|
$
|
38,453
|
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
21,845
|
|
|
|
19,172
|
|
|
|
15,834
|
|
Deferred income taxes
|
|
|
401
|
|
|
|
(4,087
|
)
|
|
|
2,445
|
|
Stock-based compensation
|
|
|
3,196
|
|
|
|
2,767
|
|
|
|
2,074
|
|
Unrealized (gains) losses on foreign currency transactions
|
|
|
(888
|
)
|
|
|
1,023
|
|
|
|
(3,776
|
)
|
Other
|
|
|
1,184
|
|
|
|
(36
|
)
|
|
|
(251
|
)
|
Provisions for inventory, warranty and bad debt
|
|
|
11,377
|
|
|
|
11,353
|
|
|
|
7,902
|
|
Changes in assets and liabilities that provided (used) cash:
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(27,308
|
)
|
|
|
9,269
|
|
|
|
(8,466
|
)
|
Inventories
|
|
|
(27,018
|
)
|
|
|
5,600
|
|
|
|
(21,661
|
)
|
Prepaid expenses and other current assets
|
|
|
(4,707
|
)
|
|
|
679
|
|
|
|
6,810
|
|
Accounts payable
|
|
|
3,411
|
|
|
|
(498
|
)
|
|
|
(2,267
|
)
|
Accrued expenses and other liabilities
|
|
|
22,119
|
|
|
|
(72
|
)
|
|
|
(304
|
)
|
Income and other taxes payable
|
|
|
5,468
|
|
|
|
3,951
|
|
|
|
(2,122
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
|
63,432
|
|
|
|
54,405
|
|
|
|
34,671
|
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of property, plant and equipment and intangible assets
|
|
|
(28,374
|
)
|
|
|
(10,498
|
)
|
|
|
(37,111
|
)
|
Acquisition of businesses, net of cash acquired
|
|
|
(4,108
|
)
|
|
|
|
|
|
|
|
|
Proceeds from sale of marketable securities
|
|
|
|
|
|
|
|
|
|
|
5,450
|
|
Other
|
|
|
(77
|
)
|
|
|
(141
|
)
|
|
|
43
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(32,559
|
)
|
|
|
(10,639
|
)
|
|
|
(31,618
|
)
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from
line-of-credit
facilities
|
|
|
13,828
|
|
|
|
19,056
|
|
|
|
29,693
|
|
Payments on
line-of-credit
facilities
|
|
|
(13,086
|
)
|
|
|
(32,851
|
)
|
|
|
(21,936
|
)
|
Purchases of NCI
|
|
|
(92
|
)
|
|
|
(508
|
)
|
|
|
(1,897
|
)
|
Proceeds from long-term borrowings
|
|
|
|
|
|
|
|
|
|
|
20,041
|
|
Principal payments on long-term borrowings
|
|
|
(1,333
|
)
|
|
|
(1,344
|
)
|
|
|
(20,196
|
)
|
Sale of redeemable NCI
|
|
|
24,806
|
|
|
|
|
|
|
|
|
|
Exercise of employee stock options, issuances under employee
stock
|
|
|
|
|
|
|
|
|
|
|
|
|
purchase plan and related tax benefit from exercise
|
|
|
13,741
|
|
|
|
3,417
|
|
|
|
4,959
|
|
Other
|
|
|
(100
|
)
|
|
|
(50
|
)
|
|
|
(212
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities
|
|
|
37,764
|
|
|
|
(12,280
|
)
|
|
|
10,452
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EFFECT OF CHANGES IN EXCHANGE RATES ON CASH AND CASH EQUIVALENTS
|
|
|
(3,697
|
)
|
|
|
151
|
|
|
|
(194
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET PROVIDED BY IN CASH AND CASH EQUIVALENTS
|
|
|
64,940
|
|
|
|
31,637
|
|
|
|
13,311
|
|
CASH AND CASH EQUIVALENTS Beginning of period
|
|
|
82,920
|
|
|
|
51,283
|
|
|
|
37,972
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS End of period
|
|
$
|
147,860
|
|
|
$
|
82,920
|
|
|
$
|
51,283
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid for interest
|
|
$
|
998
|
|
|
$
|
1,461
|
|
|
$
|
1,778
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes paid
|
|
$
|
7,417
|
|
|
$
|
4,929
|
|
|
$
|
11,751
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cash transactions:
|
|
|
|
|
|
|
|
|
|
|
|
|
Demonstration units transferred from inventory to other assets
|
|
$
|
1,620
|
|
|
$
|
8,806
|
|
|
$
|
4,981
|
|
Amounts related to acquisition of businesses included in
accounts payable and accrued expenses and other liabilities
|
|
$
|
1,120
|
|
|
$
|
|
|
|
$
|
|
|
Additions to property, plant and equipment included in accounts
payable
|
|
$
|
407
|
|
|
$
|
100
|
|
|
$
|
1,216
|
|
Purchase of NCI in exchange for Common Stock
|
|
$
|
|
|
|
$
|
3,027
|
|
|
$
|
678
|
|
Inventory contributed to unconsolidated affiliate
|
|
$
|
|
|
|
$
|
247
|
|
|
$
|
298
|
|
See notes to consolidated financial statements.
F-6
IPG
PHOTONICS CORPORATION
|
|
1.
|
NATURE OF
BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES
|
Nature of Business IPG Photonics Corporation
(the Company) designs and manufactures a broad line
of high-performance fiber lasers and fiber amplifiers for
diverse applications in numerous markets, such as materials
processing, advanced applications, communications and medical.
Our world headquarters are located in Oxford, Massachusetts. We
also have facilities and sales offices elsewhere in the United
States, Europe and Asia.
Principles of Consolidation We were
incorporated as a Delaware corporation in December 1998. The
accompanying financial statements include the accounts of the
Company and our majority-owned subsidiaries. All intercompany
accounts and transactions have been eliminated.
Use of Estimates The preparation of financial
statements in conformity with accounting principles generally
accepted in the United States of America requires management to
make estimates and assumptions that affect the reported amounts
of assets and liabilities, disclosure of contingent assets and
liabilities at the date of the financial statements and the
reported amounts of revenue and expenses during the reporting
period. Actual results could differ from those estimates.
Foreign Currency The financial information
for entities outside the United States is measured using local
currencies as the functional currency. Assets and liabilities
are translated into U.S. dollars at the exchange rate in
effect on the respective balance sheet dates. Income and
expenses are translated into U.S. dollars based on the
average rate of exchange for the corresponding period. Exchange
rate differences resulting from translation adjustments are
accounted for directly as a component of accumulated other
comprehensive income.
Cash and Cash Equivalents Cash and cash
equivalents consist primarily of highly liquid investments, such
as bank deposits, with insignificant interest rate risk and
remaining maturities of three months or less at the date of
acquisition. As more fully explained in Note 7, during
December 2010, the Company completed the sale of a 12.5%
interest in its Russian subsidiary, NTO IRE Polus
(NTO), to an unrelated third party for
$25 million. Proceeds from the sale of this interest, which
included cash and cash equivalents, are designated for the
expansion of NTOs business and can be used for investments
in fixed assets, working capital and operating expenses of NTO,
but are not available for use for other purposes.
Inventories Inventories are stated at the
lower of cost or market on a
first-in,
first-out basis. Inventories include parts and components that
may be specialized in nature and subject to rapid obsolescence.
We periodically review the quantities and carrying values of
inventories to assess whether the inventories are recoverable.
Because of our vertical integration, a significant or sudden
decrease in sales activity could result in a significant change
in the estimates of excess or obsolete inventory valuation. The
costs associated with provisions for excess quantities,
technological obsolescence, or component rejection are charged
to cost of sales as incurred.
Property, Plant, and Equipment Property,
plant, and equipment are stated at cost, less accumulated
depreciation. Depreciation is determined using the straight-line
method based on the estimated useful lives of the related
assets. In the case of leasehold improvements, the estimated
useful lives of the related assets do not exceed the remaining
terms of the corresponding leases. The following table presents
the assigned economic useful lives of property, plant, and
equipment:
|
|
|
|
|
|
|
Economic
|
Category
|
|
Useful Life
|
|
Buildings
|
|
|
30 years
|
|
Machinery and equipment
|
|
|
3-5 years
|
|
Office furniture and fixtures
|
|
|
3-5 years
|
|
Other assets
|
|
|
3-5 years
|
|
F-7
IPG
PHOTONICS CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Expenditures for maintenance and repairs are charged to
operations. Interest expense associated with significant capital
projects is capitalized as a cost of the project. We capitalized
$18,000, $75,000 and $390,000 of interest expense in 2010, 2009
and 2008, respectively.
Long-Lived Assets Long-lived assets, which
consist primarily of property, plant, and equipment, are
reviewed by management for impairment whenever events or changes
in circumstances indicate that the carrying amount may not be
recoverable. In cases in which undiscounted expected future cash
flows are less than the carrying value, an impairment loss is
recorded equal to the amount by which the carrying value exceeds
the fair value of assets. No impairment losses have been
recorded during the periods presented.
Included in other long-term assets is certain demonstration
equipment as well as intangible assets, comprised of purchased
technologies, production know-how and customer relationships.
The demonstration equipment and intangible assets are amortized
over the respective estimated economic lives, generally
3 years for demonstration equipment and 5-10 years for
intangible assets. The carrying value of the demonstration
equipment totaled $4.6 million and $8.9 million at
December 31, 2010 and 2009, respectively. Amortization
expense for the years ended December 31, 2010, 2009 and
2008, was $3.7 million, 3.6 million and
$2.7 million, respectively.
Intangible Assets Intangible assets consist
of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
Weighted-
|
|
|
|
2010
|
|
|
2009
|
|
|
Average Lives
|
|
|
|
(In thousands)
|
|
|
|
|
|
Amortizable intangible assets
|
|
|
|
|
|
|
|
|
|
|
|
|
Patents
|
|
$
|
4,664
|
|
|
$
|
3,650
|
|
|
|
6 Years
|
|
Customer relationships
|
|
|
3,633
|
|
|
|
1,934
|
|
|
|
5 Years
|
|
Production know-how
|
|
|
2,518
|
|
|
|
|
|
|
|
9 Years
|
|
Other identifiable intangibles
|
|
|
10
|
|
|
|
109
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,825
|
|
|
|
5,693
|
|
|
|
|
|
Accumulated amortization
|
|
|
(3,694
|
)
|
|
|
(1,922
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
7,131
|
|
|
$
|
3,771
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The company completed two acquisitions in 2010, one in the
U.S. in the first quarter and one in Germany in the second
quarter. Amounts paid include cash payments aggregating
$4.5 million and contingent consideration and seller
provided financing with an aggregate fair value of
$1.0 million. Net assets acquired primarily consisted of
intangible assets (patents, customer relationships, and
production know-how with weighted-average estimated useful lives
of 10 years, 5 years and 8 years, respectively)
aggregating $5.2 million.
Amortization expense for the years ended December 31, 2010,
2009 and 2008, was $1,772,000, $1,185,000 and $682,000,
respectively.
The estimated future amortization expense for intangibles as of
December 31, 2010 is as follows (in thousands):
|
|
|
|
|
|
|
|
|
2011
|
|
2012
|
|
2013
|
|
2014
|
|
Thereafter
|
|
$1,971
|
|
$1,690
|
|
$1,068
|
|
$811
|
|
$1,591
|
Revenue Recognition We recognize revenue when
four basic criteria are met: (1) persuasive evidence of an
arrangement exists; (2) delivery has occurred or services
have been rendered; (3) the fee is fixed and determinable;
and (4) collectability is reasonably assured. Revenue from
the sale of our products is generally
F-8
IPG
PHOTONICS CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
recognized upon shipment, provided that the other revenue
recognition criteria have been met. We have no obligation to
provide upgrades, enhancements or customer support subsequent to
the sale, other than warranty.
Revenue from orders with multiple deliverables is divided into
separate units of accounting when certain criteria are met. The
consideration for the arrangement is then allocated to the
separate units of accounting based on their relative fair
values. We defer revenue on multiple element arrangements if the
fair values of the undelivered elements are not known or if
customer acceptance is contingent on delivery of specified items
or performance conditions that cannot be satisfactorily tested
prior to shipment or if we have not met such conditions in the
past. Applicable revenue recognition criteria are then applied
separately for each separate unit of accounting.
Returns and customer credits are infrequent and are recorded as
a reduction to revenue. Rights of return are generally not
included in sales arrangements. Generally, we receive a customer
purchase order as evidence of an arrangement and product
shipment terms are free on board (F.O.B.) shipping point.
Periodically, our revenue arrangements include customer
acceptance clauses. If an acceptance clause defines a
performance requirement in a process or application that we
cannot effectively test prior to delivery or that has not been
accepted previously, we defer recognition of revenue until the
performance requirement has been proved.
Allowance for Doubtful Accounts We maintain
an allowance for doubtful accounts to provide for the estimated
amount of accounts receivable that will not be collected. The
allowance is based upon an assessment of customer
creditworthiness, historical payment experience and the age of
outstanding receivables.
Activity related to the allowance for doubtful accounts was as
follows (in thousands):
|
|
|
|
|
Balance at January 1, 2008
|
|
$
|
309
|
|
Provision for bad debts
|
|
|
936
|
|
Uncollectible accounts recovered or written off
|
|
|
(9
|
)
|
Foreign currency translation
|
|
|
5
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
|
1,241
|
|
Provision for bad debts
|
|
|
1,777
|
|
Uncollectible accounts recovered or written off
|
|
|
(1,795
|
)
|
Foreign currency translation
|
|
|
33
|
|
|
|
|
|
|
Balance at December 31, 2009
|
|
|
1,256
|
|
Provision for bad debts
|
|
|
1,951
|
|
Uncollectible accounts recovered or written off
|
|
|
(999
|
)
|
Foreign currency translation
|
|
|
(65
|
)
|
|
|
|
|
|
Balance at December 31, 2010
|
|
$
|
2,143
|
|
|
|
|
|
|
F-9
IPG
PHOTONICS CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Warranties In general, our products carry a
warranty against defect for a period of one to three years,
depending upon the product type and customer negotiations. The
expected cost associated with these warranty obligations is
recorded when the revenue is recognized. The warranty accrual is
reflected in accrued expenses and other liabilities in the
consolidated balance sheets. Activity related to the warranty
accrual was as follows (in thousands):
|
|
|
|
|
Balance at January 1, 2008
|
|
$
|
1,957
|
|
Provision for warranty accrual
|
|
|
3,177
|
|
Warranty claims and other reductions
|
|
|
(1,899
|
)
|
Foreign currency translation
|
|
|
(12
|
)
|
|
|
|
|
|
Balance at December 31, 2008
|
|
|
3,223
|
|
Provision for warranty accrual
|
|
|
2,962
|
|
Warranty claims and other reductions
|
|
|
(2,322
|
)
|
Foreign currency translation
|
|
|
23
|
|
|
|
|
|
|
Balance at December 31, 2009
|
|
|
3,886
|
|
Provision for warranty accrual
|
|
|
6,681
|
|
Warranty claims and other reductions
|
|
|
(3,476
|
)
|
Foreign currency translation
|
|
|
(174
|
)
|
|
|
|
|
|
Balance at December 31, 2010
|
|
$
|
6,917
|
|
|
|
|
|
|
Advertising Expense The cost of advertising
is expensed as incurred. We conduct substantially all of our
sales and marketing efforts through trade shows, professional
and technical conferences, direct sales and use of our website.
Our advertising costs were not significant for the periods
presented.
Research and Development Research and
development costs are expensed as incurred.
Income Taxes Deferred tax assets and
liabilities are recognized for the future tax consequences of
temporary differences between the financial statement carrying
amounts and tax bases of assets and liabilities and net
operating loss carryforwards and credits using enacted rates in
effect when those differences are expected to reverse. Valuation
allowances are provided against deferred tax assets that are not
deemed to be recoverable. We recognize tax positions that are
more likely than not to be sustained upon examination by
relevant tax authorities. The tax positions are measured at the
greatest amount of tax benefit that is more than 50 percent
likely to be realized upon ultimate settlement.
We provide reserves for potential payments of tax to various tax
authorities related to uncertain tax positions and other issues.
The reserves are based on a determination of whether and how
much of a tax benefit taken by us in our tax filings or
positions is more likely than not to be realized following
resolution of uncertainties related to the tax benefit, assuming
that the matter in question will be raised by the tax
authorities.
Concentration of Credit Risk Financial
instruments that potentially subject us to credit risk consist
primarily of cash and cash equivalents, marketable securities
and accounts receivable. We maintain substantially all of our
cash and marketable securities in six financial institutions,
which are believed to be high-credit, quality financial
institutions. We grant credit to customers in the ordinary
course of business and provide a reserve for potential credit
losses. Such losses historically have been within
managements expectations (see discussion related to
significant customers in Note 15).
Fair Value of Financial Instruments Our
financial instruments consist of accounts receivable, auction
rate securities, accounts payable, drawings on revolving lines
of credit, long-term debt and certain derivative instruments.
F-10
IPG
PHOTONICS CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The valuation techniques used to measure fair value are based
upon observable and unobservable inputs. Observable inputs
reflect market data obtained from independent sources, while
unobservable inputs reflect internal market assumptions. These
two types of inputs create the following fair value hierarchy:
Level 1, defined as observable inputs such as quoted prices
for identical instruments in active markets; Level 2,
defined as inputs other than quoted prices in active markets
that are either directly or indirectly observable; and
Level 3, defined as unobservable inputs for which little or
no market data exists, therefore requiring an entity to develop
its own assumptions.
The carrying amounts of accounts receivable, accounts payable
and drawings on revolving lines of credit are considered
reasonable estimates of their fair market value, due to the
short maturity of these instruments or as a result of the
competitive market interest rates, which have been negotiated.
The following table presents information about our assets and
liabilities measured at fair value (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements at December 31, 2010
|
|
|
|
Total
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds
|
|
$
|
4,223
|
|
|
$
|
4,223
|
|
|
$
|
|
|
|
$
|
|
|
Treasury bills
|
|
|
55,679
|
|
|
|
55,679
|
|
|
|
|
|
|
|
|
|
German Treasury bills
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Auction rate securities
|
|
|
921
|
|
|
|
|
|
|
|
|
|
|
|
921
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
60,823
|
|
|
$
|
59,902
|
|
|
$
|
|
|
|
$
|
921
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contingent purchase consideration
|
|
$
|
685
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
685
|
|
Warrant
|
|
|
180
|
|
|
|
|
|
|
|
|
|
|
|
180
|
|
Interest rate swaps
|
|
|
1,156
|
|
|
|
|
|
|
|
1,156
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
$
|
2,021
|
|
|
$
|
|
|
|
$
|
1,156
|
|
|
$
|
865
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements at December 31, 2009
|
|
|
|
Total
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money market funds
|
|
$
|
9,431
|
|
|
$
|
9,431
|
|
|
$
|
|
|
|
$
|
|
|
Treasury bills
|
|
|
28,678
|
|
|
|
28,678
|
|
|
|
|
|
|
|
|
|
German Treasury bills
|
|
|
4,299
|
|
|
|
4,299
|
|
|
|
|
|
|
|
|
|
Auction rate securities
|
|
|
1,284
|
|
|
|
|
|
|
|
|
|
|
|
1,284
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
43,692
|
|
|
$
|
42,408
|
|
|
$
|
|
|
|
$
|
1,284
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swap
|
|
|
1,125
|
|
|
|
|
|
|
|
1,125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
$
|
1,125
|
|
|
$
|
|
|
|
$
|
1,125
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The interest rate swaps are designated as cash flow hedges and
were based on quoted market prices or pricing models using
current market rates. Fair value at December 31, 2010 for
the auction rate securities was determined using inputs from
secondary markets for similar securities.
F-11
IPG
PHOTONICS CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
During 2010, we completed the acquisition of Photonics
Innovations, Inc., and Cosytronic, KG. The fair value of the
accrued contingent consideration incurred during these
acquisitions was determined using an income approach at the
acquisition date and reporting date. That approach is based on
significant inputs that are not observable in the market. Key
assumptions include assessing the probability of meeting certain
milestones required to earn the contingent consideration. As of
December 31, 2010, the Company has accrued a liability of
$685 for the estimated fair value of contingent consideration
expected to be payable upon the acquired company reaching
specific performance metrics over the next three years of
operation. As of December 31, 2010, the ranges of outcomes
and key assumptions have not changed materially.
In December 2010 we issued warrants in conjunction with the sale
of a redeemable noncontrolling interest more fully described in
Note 7. We valued these warrants and the embedded put and
call options attached to them by first determining the
underlying equity value of our Russian subsidiary using a
discounted cash flow model and then, using appropriate inputs
for expected volatility, revenue multiple and credit spread, ran
a binomial tree model followed by a Monte Carlo simulation to
estimate the value of the embedded derivatives.
The assets measured at fair value on a recurring basis using
significant unobservable inputs (Level 3) are auction
rate securities, contingent consideration and warrants (in
thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Auction Rate
|
|
|
Contingent
|
|
|
|
|
|
|
Securities
|
|
|
Consideration
|
|
|
Warrant
|
|
|
Balance at December 31, 2009
|
|
$
|
1,284
|
|
|
$
|
|
|
|
$
|
|
|
2010 transactions
|
|
|
|
|
|
|
675
|
|
|
|
180
|
|
Change in fair value
|
|
|
(338
|
)
|
|
|
10
|
|
|
|
|
|
ARSs redeemed by issuers at par
|
|
|
(25
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31, 2010
|
|
$
|
921
|
|
|
$
|
685
|
|
|
$
|
180
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The auction rate securities are considered
available-for-sale
securities. They had a cost basis of $1,450,000 and $1,475,000
at December 31, 2010 and 2009, respectively.
Comprehensive Income Comprehensive income
includes charges and credits to equity that are not the result
of transactions with stockholders. Included with other
comprehensive income is the cumulative translation adjustment
and unrealized gains or losses on derivatives. These adjustments
are accumulated within the consolidated statements of equity.
Total components of accumulated other comprehensive income were
as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
Foreign currency translation adjustment
|
|
$
|
1,533
|
|
|
$
|
11,802
|
|
Unrealized loss on derivatives, net of tax of $433 and $429
|
|
$
|
(723
|
)
|
|
$
|
(696
|
)
|
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive income
|
|
$
|
810
|
|
|
$
|
11,106
|
|
|
|
|
|
|
|
|
|
|
Derivative Instruments Our primary market
exposures are to interest rates and foreign exchange rates. We
may use certain derivative financial instruments to help manage
these exposures. We execute these instruments with financial
institutions we judge to be credit-worthy. We do not hold or
issue derivative financial instruments for trading or
speculative purposes.
We recognize all derivative financial instruments as either
assets or liabilities at fair value in the consolidated balance
sheet. We have used foreign currency forward contracts as cash
flow hedges of forecasted intercompany settlements denominated
in foreign currencies of major industrial countries. We have no
F-12
IPG
PHOTONICS CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
outstanding foreign currency forward contracts. We have two
interest rate swaps that are classified as cash flow hedges of
our variable rate debt.
Cash flow hedges Our cash flow hedges consist
of interest rate swaps under which we agree to pay fixed rates
of interest. All of our derivatives are accounted for as hedging
instruments. The fair value amounts in the consolidated balance
sheets at December 31, 2010 and 2009 were (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred Income Taxes and Other
|
|
|
|
Notional Amounts(1)
|
|
|
Other Assets
|
|
|
Long-Term Liabilities
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2010
|
|
|
2009
|
|
|
2010
|
|
|
2009
|
|
|
Interest rate swap(s)
|
|
$
|
16,666
|
|
|
$
|
18,000
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
1,156
|
|
|
$
|
1,125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
16,666
|
|
|
$
|
18,000
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
1,156
|
|
|
$
|
1,125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Notional amounts represent the gross contract/notional amount of
the derivatives outstanding. |
The derivative gains and losses in the consolidated statements
of operations for the years ended December 31, 2010 and
2009, related to our interest rate swap contracts were as
follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
2010
|
|
2009
|
|
Effective portion recognized in other comprehensive (loss) gain,
pretax:
|
|
|
|
|
|
|
|
|
Interest rate swap(s)
|
|
$
|
649
|
|
|
$
|
1,236
|
|
Effective portion reclassified from other comprehensive (loss)
gain to interest expense, pretax:
|
|
|
|
|
|
|
|
|
Interest rate swap(s)
|
|
$
|
(679
|
)
|
|
$
|
(684
|
)
|
Ineffective portion recognized in income:
|
|
|
|
|
|
|
|
|
Interest rate swap(s)
|
|
$
|
|
|
|
$
|
|
|
We made no adjustments to the fair value of this derivative as a
result of evaluating counterparty risk.
Business Segment Information We operate in
one segment which involves the design, development, production
and distribution of fiber lasers, fiber amplifiers and related
optical components. We have a single, company-wide management
team that administers all properties as a whole rather than as
discrete operating segments. The chief decision maker, who is
our Chief Executive Officer, measures financial performance as a
single enterprise and not on legal entity or end-market basis.
Throughout the year, the chief decision maker allocates capital
resources on a
project-by-project
basis across our entire asset base to maximize profitability
without regard to legal entity or end-market basis. We operate
in a number of countries throughout the world in a variety of
product lines. Information regarding geographic financial
information and product lines is provided in Note 15.
Recent Accounting Pronouncements In October
2009, an update was issued to the accounting guidance related to
the separation criteria used to determine the unit of accounting
for multiple element arrangements. This update removes the
objective-and-reliable-evidence-of-fair-value
criterion from the separation criteria used to determine whether
an arrangement involving multiple deliverables contains more
than one unit of accounting, replaces references to fair
value with selling price to distinguish from
the fair value measurements required under the Fair Value
Measurements and Disclosures guidance, provides a hierarchy
that entities must use to estimate the selling price, eliminates
the use of the residual method for allocation and expands the
ongoing disclosure
F-13
IPG
PHOTONICS CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
requirements. This guidance is effective for us beginning
January 1, 2011. We are evaluating the effect that
implementation of this update will have, if any, on our
consolidated financial position and results of operations.
|
|
2.
|
STOCK-BASED
COMPENSATION
|
Stock-based compensation is included in the following financial
statement captions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
|
(In thousands)
|
|
|
Cost of sales
|
|
$
|
727
|
|
|
$
|
578
|
|
|
$
|
328
|
|
Sales and marketing
|
|
|
801
|
|
|
|
727
|
|
|
|
407
|
|
Research and development
|
|
|
446
|
|
|
|
344
|
|
|
|
490
|
|
General and administrative
|
|
|
1,222
|
|
|
|
1,118
|
|
|
|
849
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stock-based compensation
|
|
|
3,196
|
|
|
|
2,767
|
|
|
|
2,074
|
|
Tax benefit recognized
|
|
|
(973
|
)
|
|
|
(792
|
)
|
|
|
(594
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net stock-based compensation
|
|
$
|
2,223
|
|
|
$
|
1,975
|
|
|
$
|
1,480
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation cost for all share-based payment awards is based on
the estimated grant-date fair value. We allocate and record
stock-based compensation expense on a straight-line basis over
the requisite service period.
We calculate the fair value of stock option grants using the
Black-Scholes option pricing model. Determining the appropriate
fair value model and calculating the fair value of stock-based
payment awards require the use of highly subjective assumptions,
including the expected life of the stock-based payment awards
and stock price volatility. The assumptions used in calculating
the fair value of stock-based payment awards represent
managements best estimates, but the estimates involve
inherent uncertainties and the application of management
judgment. As a result, if factors change and we use different
assumptions, our stock-based compensation expense could be
materially different in the future. The weighted average
assumptions used in the Black-Scholes model or the calculation
of compensation were as follows for the years ended December 31:
|
|
|
|
|
|
|
|
|
2010
|
|
2009
|
|
2008
|
|
Expected term
|
|
2.9-5.9 years
|
|
1.74-7.10 years
|
|
4.33-7.23 years
|
Volatility
|
|
42%-48%
|
|
46%-65%
|
|
39%-65%
|
Risk-free rate of return
|
|
0.34%-2.68%
|
|
0.56%-2.78%
|
|
2.51%-5.20%
|
Dividend yield
|
|
0%
|
|
0%
|
|
0%
|
Forfeiture rate
|
|
0%-5.0%
|
|
2%-6.6%
|
|
2%-5%
|
There is a lack of sufficient company-specific historical and
implied volatility information for options granted with an
expected term that is longer than the period for which our stock
has been publically traded. For these awards we based our
estimate of expected volatility on the expected volatility of
similar entities whose share prices are publicly available. We
used the following factors to identify similar public entities:
industry, stage of life cycle, size and profitability. We intend
to continue to consistently apply this process using the same or
similar entities until a sufficient amount of historical
information regarding the volatility of its own share price
becomes available, or unless circumstances change such that the
identified entities are no longer similar to us. In this latter
case, more suitable, similar entities whose share prices are
publicly available would be utilized in the calculation. There
were option awards made in 2010 for which the expected term is
F-14
IPG
PHOTONICS CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
shorter than the period for which our stock has been publically
traded. For these awards, the company-specific historical and
implied volatility information was used.
Incentive Plans In April 2000, our board of
directors adopted the 2000 Incentive Compensation Plan, or 2000
plan, and in February 2006, our board of directors adopted the
2006 Incentive Compensation Plan, or 2006 plan, which provide
for the issuance of stock options and other stock and non-stock
based awards to our directors, employees, consultants and
advisors. We reserved 5,833,333 shares under the 2000 plan
and 4,000,000 shares under the 2006 plan for the issuance
of awards under the plans. In June 2006, our board of directors
adopted the Non-Employee Directors Stock Plan (the
Directors Plan). Only non-employee directors are
eligible to receive awards under the Directors Plan. We reserved
486,660 shares for issuance under the Directors Plan. Under
the three plans, we may grant nonstatutory stock options at an
exercise price at least equal to the fair value of our common
stock on the date of grant, unless the board of directors or
compensation committee determines otherwise on the date of
grant. Incentive stock options may be granted under the 2000
plan and the 2006 plan at exercise prices equal to or exceeding
the fair value of the common stock on the date of grant. Options
generally become exercisable over periods of one to five years
and expire seven to ten years from the date of the grant. The
awards under the 2000 plan and the 2006 plan may become
exercisable earlier upon the occurrence of certain change of
control events at the election of the board of directors or
compensation committee, and all awards under the Directors Plan
automatically become exercisable upon a change of control. All
shares issued under the stock option plans are registered shares
newly issued by us. At December 31, 2010,
1,526,358 shares were available for future grant under the
three option plans.
A summary of option activity is presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-
|
|
|
|
|
|
|
|
|
|
Weighted-
|
|
|
Average
|
|
|
Aggregate
|
|
|
|
Number of
|
|
|
Average
|
|
|
Remaining
|
|
|
Intrinsic
|
|
|
|
Options
|
|
|
Exercise Price
|
|
|
Contractual Life
|
|
|
Value
|
|
|
|
|
|
|
|
|
|
(In years)
|
|
|
(In thousands)
|
|
|
Outstanding January 1, 2010
|
|
|
3,027,948
|
|
|
$
|
8.01
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
729,590
|
|
|
|
16.21
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(865,123
|
)
|
|
|
6.71
|
|
|
|
|
|
|
|
|
|
Forfeited/Expired
|
|
|
(155,972
|
)
|
|
|
11.39
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding December 31, 2010
|
|
|
2,736,443
|
|
|
$
|
10.33
|
|
|
|
6.93
|
|
|
$
|
57,101
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vested or expected to vest December 31, 2010
|
|
|
2,631,089
|
|
|
$
|
9.96
|
|
|
|
4.97
|
|
|
$
|
56,992
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable December 31, 2010
|
|
|
1,205,572
|
|
|
$
|
6.11
|
|
|
|
5.30
|
|
|
$
|
30,946
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The intrinsic value of the options exercised during the years
ended December 31, 2010, 2009 and 2008, was $13,431,000,
$7,656,000 and $14,287,000, respectively.
The weighted-average grant fair value for options granted during
the years ended December 31, 2010, 2009 and 2008, was
$7.66, $3.94 and $8.68, respectively.
The total compensation cost related to nonvested awards not yet
recorded at December 31, 2010 was $8,412,000, which is
expected to be recognized over a weighted average of
2.9 years.
The fair value of awards vested during the year ended
December 31, 2010 was $3,121,000.
F-15
IPG
PHOTONICS CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Inventories consist of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
Components and raw materials
|
|
$
|
25,126
|
|
|
$
|
17,801
|
|
Work-in-process
|
|
|
24,392
|
|
|
|
21,375
|
|
Finished goods
|
|
|
22,952
|
|
|
|
13,693
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
72,470
|
|
|
$
|
52,869
|
|
|
|
|
|
|
|
|
|
|
We recorded inventory provisions totaling $2,745,000, $5,259,000
and $3,789,000 in 2010, 2009 and 2008, respectively. These
provisions were recorded as a result of uncertainties related to
the recoverability of the value of inventories due to
technological changes and excess quantities. These provisions
are reported as a reduction to components and raw materials and
finished goods. In addition, we recorded a $1.3 million
reduction in value of certain components in inventory in 2009.
|
|
4.
|
PROPERTY,
PLANT, AND EQUIPMENT
|
Property, plant, and equipment consist of the following (in
thousands):
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
Land
|
|
$
|
12,380
|
|
|
$
|
7,340
|
|
Buildings
|
|
|
87,492
|
|
|
|
86,928
|
|
Machinery and equipment
|
|
|
92,363
|
|
|
|
82,818
|
|
Office furniture and fixtures
|
|
|
16,607
|
|
|
|
16,850
|
|
Construction-in-progress
|
|
|
5,392
|
|
|
|
2,019
|
|
|
|
|
|
|
|
|
|
|
Total property, plant, and equipment
|
|
|
214,234
|
|
|
|
195,955
|
|
Accumulated depreciation
|
|
|
(93,551
|
)
|
|
|
(84,502
|
)
|
|
|
|
|
|
|
|
|
|
Total property, plant, and equipment net
|
|
$
|
120,683
|
|
|
$
|
111,453
|
|
|
|
|
|
|
|
|
|
|
We recorded depreciation expense of $16,212,000, $14,296,000 and
$12,481,000 in 2010, 2009 and 2008, respectively.
|
|
5.
|
ACCRUED
EXPENSES AND OTHER LIABILITIES
|
Accrued expenses and other liabilities consist of the following
(in thousands):
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
Accrued compensation
|
|
$
|
16,065
|
|
|
$
|
5,265
|
|
Customer deposits and deferred revenue
|
|
|
20,685
|
|
|
|
8,189
|
|
Accrued warranty
|
|
|
6,917
|
|
|
|
3,886
|
|
Other
|
|
|
6,438
|
|
|
|
3,849
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
50,105
|
|
|
$
|
21,189
|
|
|
|
|
|
|
|
|
|
|
F-16
IPG
PHOTONICS CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
6.
|
FINANCING
ARRANGEMENTS
|
Our existing borrowings under financing arrangements consist of
the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
Revolving
Line-of-Credit
Facilities:
|
|
|
|
|
|
|
|
|
Euro Overdraft Facilities
|
|
$
|
1,882
|
|
|
$
|
977
|
|
Foreign subsidiary drawings on U.S. Line of Credit
|
|
|
4,959
|
|
|
|
5,030
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
6,841
|
|
|
$
|
6,007
|
|
|
|
|
|
|
|
|
|
|
Term Debt:
|
|
|
|
|
|
|
|
|
U.S. Long-Term Note
|
|
$
|
16,666
|
|
|
$
|
18,000
|
|
Other notes payable
|
|
|
311
|
|
|
|
|
|
Less: current portion
|
|
|
(1,333
|
)
|
|
|
(1,333
|
)
|
|
|
|
|
|
|
|
|
|
Total long-term debt
|
|
$
|
15,644
|
|
|
$
|
16,667
|
|
|
|
|
|
|
|
|
|
|
Revolving
Line-of-Credit
Facilities:
U.S. Line of Credit We maintain an
unsecured revolving line of credit with available principal of
up to $35,000,000 expiring in June 2015. The line of credit
bears interest at a variable rate of LIBOR plus 1.125% to 1.625%
depending on our financial performance (1.445% at
December 31, 2010). $12.0 million of this credit
facility is available to our foreign subsidiaries including
those in India, China, Japan and South Korea. Total drawings at
December 31, 2010 were $5.0 million with a weighted
average interest rate of 1.9%. At December 31, 2010, the
remaining availability under the U.S. Line of Credit
totaled $30,041,000.
Euro Line of Credit We maintain an unsecured
revolving line of credit with a principal amount of
Euro 15,000,000 (approximately $19,878,000 at
December 31, 2010) that expires in June 2012. The
credit facility bears interest at various rates based upon the
type of loan. $4.0 million of this credit facility is
available to our Russian subsidiary and $4.0 million is
available to our Italian subsidiary. Total drawings at
December 31, 2010 were $0.5 million with an interest
rate of 1.8%. No amounts were drawn on the Euro Line of Credit
during 2009.
Euro Overdraft Facilities We maintain a
syndicated overdraft facility with available principal of
Euro 850,000 (approximately $1,126,000 at December 31,
2010). This amount is available through September 2011.
This facility bears interest at market rates that vary depending
upon the bank within the syndicate that advances the principal
outstanding (6.5% at December 31, 2010). This facility is
collateralized by a common pool of the assets of our German
subsidiary, IPG Laser GmbH.
Other European Facilities We maintain two
Euro credit lines in Italy with aggregate available principal of
Euro 1,750,000 (approximately $2,319,000 as of
December 31, 2010) which bear interest at rates
ranging from 2.5% to 2.8% and expire in September 2011. Total
drawings at December 31, 2010 were $1.4 million. No
amounts were drawn on the Euro Line of Credit during 2009. At
December 31, 2010, the aggregate remaining availability
under these lines was $901,000. These facilities are
collateralized by a common pool of the assets of our Italian
subsidiary, IPG Photonics (Italy) S.r.l. (IPG Italy).
Term
Debt:
U.S. Long-Term Note In 2010, we extended
the maturity of the U.S Long-Term Note from August 2013 to June
2015. Outstanding principal under the U.S. Long-Term Note
bears interest at LIBOR plus 0.9% to 1.3%, depending on certain
financial ratios and requires monthly principal payments of
$111,000 and
F-17
IPG
PHOTONICS CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
interest through June 2015, at which time the remaining
principal is payable. This note is collateralized by a mortgage
on the real estate and building, in Massachusetts, housing our
U.S. operations. We entered into an interest rate swap
instrument which converts the variable LIBOR rate on the
original term note to a fixed rate of 5.0%. For the extended
term from August 2013 to June 2015, we entered into a separate
interest rate swap instrument which converts the variable LIBOR
rate to a fixed rate of 3.47%. Changes in fair value of the
swaps are included in Accumulated Other Comprehensive
Income. The unrealized loss on the swap will be recognized
into income over the term of the swap as a charge to interest
expense.
We are required to meet certain financial covenants associated
with our U.S. Line of Credit and U.S. Long-Term Note.
These covenants, tested quarterly, include a debt service
coverage ratio and a funded debt to earnings before interest,
taxes, depreciation and amortization (EBITDA) ratio.
The debt service coverage covenant requires us to maintain a
trailing twelve month ratio of cash flow to debt service that is
greater than 1.5:1. Debt service is defined as required
principal and interest payments during the period. Cash flow is
defined as EBITDA less unfunded capital expenditures. For
trailing twelve month periods until June 2010, up to
$15.0 million of our capital expenditures are treated as
being funded from the proceeds of our initial public offering.
The funded debt to EBITDA covenant requires that the sum of all
indebtedness for borrowed money on a consolidated basis shall be
less than two times our trailing twelve months EBITDA.
|
|
7.
|
REDEEMABLE
NONCONTROLLING INTERESTS, STOCKHOLDERS EQUITY AND
NONCONTROLLING INTERESTS
|
Redeemable Noncontrolling Interests
Redeemable Noncontrolling interests reported in the
accompanying consolidated financial statements as of
December 31, 2010 consist of 12.5% of the Companys
Russian subsidiary, NTO IRE Polus (NTO).
|
|
|
|
|
|
|
Redeemable
|
|
|
|
Noncontrolling
|
|
|
|
Interest
|
|
|
Balance at December 31, 2009
|
|
$
|
|
|
Initial interest in book value of subsidiary
|
|
|
8,342
|
|
Increase to the initial redemption value
|
|
|
16,285
|
|
Net income attributable to redeemable NCI
|
|
|
276
|
|
|
|
|
|
|
Balance at December 31, 2010
|
|
$
|
24,903
|
|
|
|
|
|
|
In December 2010, the Company entered into an investment
agreement with an unrelated third party, The Russian Corporation
for Nanotechnology (Rusnano) (the Investment
Agreement). Under the Investment Agreement, Rusnano
acquired a 12.5% noncontrolling interest (NCI) in
NTO and warrants to purchase up to an additional 12.5% of NTO in
three tranches (two additional 5% interests for a purchase price
of $10 million each, and a 2.5% interest for
$5 million) if certain sales targets are achieved before
December 2015. Rusnano invested $25 million in NTO in
December 2010.
In connection with the Investment Agreement, the Company and
Rusnano entered into an option agreement (the Option
Agreement) granting the Company the right to buy back,
after the third and before the seventh anniversary of the Option
Agreement, Rusnanos ownership stake in NTO at the original
purchase price under the Investment Agreement plus interest at
8-10% per annum. Rusnano obtained the right to sell to the
Company, after the fifth and before the seventh anniversary of
the Option Agreement, Rusnanos ownership stake in NTO at
the original purchase price plus interest at 4% per annum (the
Put). Any shares purchased under the warrants in the
Investment Agreement are also subject to the Option Agreement.
Due to the Put, the NCI in NTO held by Rusnano (the
Rusnano NCI) has been classified as temporary equity
and reported as a Redeemable Noncontrolling Interest on our
consolidated balance sheet. The initial net proceeds,
$25 million less transaction expenses of $0.2 million,
were allocated first to the fair value of the
F-18
IPG
PHOTONICS CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
warrants ($0.2 million) and then to the initial carrying
value of the Rusnano NCI. The subsequent carrying value of the
Rusnano NCI is the higher of (1) the initial carrying
amount (plus any subsequent investments in NTO under the
warrants), increased or decreased by the NCIs share of
NTOs net income or loss, the NCIs share of
NTOs other comprehensive income (loss), and dividends or
(2) the redemption value. The redemption value is the
initial carrying value of the Rusnano NCI plus the accretion of
the discount created by warrant and transaction expenses using
the interest method to the fifth anniversary of the agreement
(the earliest redemption date) plus any subsequent investments
in NTO under the warrants plus interest on the initial and any
subsequent investments under the warrants at an annual rate of
4%.
Authorized Capital We have authorized capital
stock consisting of 175,000,000 shares of common stock, par
value $0.0001 per share, and 5,000,000 shares of preferred
stock, par value $0.0001 per share. There are no shares of
preferred stock outstanding.
Noncontrolling Interests Noncontrolling
interests reported in the accompanying consolidated financial
statements as of December 31, 2010 consist of the 10% of
IPG Photonics (Korea) Ltd. (IPG Korea) held by the
management of IPG Korea.
For the year ended December 31, 2010, the net income
attributable to NCI of $0.4 million consisted of amounts
related to the Rusnano NCI of $0.3 million and the NCI
classified as permanent equity of $0.1 million.
Prior to the Rusnano investment, we purchased the interests of
certain noncontrolling stockholders of NTO. In 2008, we
purchased a 7.3% interest for $1,220,000; in 2009, we purchased
a 34% interest held by our Chief Executive Officer and certain
other Company employees for $2,644,000; and in 2010, we
purchased the remaining 0.1% interest for $92,000.
In 2008, we purchased the 20% NCI in IPG Photonics (Italy)
S.r.l. for $1,355,000 in cash and shares of the Company. In
2009, we purchased the 20% NCI in IPG Photonics (Japan) Ltd. for
$891,000 in cash and shares of the Company.
|
|
8.
|
RELATED-PARTY
TRANSACTIONS
|
Until July 2010, we subleased office space in the United Kingdom
from an entity controlled by our Chief Executive Officer and
reimbursed the entity for general and administrative expenses.
The costs related to the lease and services totaled $46,000,
$107,000 and $183,000 for 2010, 2009 and 2008, respectively.
During 2008, a director of one of our customers served on our
board of directors. Sales to this customer totaled $2,351,000 in
2008. The Companys director did not serve as a director of
the customer in 2009 or 2010.
We paid $182,000, $187,000 and $295,000 to the father of our
chief financial officer in 2010, 2009 and 2008, respectively.
The amounts included payments for consulting services,
commissions and reimbursement of expenses.
A member of our board of directors is affiliated with several
holders of our subordinated notes that were repaid in 2008.
These holders earned $320,000 of interest on such notes in 2008.
F-19
IPG
PHOTONICS CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
9.
|
NET
INCOME ATTRIBUTABLE TO IPG PHOTONICS CORPORATION PER
SHARE
|
The following table sets forth the computation of basic and
diluted net income attributable to IPG Photonics Corporation per
share (in thousands, except per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
Net income attributable to IPG Photonics Corporation
|
|
$
|
53,991
|
|
|
$
|
5,419
|
|
|
$
|
36,654
|
|
Weighted average shares
|
|
|
46,424
|
|
|
|
45,489
|
|
|
|
44,507
|
|
Dilutive effect of common stock equivalents
|
|
|
1,170
|
|
|
|
1,106
|
|
|
|
1,716
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted weighted average common shares
|
|
|
47,594
|
|
|
|
46,595
|
|
|
|
46,223
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic net income attributable to IPG Photonics Corporation per
share
|
|
$
|
1.16
|
|
|
$
|
0.12
|
|
|
$
|
0.82
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net income attributable to IPG Photonics Corporation per
share
|
|
$
|
1.13
|
|
|
$
|
0.12
|
|
|
$
|
0.79
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The computation of diluted weighted average common shares
excludes 35,000, 343,000 and 667,000 shares for the years
ended December 31, 2010, 2009 and 2008, respectively,
because the effect on net income attributable to IPG Photonics
Corporation per share would have been anti-dilutive.
|
|
10.
|
COMMITMENTS
AND CONTINGENCIES
|
Operating Leases We lease certain facilities
under cancelable and noncancelable operating lease agreements
which expire through January 2014. In addition, we lease capital
equipment under operating leases. Rent expense for the years
ended December 31, 2010, 2009 and 2008, totaled $713,000,
$794,000 and $791,000, respectively.
Commitments under the noncancelable lease agreements as of
December 31, 2010 are as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ending December 31
|
|
Facilities
|
|
|
Equipment
|
|
|
Total
|
|
|
2011
|
|
$
|
1,060
|
|
|
$
|
2,092
|
|
|
$
|
3,152
|
|
2012
|
|
|
354
|
|
|
|
1,484
|
|
|
|
1,838
|
|
2013
|
|
|
162
|
|
|
|
1,013
|
|
|
|
1,175
|
|
2014
|
|
|
122
|
|
|
|
450
|
|
|
|
572
|
|
2015
|
|
|
122
|
|
|
|
23
|
|
|
|
145
|
|
2016
|
|
|
122
|
|
|
|
23
|
|
|
|
145
|
|
Thereafter
|
|
|
911
|
|
|
|
41
|
|
|
|
952
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
2,853
|
|
|
$
|
5,126
|
|
|
$
|
7,979
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employment Agreements We have entered into
employment agreements with certain members of senior management.
The terms of these agreements are up to two years and include
noncompete and nondisclosure provisions, as well as providing
for defined severance for certain terminations of employment.
Contractual Obligations We have entered into
various purchase obligations that include agreements to purchase
raw materials and equipment. Obligations under these agreements
were $6,911,000 as of December 31, 2010.
In November 2006, the Company was sued for patent infringement
relating to certain products, including but not limited to fiber
lasers and fiber amplifiers. The plaintiff filed a complaint for
damages of over
F-20
IPG
PHOTONICS CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
$10 million, treble damages for alleged willful
infringement and injunctive relief. Discovery is complete and
pre-trial motions have been filed. The trial date has not been
scheduled. The Company believes it has meritorious defenses and
is vigorously contesting the claims. No loss was deemed probable
at December 31, 2010 and no amounts have been accrued in
respect of this contingency.
|
|
12.
|
EMPLOYEE
BENEFIT PLANS
|
We maintain a 401(k) retirement savings plan covering all of our
U.S. employees. We make matching contributions equal to 50%
of the employees contributions, subject to a maximum of 6%
of eligible compensation. Compensation expense related to our
contribution to the plan for the years ended December 31,
2010, 2009 and 2008, approximated $607,000, $463,000 and
$504,000, respectively.
We have offered an employee stock purchase plan covering our
U.S. and German employees. The plan allows employees who
participate to purchase shares of common stock through payroll
deductions at a 15% discount to the lower of the stock price on
the first day or the last day of the six-month purchase period.
Payroll deductions may not exceed 10% of the employees
compensation. Compensation expense related to the employee stock
purchase plan approximated $206,000, $205,000 and $67,000 for
the years ended December 31, 2010, 2009 and 2008,
respectively.
|
|
13.
|
BUSINESS
COMBINATIONS
|
In January 2010, we completed the acquisition of the outstanding
shares of privately-held, Birmingham, Alabama-based Photonics
Innovations, Inc., a maker of active and passive laser materials
and tunable lasers for scientific, biomedical, technological,
and eyesafe range-finding applications. The acquisition allows
us to expand our product offerings to the middle infrared
(approximately 2 to 5 micron). In April 2010, we completed the
acquisition of privately-held, Germany-based Cosytronic KG, a
specialist in the joining technology with an emphasis on
engineering know-how in automated welding turnkey solutions. The
acquisition allows us to extend our product offerings to include
a welding tool that integrates seamlessly with IPGs fiber
laser.
The total cash paid for these acquisitions in 2010 was
$4.5 million. The acquisitions also included seller
financing and contingent consideration which is more fully
discussed in the fair value disclosures in footnote 1. The
assets acquired were primarily intangible and included patents,
production know-how and customer relationships which are more
fully described in the intangible asset disclosures in footnote
1. The acquisitions did not have a material effect on the
financial results in 2010.
Income before the impact of income taxes for the years ended
December 31, consisted of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
U.S.
|
|
$
|
17,879
|
|
|
$
|
(2,844
|
)
|
|
$
|
11,257
|
|
Foreign
|
|
|
61,373
|
|
|
|
10,613
|
|
|
|
45,037
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
79,252
|
|
|
$
|
7,769
|
|
|
$
|
56,564
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-21
IPG
PHOTONICS CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Our provision for income taxes for the years ended
December 31, consisted of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
Current:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
$
|
(9,453
|
)
|
|
$
|
(98
|
)
|
|
$
|
(1,215
|
)
|
State
|
|
|
(19
|
)
|
|
|
|
|
|
|
|
|
Foreign
|
|
|
(16,467
|
)
|
|
|
(5,674
|
)
|
|
|
(14,451
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current
|
|
|
(25,939
|
)
|
|
|
(5,772
|
)
|
|
|
(15,666
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
|
989
|
|
|
|
1,448
|
|
|
|
(3,177
|
)
|
State
|
|
|
70
|
|
|
|
129
|
|
|
|
(308
|
)
|
Foreign
|
|
|
(20
|
)
|
|
|
1,918
|
|
|
|
731
|
|
Change in valuation allowance
|
|
|
|
|
|
|
(208
|
)
|
|
|
309
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total deferred
|
|
|
1,039
|
|
|
|
3,287
|
|
|
|
(2,445
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes
|
|
$
|
(24,900
|
)
|
|
$
|
(2,485
|
)
|
|
$
|
(18,111
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A reconciliation of income tax expense at the U.S. federal
statutory income tax rate to the recorded tax provision for the
years ended December 31, is as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
Tax at statutory rate
|
|
$
|
(27,738
|
)
|
|
$
|
(2,719
|
)
|
|
$
|
(19,797
|
)
|
Non-U.S.
rate differential net
|
|
|
5,867
|
|
|
|
598
|
|
|
|
2,261
|
|
State income taxes net
|
|
|
(625
|
)
|
|
|
(59
|
)
|
|
|
(308
|
)
|
Effect of changes in enacted tax rates on deferred tax assets
and liabilities
|
|
|
(186
|
)
|
|
|
196
|
|
|
|
(176
|
)
|
Nondeductible stock compensation expense
|
|
|
(312
|
)
|
|
|
(321
|
)
|
|
|
(234
|
)
|
Other nondeductible expenses
|
|
|
(603
|
)
|
|
|
(141
|
)
|
|
|
(214
|
)
|
Tax credits
|
|
|
1,104
|
|
|
|
737
|
|
|
|
1,183
|
|
Change in reserves, including interest and penalties
|
|
|
(1,501
|
)
|
|
|
(666
|
)
|
|
|
(934
|
)
|
Settlements, interest & penalties
|
|
|
(987
|
)
|
|
|
|
|
|
|
|
|
Change in valuation allowance
|
|
|
(106
|
)
|
|
|
(208
|
)
|
|
|
309
|
|
Other net
|
|
|
187
|
|
|
|
98
|
|
|
|
(201
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(24,900
|
)
|
|
$
|
(2,485
|
)
|
|
$
|
(18,111
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-22
IPG
PHOTONICS CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The tax effects of temporary differences that give rise to
significant portions of the deferred tax assets and deferred tax
liabilities at December 31, are as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
Property, plant, and equipment
|
|
$
|
1,075
|
|
|
$
|
480
|
|
Inventory provisions
|
|
|
7,294
|
|
|
|
5,498
|
|
Allowances and accrued liabilities
|
|
|
(1,830
|
)
|
|
|
1,920
|
|
Other tax credits
|
|
|
1,994
|
|
|
|
2,544
|
|
Deferred compensation
|
|
|
1,417
|
|
|
|
(582
|
)
|
Net operating loss carryforwards
|
|
|
56
|
|
|
|
274
|
|
Valuation allowance
|
|
|
(314
|
)
|
|
|
(208
|
)
|
|
|
|
|
|
|
|
|
|
Net deferred tax assets
|
|
$
|
9,692
|
|
|
$
|
9,926
|
|
|
|
|
|
|
|
|
|
|
In general, it is our practice and intention to reinvest the
earnings of
non-U.S. subsidiaries
in those operations. Accordingly, we have not made any provision
for additional U.S. or foreign withholding taxes in respect
to repatriation of earnings of non-US subsidiaries.
Deferred tax assets and liabilities shown above do not include
certain deferred tax assets from tax deductions related to
tax-deductible equity compensation in excess of equity
compensation recognized for financial reporting. As of
December 31, 2010, we have U.S. federal and state
credit carryforwards available for future periods of
approximately $333,000 and $2,438,000, respectively. The federal
and state credit carryforwards begin expiring in 2022 and 2011,
respectively.
The following is a tabular reconciliation of the total amounts
of unrecognized tax benefits (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
Unrecognized tax benefit January 1
|
|
$
|
2,131
|
|
|
$
|
1,672
|
|
|
$
|
867
|
|
Settlements of prior period positions
|
|
|
(1,336
|
)
|
|
|
|
|
|
|
|
|
Gross increases tax positions in prior period
|
|
|
|
|
|
|
459
|
|
|
|
773
|
|
Gross increases tax positions in current period
|
|
|
2,156
|
|
|
|
|
|
|
|
32
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrecognized tax benefit December 31
|
|
$
|
2,951
|
|
|
$
|
2,131
|
|
|
$
|
1,672
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated penalties and interest related to the underpayment of
income taxes are $4,000, $206,000 and $129,000 for the years
ended December 31, 2010, 2009 and 2008, respectively, and
are included within the provision for income taxes. Total
accrued penalties and interest related to the underpayment of
income taxes are $142,000 and $514,000 for the years ended
December 31, 2010 and 2009, respectively.
Our uncertain tax positions are related to tax years that remain
subject to examination by the relevant taxing authorities. If
realized, all of our uncertain tax positions would affect our
effective tax rate. None of the uncertain tax positions are
expected to settle within one year. Open tax years by major
jurisdictions are:
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
2002 2010
|
|
|
|
|
Germany
|
|
2009 2010
|
|
|
|
|
Russia
|
|
2009 2010
|
F-23
IPG
PHOTONICS CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
15.
|
GEOGRAPHIC
AND PRODUCT INFORMATION
|
We market and sell our products throughout the world through
both direct sales and distribution channels. The geographic
sources of our net sales, based on billing addresses of our
customers are as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
United States and other North America
|
|
$
|
61,706
|
|
|
$
|
45,668
|
|
|
$
|
52,018
|
|
Europe:
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany
|
|
|
46,282
|
|
|
|
28,242
|
|
|
|
44,771
|
|
Other including Eastern Europe/CIS
|
|
|
66,174
|
|
|
|
42,171
|
|
|
|
49,306
|
|
Asia and Australia:
|
|
|
|
|
|
|
|
|
|
|
|
|
Japan
|
|
|
35,878
|
|
|
|
29,937
|
|
|
|
41,310
|
|
China
|
|
|
57,762
|
|
|
|
20,942
|
|
|
|
14,781
|
|
Other
|
|
|
30,614
|
|
|
|
15,221
|
|
|
|
21,491
|
|
Rest of the World
|
|
|
840
|
|
|
|
3,713
|
|
|
|
5,399
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
299,256
|
|
|
$
|
185,894
|
|
|
$
|
229,076
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales are derived from products for different applications:
fiber lasers, diode lasers and diodes for materials processing,
fiber lasers and amplifiers for advanced applications, fiber
amplifiers for communications applications, and fiber lasers for
medical applications. Net sales for these product lines are as
follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
2008
|
|
|
Materials processing
|
|
$
|
252,014
|
|
|
$
|
140,864
|
|
|
$
|
187,720
|
|
Advanced applications
|
|
|
25,196
|
|
|
|
26,557
|
|
|
|
24,670
|
|
Communications
|
|
|
14,020
|
|
|
|
10,867
|
|
|
|
12,904
|
|
Medical
|
|
|
8,026
|
|
|
|
7,606
|
|
|
|
3,782
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
299,256
|
|
|
$
|
185,894
|
|
|
$
|
229,076
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No single customer comprised more than 10% of net sales during
the years ended December 31, 2010, 2009 or 2008.
The geographic locations of our long-lived assets, based on
physical location of the assets, as of December 31, 2010
and 2009, are as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2010
|
|
|
2009
|
|
|
United States
|
|
$
|
59,072
|
|
|
$
|
57,898
|
|
Germany
|
|
|
41,065
|
|
|
|
46,567
|
|
Russia
|
|
|
16,578
|
|
|
|
10,154
|
|
China
|
|
|
3,865
|
|
|
|
4,205
|
|
Other
|
|
|
4,723
|
|
|
|
1,512
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
125,303
|
|
|
$
|
120,336
|
|
|
|
|
|
|
|
|
|
|
F-24
IPG
PHOTONICS CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
16.
|
SELECTED
QUARTERLY FINANCIAL DATA
(UNAUDITED)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First
|
|
Second
|
|
Third
|
|
Fourth
|
2010
|
|
Quarter
|
|
Quarter
|
|
Quarter
|
|
Quarter
|
|
|
(In thousands, except per share data)
|
|
Net sales
|
|
$
|
51,204
|
|
|
$
|
67,258
|
|
|
$
|
79,809
|
|
|
$
|
100,985
|
|
Gross profit
|
|
|
20,547
|
|
|
|
30,461
|
|
|
|
39,931
|
|
|
|
55,519
|
|
Net income attributable to IPG Photonics Corporation
|
|
|
3,397
|
|
|
|
10,306
|
|
|
|
13,226
|
|
|
|
27,062
|
|
Basic earnings per share
|
|
|
0.07
|
|
|
|
0.22
|
|
|
|
0.28
|
|
|
|
0.58
|
|
Diluted earnings per share
|
|
|
0.07
|
|
|
|
0.22
|
|
|
|
0.28
|
|
|
|
0.56
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First
|
|
Second
|
|
Third
|
|
Fourth
|
2009
|
|
Quarter
|
|
Quarter
|
|
Quarter
|
|
Quarter
|
|
|
(In thousands, except per share data)
|
|
Net sales
|
|
$
|
45,408
|
|
|
$
|
40,385
|
|
|
$
|
45,808
|
|
|
$
|
54,293
|
|
Gross profit
|
|
|
15,861
|
|
|
|
11,772
|
|
|
|
16,723
|
|
|
|
19,912
|
|
Net income attributable to IPG Photonics Corporation
|
|
|
1,271
|
|
|
|
(1,229
|
)
|
|
|
2,255
|
|
|
|
3,122
|
|
Basic earnings per share
|
|
|
0.03
|
|
|
|
(0.03
|
)
|
|
|
0.05
|
|
|
|
0.07
|
|
Diluted earnings per share
|
|
|
0.03
|
|
|
|
(0.03
|
)
|
|
|
0.05
|
|
|
|
0.07
|
|
F-25
EXHIBIT
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
3
|
.1
|
|
Form of Second Amended and Restated Certificate of Incorporation
of the Registrant (incorporated by reference to Exhibit 3.2
to Registration Statement
No. 333-136521
filed with the Securities and Exchange Commission (the
Commission) on August 11, 2006)
|
|
3
|
.2
|
|
Form of Certificate of Amendment of Certificate of Incorporation
of the Registrant (incorporated by reference to Exhibit 3.4
to Registration Statement
No. 333-136521
filed with the Commission on November 24, 2006)
|
|
3
|
.3
|
|
Amended and Restated By-laws of the Registrant (incorporated by
reference to Exhibit 3.4 to Registration Statement
No. 333-136521
filed with the Commission on August 11, 2006)
|
|
4
|
.1
|
|
Specimen Stock Certificate (incorporated by reference to
Exhibit 4.1 to Registration Statement
No. 333-136521
filed with the Commission on November 14, 2006)
|
|
4
|
.2
|
|
Form of Indenture, to be entered into between the Company and
the trustee designated therein (incorporated by reference to
Exhibit 4.1 to the Registrants Current Report on
Form 8-K
filed with the Commission on December 2, 2009)
|
|
10
|
.1
|
|
2000 Incentive Compensation Plan (incorporated by reference to
Exhibit 10.2 to the Registrants Quarterly Report on
Form 10-Q
filed with the Commission on May 15, 2007)
|
|
10
|
.2
|
|
Amendment to Section 4.2 of 2000 Incentive Compensation
Plan (incorporated by reference to Exhibit 10.5 to the
Registrants Current Report on
Form 8-K
filed with the Commission on May 13, 2008)
|
|
10
|
.3
|
|
2006 Incentive Compensation Plan (incorporated by reference to
Exhibit 10.3 to the Registrants Quarterly Report on
Form 10-Q
filed with the Commission on May 15, 2007)
|
|
10
|
.4
|
|
Amendment to Section 4.2 of 2006 Incentive Compensation
Plan (incorporated by reference to Exhibit 10.6 to the
Registrants Current Report on
Form 8-K
filed with the Commission on May 13, 2008)
|
|
10
|
.5
|
|
Non-Employee Directors Stock Plan, as amended April 2, 2010
(incorporated by reference to Exhibit 10.1 to the
Registrants Current Report on
Form 8-K
filed with the Commission on June 8, 2010)
|
|
10
|
.6
|
|
IPG Photonics Non-Employee Director Compensation Plan, amended
February 23, 2011 (incorporated by reference to
Exhibit 10.1 to the Registrants Current Report on
Form 8-K
filed with the Commission on March 3, 2011)
|
|
10
|
.7
|
|
Senior Executive Short-Term Incentive Plan (incorporated by
reference to Exhibit 10.5 to Registration Statement
No. 333-136521
filed with the Commission on August 11, 2006)
|
|
10
|
.8
|
|
2008 Employee Stock Purchase Plan (incorporated by reference to
Exhibit 10.8 to the Registrants Current Report on
Form 8-K
filed with the Commission on May 13, 2008)
|
|
10
|
.9
|
|
Amendment to 2008 Employee Stock Purchase Plan (incorporated by
reference to Exhibit 10.1 to the Registrants Current
Report on
Form 8-K
filed with the Commission on June 15, 2009)
|
|
10
|
.10
|
|
Employment Agreement by and between the Registrant and Valentin
P. Gapontsev, dated May 9, 2008 (incorporated by reference
to Exhibit 10.1 to the Registrants Current Report on
Form 8-K
filed with the Commission on May 13, 2008)
|
|
10
|
.11
|
|
First Amendment to Employment Agreement dated September 16,
2010, between the Registrant and Valentin Gapontsev
(incorporated by reference to Exhibit 10.2 to the
Registrants Current Report on
Form 8-K
filed with the Commission on August 5, 2010)
|
|
10
|
.12
|
|
Service Agreement by and between the Registrant and Eugene
Shcherbakov, dated May 9, 2008 (incorporated by reference
to Exhibit 10.2 to the Registrants Current Report on
Form 8-K
filed with the Commission on May 13, 2008)
|
|
10
|
.13
|
|
Form of Employment Agreement dated May 9, 2008, between the
Registrant and each of Timothy P.V. Mammen, Angelo P. Lopresti,
George H. BuAbbud, William S. Shiner and Alexander Ovtchinnikov
(incorporated by reference to Exhibit 10.3 to the
Registrants Current Report on
Form 8-K
filed with the Commission on May 13, 2008)
|
|
10
|
.14
|
|
Form of Amendment to Employment Agreement dated
December 21, 2009, between the Registrant and each of
Eugene Shcherbakov, Timothy P.V. Mammen, Angelo P. Lopresti,
George H. BuAbbud, William S. Shiner and Alexander Ovtchinnikov
(incorporated by reference to Exhibit 10.1 to the
Registrants Current Report on
Form 8-K
filed with the Commission on December 21, 2009)
|
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
10
|
.15
|
|
Form of Second Amendment to Employment Agreement dated
September 16, 2010, between the Registrant and each of
Eugene Shcherbakov, Timothy P.V. Mammen, Angelo P. Lopresti,
George H. BuAbbud, William S. Shiner and Alexander Ovtchinnikov
dated as of August 5, 2010 (incorporated by reference to
Exhibit 10.1 to the Registrants Current Report on
Form 8-K
filed with the Commission on September 16, 2010)
|
|
10
|
.16
|
|
Form of Confidentiality, Non-Competition and Confirmatory
Assignment Agreement between the Registrant and each of the
named executive officers and certain other executive officers.
(incorporated by reference to Exhibit 10.4 to the
Registrants Current Report on
Form 8-K
filed with the Commission on May 13, 2008)
|
|
10
|
.17
|
|
Form of Indemnification Agreement between the Registrant and
each of its Directors and Executive Officers (incorporated by
reference to Exhibit 10.13 to Registration Statement
No. 333-136521
filed with the Commission on August 11, 2006)
|
|
10
|
.18
|
|
Form of Stock Option Agreement under the 2000 Incentive
Compensation Plan (incorporated by reference to
Exhibit 10.5 to the Registrants Quarterly Report on
Form 10-Q
filed with the Commission on May 15, 2007)
|
|
10
|
.19
|
|
Form of Stock Option Agreement under the 2006 Incentive
Compensation Plan (incorporated by reference to
Exhibit 10.6 to the Registrants Quarterly Report on
Form 10-Q
filed with the Commission on May 15, 2007)
|
|
10
|
.20
|
|
Form of Stock Option Agreement under the 2006 Non-Employee
Directors Stock Plan (incorporated by reference to
Exhibit 10.7 to the Registrants Quarterly Report on
Form 10-Q
filed with the Commission on May 15, 2007)
|
|
10
|
.21
|
|
Loan Agreement between the Registrant and Bank of America, N.A.
dated as of June 4, 2008 (incorporated by reference to
Exhibit 10.1 to the Registrants Current Report on
Form 8-K
filed with the Commission on June 9, 2008)
|
|
10
|
.22
|
|
Revolving Credit Note by the Registrant dated June 4, 2008
(incorporated by reference to Exhibit 10.2 to the
Registrants Current Report on
Form 8-K
filed with the Commission on June 9, 2008)
|
|
10
|
.23
|
|
Term Note by the Registrant dated June 4, 2008
(incorporated by reference to Exhibit 10.3 to the
Registrants Current Report on
Form 8-K
filed with the Commission on June 9, 2008)
|
|
10
|
.24
|
|
Mortgage and Security Agreement between Registrant and Bank of
America, N.A. dated as of June 4, 2008 (incorporated by
reference to Exhibit 10.4 to the Registrants Current
Report on
Form 8-K
filed with the Commission on June 9, 2008)
|
|
10
|
.25
|
|
Second Amendment to Loan Agreement, between the Registrant and
Bank of America, N.A., dated as of September 30, 2010
(incorporated by reference to Exhibit 10.1 to the
Registrants Quarterly Report on
Form 10-Q
filed with the Commission on November 9, 2010)
|
|
10
|
.26
|
|
Revolving Credit Note Modification Agreement No. 1, between
the Registrant and Bank of America, N.A., dated as of
September 30, 2010 (incorporated by reference to
Exhibit 10.2 to the Registrants Quarterly Report on
Form 10-Q
filed with the Commission on November 9, 2010)
|
|
10
|
.27
|
|
Term Note Modification Agreement No. 1, between the
Registrant and Bank of America, N.A., dated as of
September 30, 2010 (incorporated by reference to
Exhibit 10.3 to the Registrants Quarterly Report on
Form 10-Q
filed with the Commission on November 9, 2010)
|
|
10
|
.28
|
|
Credit Facility Agreement between IPG Laser GmbH and Deutsche
Bank AG dated June 28, 2010
|
|
10
|
.29
|
|
Guarantee of the Registrant dated October 10, 2007
(incorporated by reference to Exhibit 10.2 to the
Registrants Quarterly Report on
Form 10-Q
filed with the Commission on November 8, 2007)
|
|
10
|
.30
|
|
Annex 1 dated March 5, 2009, to Guaranty of the
Registrant dated October 10, 2007 (incorporated by
reference to Exhibit 10.28 to the Registrants Annual
Report on
Form 10-K
filed with the Commission on March 11, 2009)
|
|
10
|
.31
|
|
Agreement and Plan of Reorganization among the Registrant, IPG
Laser GmbH, Valentin P. Gapontsev and Igor Samartsev, dated as
of August 5, 2008 (incorporated by reference to
Exhibit 10.1 to the Registrants Quarterly Report on
Form 10-Q
filed with the Commission on August 11, 2008)
|
|
10
|
.32
|
|
Investment Agreement by and among the Registrant, The Russian
Corporation of Nanotechnologies, IPG Laser GmbH and NTO
IRE-Polus, dated October 29, 2010 (incorporated by
reference to Exhibit 10.1 to the Registrants Current
Report on
Form 8-K
filed with the Commission on November 4, 2010)
|
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description
|
|
|
10
|
.33
|
|
Form of Put and Call Option Agreement between the Registrant and
The Russian Corporation of Nanotechnologies (incorporated by
reference to Exhibit 10.2 to the Registrants Current
Report on
Form 8-K
filed with the Commission on November 4, 2010)
|
|
12
|
.1
|
|
Statement re Computation of Earnings to Fixed Charges
|
|
21
|
.1
|
|
List of Subsidiaries
|
|
23
|
.1
|
|
Consent of Deloitte & Touche LLP
|
|
31
|
.1
|
|
Certification of Chief Executive Officer pursuant to
Rule 13a-14(a)
|
|
31
|
.2
|
|
Certification of Chief Financial Officer pursuant to
Rule 13a-14(a)
|
|
32
|
.1
|
|
Certification of Chief Executive Officer and Chief Financial
Officer pursuant to Section 1350
|